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Abstract 
Campylobacter JeJum IS the leading cause of foodborne gastroenteritis 
worldwide, yet despite the organism's prevalence, relatively little is known about 
the mechanisms of pathogenesis. This is mainly due to the lack of a convenient 
small animal model of infection combined with certain inherent weaknesses with 
widely used in vitro models. The aim was to develop two improved models to 
study C. jejuni interactions with intestinal epithelial cells. The Ex Vivo Organ 
Culture (EVOC) model involves co-culturing C. jejuni with human intestinal 
biopsies. C. jejuni 11168H and 81-176 wild-type strains were demonstrated to 
induce the secretion of human beta-defensins 2 and 3 (hBD-2 and hBD-3). 
Furthermore, the supernatants of infected biopsies were demonstrated to contain 
significantly higher levels of IL-l~, IL-6, IL-12 and IL-23 compared to 
uninfected controls. Experiments using 11168H flaA and neuBl mutants 
demonstrated that the induced defensin response was not due to host recognition 
of either flagellin or the terminal sialic acid residue of C. jejuni illS. The 
Vertical Diffusion Chamber (VDC) model involves co-culturing C. jejuni with 
polarised human intestinal epithelial cells (lECs) with micro aerobic conditions at 
the apical surface and aerobic conditions at the basolateral surface. Survival and 
integrity of the IECs under these conditions over 24 hours was demonstrated. Co-
culture experiments under these conditions resulted in an increase in both C. 
jejuni interaction with and invasion of IECs. This was mirrored by an increased, 
polarised host innate immune response. Transcriptional analysis of aerobically 
and microaerobically co-cultured C. jejuni 11168H identified several genes that 
may playa role in these increased interactions. The levels of interaction and 
invasion of defined C. jejuni 11168H mutants with Caco-2 cells were analysed to 
identify bacterial factors that contribute to these increased interactions. Both 
11168HflaA and rpoN mutants exhibited lower levels of interaction and invasion 
than the wild-type strain, suggesting the involvement of bacterial motility in the 
increased interactions under micro aerobic conditions. The reduction in this 
increased interaction phenotype was more pronounced at shorter co-incubation 
times, suggesting that motility is particularly important during the early phases of 
interaction. The development of these two model systems should allow· future 
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experiments to more accurately investigate host-pathogen interactions during C. 
jejuni infection of the human intestinal tract. 
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1 Introduction 
1.1 Campylobacter jejuni 
1.1.1 Background 
The earliest report of an organism that most likely belonged to the genus 
Campylobacter dates back to the early 20th century when John McFadyean and 
his associate Stewart Stockman were working on a government project 
investigating epizoonotic abortion in cattle and sheep (McFadyean, 1913, 
Skirrow, 2006). They reported "large numbers of peculiar organisms" that were 
"comma shaped" and classified them as Vibrios due to the morphology. In fact, 
they had most probably isolated C. fetus. In 1963, Sebald and Veron reclassified 
the organism into the new genus Campylobacter (campylo: Greek: crooked, 
bent). However, it took another 14 years until campylobacters were accepted as a 
causative agent of gastroenteritis in humans (Skirrow, 1977). 
Despite the early discovery of campylobacters, the importance of the genus as a 
human intestinal pathogen remained unappreciated for a relatively long time. 
One reason for this may be that C. fetus, the species isolated by McFadyean and 
Stockman, is not a major human pathogen. Furthermore, isolation and in vitro 
culturing of Campylobacter is much more difficult than the culturing of other 
intestinal pathogens such as pathogenic Escherichia coli or Salmonella species. It 
was not until 1973, when techniques used to isolate Campylobacter species from 
ovine and bovine genital tracts were applied to a faecal sample from a young 
woman with acute diarrhoea, that the first successful isolation of the organism 
from a patient with gastroenteritis was reported (Butzler et al., 1973). Further 
advances in culturing techniques (Bolton et al., 1984, Karmali et al., 1986) and 
rising awareness of the organism quickly lead to the finding that Campylobacter 
species were indeed important causative agents of gastroenteritis (Skirrow, 
1977). 
Since then, advances have been made in understanding the molecular basis of 
Campylobacter pathogenicity (Young et al., 2007). However, the level of 
knowledge still lags behind that of other important enteric pathogens. This is 
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mainly due to the lack of suitable in vitro and in vivo models to study the 
organism. In light of the importance of the organism, developing a thorough, 
reproducible model of infection is essential to fully unravel the pathobiology of 
this important human pathogen. 
1.1.2 Biology 
Campylobaeter jejuni is a member of the epsilon class of proteobacteria and 
belongs to the order of Campylobaeteriales. This order also includes the genera 
Wolinella and Helieobaeter. The genus Campylobaeter contains several species, 
of which C. jejuni and C. eoli are most commonly associated with human 
disease. In contrast, the first identified organisms from this genus, 
Campylobaeter fetus spp. fetus and Campylobaeter fetus spp. venerealis are 
implicated in disease in animals (Crushell et aI., 2004, Hoffer, 1981). 
Campylobacters are Gram-negative, flagellated bacteria and can be 
microscopically distinguished from other bacteria by their "spiral morphology 
and extremely rapid darting and spinning motions" (Butzler, 2004). The natural 
niche of C. jejuni is the intestinal tract of avian species, which can be colonised 
to exceptionally high numbers, with up to 1010 colony forming units (CFU) per 
gram of cecal contents having been found in chickens (Jacobs-Reitsma, 1995). 
The question of whether C. jejuni is an avian pathogen or a commensal has not 
been fully explored. There are several reports demonstrating an inflammatory 
response generated by cells of avian origin after Campylobaeter challenge, both 
in vivo and in vitro (Borrmann et aI., 2007, Knudsen et al., 2006, Smith et al., 
2008, Smith et al., 2005, Byrne et al., 2007). However, chickens colonised with 
C. jejuni have not been shown to develop symptoms analogous to those observed 
in humans. 
1.1.3 Transmission 
Several pathways of C. jejuni transmission have been identified to date. As the 
natural niche of the organism is the intestinal tract of birds and most commercial 
chicken flocks are colonised by C. jejuni (Blaser et al., 1983b), handling and 
consumption of raw or undercooked (contaminated) chicken meat is tho~ght to 
be the main source of C. jejuni infections in humans (Skirrow, 1991). Direct 
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transmission from animals has also been reported, with animal/carcass handlers 
such as farmers, butchers and veterinarians more prone to infection than people 
not in close contact with animals (Blaser et al., 1983b). Other possible means of 
transmission such as consumption of unpasteurised milk (Blaser et al., 1983b), 
contaminated river water (Schonberg-No rio et al., 2004), contaminated drinking 
water (Vogt et al., 1982) and even transmission by flies (Ekdahl et aI., 2005) 
have been proposed. 
1.1.4 Epidemiology 
Interestingly, the incidence of Campylobaeter-related disease has increased 
during the last decade of the 20th century (Nachamkin, 2008). This is probably 
due in part to the implementation of better diagnostic methods and detection and 
may not directly reflect a real trend. However, the often self-limiting nature of 
the infection must also be considered, as this leads to many cases not being 
reported. Depending on the country, the true incidence is considered to be 8 to 30 
times higher than the number of reported cases (Wheeler et al., 1999, Samuel et 
aI., 2004). Intriguingly, Campylobaeter epidemiology and incidence differ 
markedly between the developing and the developed world. In the developed 
world, reported numbers of Campylobaeter-related disease range from zero to 
396 cases per 100,000 people (Janssen et al., 2008). People of all ages can be 
affected, although one peak occurs in young children and a second occurs in 
young adults (Nachamkin, 2008). Some data suggests that not only the incidence 
of Campylobaeter infection, but also the prevalence of certain strains as 
causative agents, depend on age. It has been reported that older patients are 
generally infected with rarer serotypes than young patients (Miller et al., 2005). 
This suggests that a basal level of immunity develops during life, but is not 
protective against all serotypes. In addition to an infection pattern changing with 
the age of the patient, Campylobaeter infections in the developed world also 
show a seasonal pattern, with higher numbers appearing during the warmer 
months of the year (Altekruse et al., 1999). This was originally attributed to 
different human behaviour in the summer months, such as having more 
barbeques and hence being SUbjected to a higher risk of cross-contamination 
(Kapperud et al., 1992b). Recently, other factors such as the higher temp~rature 
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directly aiding the survival of the bacteria in the environment have also been 
implicated in causing the seasonal fluctuation (Louis et al., 2005). In the 
developing world, Campylolobaeter related disease is mainly hyperendemic and 
usually associated with unhygienic conditions as well as close contact to animals 
(Rao et al., 2001). Cases of enteritis peak in infants and young children and then 
decline rapidly. Case-control studies have suggested incidences of 40,000 to 
60,000 cases per 100,000 children of less than 5 years of age. Additionally, 
asymptomatic carriage is more common in the developing world (Blaser et al., 
1985). This again suggests that infection leads to at least partial immune 
protection; if not against colonisation, then at least against disease. Whether this 
is due to a decreased interaction between the bacteria and the host cells or other 
factors is unknown. There is recent intriguing evidence from Vietnam suggesting 
that when living standards improve in a country, the presentation of C. jejuni 
related disease also changes (Dr Stephen Baker, Oxford University Clinical 
Research Unit, personal communication). This is in agreement with the 
differences observed between C. jejuni infections in the developing compared to 
the developed world. 
1.1.5 Human disease 
Human infection with Campylobaeter occurs by the oral route. The first hurdle 
the bacteria have to overcome is the acidic environment of the stomach. 
Depending on the ingested dose and the buffering capacity of the food, most 
bacteria will be killed by the harsh acidic stomach environment. Survival of even 
a few organisms, however, has been shown to be sufficient to cause disease. The 
infectivity of Campylobaeter is amongst the highest observed in intestinal 
pathogens, with infectious doses as low as 500 to 800 organisms sufficing to 
cause disease (Black et al., 1988, Robinson, 1981). A probability for each 
individual CPU ingested to cause disease has been calculated at around 2% 
(Black et ai., 1988). Once the bacteria have passed through the stomach, the 
organisms establish themselves within the intestine resulting in infection, 
although asymptomatic carriage may also occur (Cawthraw et ai., 2000). In most 
immunocompetent people, infection is restricted to the intestinal tract, although 
systemic bacteraemia has been observed, ranging from 1.5 to 8 cases per 100,000 
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(Kapperud et ai., 1992a, Skirrow et aI., 1993). Intestinal disease commonly 
manifests itself as acute gastroenteritis after an incubation period of 1 to 7 days, 
which is longer than most other intestinal pathogens (AlIos, 2001). The 
colonisation usually starts in the small bowel and subsequently moves to the 
colon and the rectum (Black et ai., 1988). The symptoms first encountered are 
mostly abdominal pain and cramping, often accompanied by fever, vomiting and 
headaches (AlIos, 2001). This can make it difficult to distinguish early 
campylobacteriosis from influenza-like infections or even acute appendicitis 
(Blakelock et ai., 2003). Diarrhoea will start in parallel or slightly later than the 
above symptoms and can range from mild and watery to severe and bloody 
(Havelaar et ai., 2000, Blaser, 1997, Nachamkin, 2008). These differences in 
disease presentation have been attributed to both the infecting strain of 
Campyiobacter as well as host factors (Black et ai., 1988). In an 
immunocompetent individual, the symptoms will usually subside within 3 to 7 
days, although the bacteria may still be found in the faeces for several weeks 
(Kapperud et ai., 1992a). The disease is usually self-limiting, but can be treated 
with antimicrobials such as erythromycin or fluoroquinolones, if necessary 
(Anders et ai., 1982, Nachamkin, 2008). 
1.1.6 Post-infectious sequelae 
One important feature of Campyiobacter infections is the possibility of 
developing post-infectious complications. These sequelae can be grouped into 
intestinal and non-intestinal manifestations. 
1.1.6.1 Intestinal sequelae 
Recent evidence suggests that Campyiobacter infection may be linked to irritable 
bowel syndrome (IBS) (Smith et ai., 2007, Spiller et ai., 2000). IBS is 
characterised by abdominal pain associated with altered bowel habit after 
bacterial enteritis (Spiller, 2007). Inflammatory bowel diseases (IBDs) such as 
Crohn's disease have also been implicated to be linked with C. jejuni infection. 
(Berberian et ai., 1994, Weber et ai., 1992). 
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1.1.6.2 Extraintestinal sequelae 
Although C. jejuni infection mainly leads to gastroenteric disease, the organism 
has also been linked to extra-intestinal sequelae. The most serious of these is 
Guillain-Barre syndrome (GBS), an autoimmune disease of the peripheral 
nervous system (Ang et al., 2001, van Doom et al., 2008). Approximately 1 to 2 
per 1000 people infected with C. jejuni go on to develop GBS (Mishu et aI., 
1993). The disease is caused by molecular mimicry, as certain strains of C. jejuni 
possess lipo-oligosaccharide (LOS) structures that mimic glycans found on 
myelin sheaths in the peripheral nervous system (PNS). Infection with these 
strains leads to the development of auto-reactive antibodies, resulting in cross-
reaction with and subsequent demyelisation of peripheral nerve cells (Yuki et aI., 
2005). Mortality rates due to GBS in the developed world are around 2%, but 
most patients fully recover within 6-12 months (Nachamkin, 2008). Miller-Fisher 
syndrome, a sub-variant of GBS affecting mainly the nerves controlling eye 
movement, has also been implicated with C. jejuni infection (Yuki et al., 1995). 
Reactive arthritis is another sequela associated with C. jejuni infection, although 
much less is known about this condition than about GBS. The incidence of 
reactive arthritis is believed to be around 4.3 per 100,000 individuals infected 
with C. jejuni. Small joints and knees are mostly affected, and a full recovery is 
usually made (pope et al., 2007). Even rarer, a few reports have implicated C. 
jejuni as a causative agent of haemolytic-uremic syndrome (Delans et aI., 1984), 
but this connection is still unclear and based only on a few studies. One common 
finding is that not all strains of C. jejuni cause the same symptoms and/or 
sequelae, and that even within the same strain there are differences, suggesting 
that host factors also playa part in determining the outcome of an infection. 
1.2 Molecular basis of pathogenesis 
The completion of the first genome sequence of C. jejuni, strain NCTC11168 in 
2000 (Parkhill et aI., 2000), followed by that of other strains such as the highly 
virulent 81-176 (Hofreuter et al., 2006) and RM1221 (Fouts et aI., 2005) greatly 
facilitated the search for molecular virulence determinants of C. jejuni. 
Availability of these genome sequences meant that genomic tools such as 
microarrays, transposon mutagenesis, targeted insertional mutagenesis, 
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proteomics and expression of recombinant proteins such as Green Fluorescent 
Protein (GFP) could now be utilised with this organism (Dorrell et al., 2001, 
Hendrixson et al., 2001, Kadyshev et al., 200Sb). It soon became clear, however, 
that the search would be hampered by several factors. Firstly, analysis of the 
sequences of C. jejuni genes revealed limited homology to those of other well 
studied enteric pathogens such as Salmonella species, pathogenic E. eoli species 
or Shigella species, limiting the possibilities of homology-based studies. 
Secondly, even within the C. jejuni species, there is variation between the strains 
with regard to the presence of many genes (Dorrell et al., 2001). Many of these 
differences are located within gene clusters that code for the biosynthesis and 
modification of surface structures such as the LOS, the capsular polysaccharide 
(CPS) or the flagellum, whereas genes involved in metabolism and regulation 
were more conserved between different strains. Interestingly, many genes 
displaying variability between strains are also those that have been shown to 
contain hypervariable sequences consisting of homopolymeric tracts (Parkhill et 
al., 2000). This leads to differential expression of these genes as a result of phase 
variation, which in tum can lead to changes in phenotypic features such as 
ganglioside mimicry, motility or invasion (Linton et al., 2000a, Gilbert et al., 
2002, Guerry et al., 2006, Guerry et al., 2002, Karlyshev et al., 2002). 
Significant advances have been made in the last decade to solve the molecular 
and biochemical properties of C. jejuni pathogenesis; however the molecular 
basis for inducing diarrhoeal disease remains elusive. The following section will 
give an overview of the current knowledge of C. jejuni virulence factors. 
1.2.1 Adhesion and invasion to host epithelial cells 
It has long been acknowledged that entry into host cells is a way for pathogenic 
bacteria to evade the host's immune system and access a niche which the 
pathogen does not have to share with other organisms and that is potentially full 
of nutrients and other essential compounds. Colonic biopsies from patients with 
colitis and stool cultures positive for Campylobaeter jejuni were shown to 
contain bacteria associated with the mucous layer on the surface of the 
epithelium as well as within the intestinal epithelial cells (IECs), suggesting that 
adherence and invasion of host IECs is one hallmark of Campylobaeter infection 
19 
(van Spreeuwel et al., 1985). These in vivo findings were followed by the 
discovery that C. jejuni isolates would adhere to and invade various epithelial 
cell lines in vitro (Konkel et al., 1989, Szymanski et al., 1995, Everest et al., 
1992). Multiple factors involved in bacterial adhesion and invasion have since 
been identified, both on the bacterial side as well as on the host side. 
Several C. jejuni proteins have been termed adhesins, as their mutagenesis has 
led to a decrease in or loss of bacterial adhesion in in vitro tissue culture models. 
These proteins are usually surface associated and include the fibronectin binding 
protein CadF (Monteville et al., 2003), Peb1a (Pei et al., 1998), Peb3 
(Rangarajan et al., 2007), Peb4 (Asakura et al., 2007) the surface lipoprotein 
JlpA (Jin et al., 2001), the major outer membrane protein MomP (Moser et al., 
1997) and FlpA (Flanagan et al., 2009). Apart from these adhesins, several other 
cellular structures and properties of C. jejuni have been implicated in adherence 
to and invasion of the epithelium such as surface charges and hydrophobicity 
(Walan et al., 1988), the flagellum (see section 1.2.2), protein N- linked-
glycosylation (see section 1.2.3.3), the secreted protein FlaC (Song et al., 2004), 
the HtrA protease (Brondsted et al., 2005), flagellin glycosylation (see section 
1.2.3.4), the autotransporter CapA (Ashgar et al., 2007), the CPS (see section 
1.2.3.1), the global post-translational regulator CsrA (Fields et al., 2008) and 
LOS (see section 1.2.3.2) However, the exact roles of most of these structures 
and proteins in bacterial adhesion and invasion remain poorly defined. 
Most invasive bacteria manipulate the host cytoskeleton in one way or another 
during and after invasion, either by receptor ligand binding on the cell surface or 
by direct introduction of bacterial effector proteins into the host cytosol through 
specific secretion systems (for a review see (Pizarro-Cerda et al., 2006). Some 
organisms such as Shigella dysenteriae will interfere with microtubule 
polymerisation/depolymerisation, while others such as Salmonella species will 
manipulate the actin filament assembly to gain entry into the host cells or localise 
themselves within a certain area of the host cell when internalised. In the case of 
C. jejuni, several studies have been conducted to analyse the pathway(s) used by 
the pathogen. An early study demonstrated that the chemical inhibition of actin 
filament formation by cytochalasin inhibited C. jejuni internalisation by IECs in 
a dose-dependent fashion (Konkel et al., 1992). This suggested that' actin 
filaments played an important role in the pathogen's internalisation into host 
20 
cells. The authors also commented that colchicine, an inhibitor of microtubule 
polymerisation, demonstrated dose-independent inhibitory effects on C. jejuni 
internalisation. An article published one year later, on the other hand, 
demonstrated that actin filament inhibitors showed only minimal effect on C. 
jejuni internalisation, whereas inhibitors of microtubule polymerisation had 
strong inhibitory effects on C. jejuni internalisation (Oelschlaeger et al., 1993). 
Intriguingly, over the following years, two dogmas appear to have evolved, being 
carried by two of the authors of the initial reports. Konkel and colleagues 
pursued the actin filament path (Monteville et al., 2003), while Kopecko and 
colleagues carried out further experiments to demonstrate the involvement of 
microtubules (Hu et al., 1999, Kopecko et al., 2001). Furthermore, another report 
suggested that inhibition of both actin filaments and micro tubules led to a 
decrease of internalised C. jejuni (Biswas et al., 2003, Biswas et al., 2000). 
Whether these discrepancies between the experimental results reflect differences 
between the bacterial strains or the cell lines used or stem from different 
experimental procedures and beliefs is unclear. To date, no clear mechanism of 
C. jejuni cytoskeletal manipulation has been reported, and the means by which 
the bacteria trigger their uptake remain to be elucidated. 
Once internalised, pathogenic bacteria have evolved numerous ways to avoid 
being degraded by the host defences. Some bacteria, such as Shigella species, 
remain inside a membrane-bound compartment but inhibit the host from 
degrading them. Others, such as Listeria species, escape from the compartment, 
replicate freely in the host cytoplasm, and from there invade neighbouring cells. 
In the case' of C. jejuni, the intracellular fate of the bacteria is still relatively 
unclear. Recent evidence suggests that the organism survives within IECs inside 
Campylobaeter containing vacuoles (CCV) and thereby avoids delivery to 
lysosomes (Watson et al., 2008). These vacuoles have been postulated to localise 
in proximity to the Golgi apparatus. However, the exact role of the CCV in 
Campylobaeter pathogenesis remains to be elucidated. 
1.2.2 Flagellum 
C. jejuni cells possess one or two polar, unsheathed flagella. The flagellum of C. 
jejuni has long been implicated in pathogenesis, as a mutant lacking the main 
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flagellar structural protein FlaA showed lower rates of invasion of IECs 
(Wassenaar et aI., 1991). This was initially believed to be the result of a lack of 
motility. Recent evidence, however, suggests that the flagella of C. jejuni do not 
exclusively have a role in bacterial motility, but also in the secretion of a set of 
proteins, termed the Campylobacter invasion ~ntigens (Cia). These proteins were 
initially believed to be secreted by a type three secretion system (TTSS) due to 
amino acid sequence similarity with TTSS effector proteins (Konkel et al., 
1999a). However, the sequencing of the first C. jejuni strain NCTC11168 in 
2000 revealed the absence of genes coding for a TTSS, suggesting that these 
proteins were secreted by a novel mechanism. As a result of this finding, the 
flagellum has been proposed as the system for secretion of the Cia proteins, as a 
functional flagellar apparatus is necessary for protein secretion to occur (Konkel 
et al., 2004). Secretion of these proteins has been shown to be inducible in vitro 
by components of bile, most notably by the bile salt sodium deoxycholate 
(Malik-Kale et al., 2008). Recently, a genetic screen revealed an N-terminal 
secretion sequence, which targets both flagellar and non-flagellar proteins to be 
secreted via the flagellum (Christensen et al., 2009). The same screen revealed a 
novel protein of the Cia family termed CiaC which is involved in maximal 
invasion of host cells. However, the exact molecular mechanisms of action of 
these secreted virulence proteins remain to be elucidated. C. jejuni flagella have 
also been shown to be post-translationally modified by O-linked glycans (see 
section 1.2.3.4). Recent evidence using primary human intestinal tissue explants 
suggests that the flagella are involved in adhesion to the tissue epithelium as well 
as in bacteria-bacteria microcolony formation on the tissue (Haddock et al., 
2010). Once again, however, there is no consensus within the Campylobacter 
research community about the role of the flagellum and the Cia proteins during 
host-pathogen interactions. A recent article sheds doubt on the involvement of 
CiaB in host cell invasion by reporting the construction of a ciaB mutant in 
another C. jejuni strain (81-176) and demonstrating no difference in host cell 
invasion compared to the parental wild-type. (Novik et al., 2010). The authors 
postulate that possible polar effects resulting in reduced motility led to the 
original findings and not a direct involvement of CiaB. Taken together, the exact 
role of C. jejuni flagella in secretion of effector proteins and host cell interaCtions 
remains to be fully elucidated. 
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1.2.3 Glycan structures 
Sequencing of the first C. jejuni strain in 2000 revealed the presence of three 
major loci potentially involved in carbohydrate synthesis and transfer (Parkhill et 
al., 2000). These include a CPS, a LOS moiety, as well as a system for post-
translational modification of flagellar proteins. At about the same time, 
independent studies led to the identification of a fourth locus, demonstrated to be 
part of a protein N-glycosylation machinery (Szymanski et al., 1999). Since then 
substantial analysis of all the four loci has been performed and all four have been 
confirmed functionally. 
1.2.3.1 Capsular polysaccharide 
CPSs are common in both Gram-positive and Gram-negative bacteria. CPS have 
been implicated in a variety of processes such as the prevention of desiccation, 
adherence of bacteria to each other and to other surfaces and resistance to 
complement (Roberts, 1996). As the CPS constitutes one of the outermost layers 
of the bacterial cell, this is also one of the first structures to come in contact with 
any host and has thus also been implicated in host recognition of pathogens. 
Until about 10 years ago, a high molecular weight polysaccharide detected on 
exopolysaccharide preparations of C. jejuni was believed to be the O-antigen 
repeat of a lipopolysaccharide (LPS). Analysis of the genome sequence, 
however, demonstrated the presence of two groups of genes containing kps 
orthologues flanking genes coding for proteins involved in sugar biosynthesis. 
The kps gene products are involved in CPS synthesis, transport and assembly and 
have been widely studied in E. coli (Silver et al., 2001). Further functional 
studies provided evidence that these sugars were in fact a highly variable CPS 
(Karlyshev et al., 2000). The sugar moieties were lost in bacteria with mutations 
in the kpsM, kpsS and kpsC genes; all three genes are orthologues of CPS export 
proteins in E. coli. Furthermore, the bacterial serodeterminant utilised in the 
standard serotyping procedure for C. jejuni, the Penner serotyping of heat stable 
antigens (Moran et al., 1999), was shown to be the CPS (Karlyshev et al., 2000). 
The presence of the CPS was also demonstrated by electron microscopy 
(Karlyshev et al., 2001). Since its discovery, the C. jejuni CPS has been shown to 
be involved in virulence (Bacon et al., 2001) and to be highly variable and 
23 
structurally diverse between serotypes (Karlyshev et al., 2005 a). Interestingly, 
one study suggests that the CPS is not involved in modulating an innate immune 
response nor in the resistance of C. jejuni against antimicrobial peptides 
(Zilbauer et al., 2005). Another study demonstrated down-regulation of C. jejuni 
CPS in the presence of IECs (Corcionivoschi et al., 2009). Recent work 
demonstrated the use of a CPS-conjugate vaccine as a protective compound 
against diarrhoeal disease in the new world monkey Aotus nancymaae (Monteiro 
et al., 2009). 
1.2.3.2 Lipo-oligosaccbaride 
LPS or illS decorate the outer membrane of many Gram-negative bacterial 
species. LPS consists of a lipid A moiety which anchors the LPS in the outer 
leaflet of the outer membrane, a core oligosaccharide usually containing one Kdo 
residue (3-Deoxy-D-manno-Octulosonic acid), and an a-antigen repeat 
consisting of polymerised oligosaccharides. The lipid A as well as the core-
oligosaccharide are generally more conserved in structure and sugar content, 
while the a-antigen shows more variability between species and even strains. 
LOS differs from LPS in that it does not contain the a-antigen repeats and 
consists only of the Lipid A and the core oligosaccharide. LPS and LOS have 
been shown to be major antigenic and toxic compounds of Gram-negative 
bacteria, with the lipid A and the core oligosaccharide exhibiting the strongest 
immunogenic and toxic properties (Alexander et aI., 2001). Initially, the 
appearance of high molecular weight glycan structures in LPS/illS preparations 
of C. jejuni was believed to indicate either that the organism possessed both LOS 
and LPS structures in the outer membrane (Blake et aI., 1993) or that the bacteria 
only possessed illS structures that aggregated during the preparation steps 
(Mills et al., 1985). The debate was ended by the discovery that the high 
molecular weight polysaccharide was in fact a CPS (see section 1.2.3.1). The 
illS structures of several C. jejuni strains have since been determined, showing a 
strong degree of variability in the outer core region, whilst the inner core is more 
conserved amongst strains (Gilbert et al., 2002). Additionally, the function of 
several genes involved in the synthesis and modification of the illS glycan 
structures have been biochemically determined (Kanipes et al., 2008). Consistent 
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with many other bacteria, the first sugar attached to the lipid A is Kdo residue. 
Two heptose sugars are then sequentially added by the action of the 
heptosyltransferases I and II, encoded by the waaC and waaF genes, respectively 
(Kanipes et al., 2006, Oldfield et al., 2002). The outer core is more variable 
between different strains of C. jejuni, and can even vary between different 
bacterial sub-populations of the same strain due to the phase variable expression 
of some of the glycosyltransferase genes. For example, phase variation of the p-
1,3 galactosyltransferase WlaN in strain NCTC11168 can lead to the WS either 
expressing a ganglioside GMt or a GM2 mimicking structure (Linton et al., 
2000a). The outer core is also responsible for perhaps the most intriguing 
property of C. jejuni LOS, the structural mimicry of several human ganglioside 
glycans. This mimicry has been demonstrated to be the key cause of possible 
post-infectious GBS complications. The key glycan involved in this mimicry is a 
branched N-acetylneuraminic acid (NANA, sialic acid), a sugar rarely found in 
bacteria (Xiang et al., 2006). Recent evidence suggests that LOS sialylation is an 
important determinant of mc invasion in vitro (Louwen et al., 2008) and 
recognition of the sialic acid residue by sialoadhesin, a lectin present on a subset 
of macrophages, has been demonstrated (Heikema et al., 2010) Furthermore, 
stronger dendritic cell (DC) activation was detected after in vitro exposure to 
sialated purified WS compared to unsialated WS (Kuijf et al., 2010). An 
association between sialated LOS and severe gastro-enteritis and reactive 
arthritis in vivo has also been demonstrated (Mortensen et al., 2009). Taken 
together, C. jejuni WS appears to play various roles during human infection. 
1.2.3.3 N-linked glycosylation 
N-linked glycosylation of proteins is a very common post-translational 
modification in eukaryotic cells, where the glycans play an important role in 
protein folding, oligomerization, quality control, sorting and transport (Helenius 
et al., 2001). Until recently, it was believed that this process was restricted to 
eukaryotes and archaea. However, in 1999, Szymanski and co-workers 
discovered an operon in C. jejuni strain 81-176 that was similar to a WS/LPS 
biosynthesis operon. When genes from the operon were mutated, however, no 
change in WS electrophoretic mobility was detected. Instead, the 
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immunogenicity of several proteins was altered, indicating the presence of a 
protein modification system (Szymanski et ai., 1999). The locus was named pgi 
(nrotein glycosylation) and studied intensely in the following years. In an initial 
screen, 22 proteins were found to be modified with N-linked glycans and the 
structure of the glycan was determined (Young et ai., 2002). Subsequent 
functional transfer of the entire C. jejuni glycosylation locus into E. coli allowed 
for easier studying of the individual genes in the operon and opened up the novel 
possibility for generating recombinant glycoproteins (Wacker et ai., 2002). With 
regards to pathogenesis, the role of the N-linked protein glycosylation in C. jejuni 
has not been fully elucidated. It has been demonstrated that 81-176 pglB and 
pgLE mutants, which lack the whole N-linked glycan due to either the absence of 
the oligosaccharyltransferase or the inability to synthesise the first end sugar, 
respectively, invade INT 407 cells at lower rates than the C. jejuni 81-176 wild-
type strain and are impaired in the colonisation of the mouse gastrointestinal tract 
(Szymanski et ai., 2002). A 81116 pglH mutant, in which only a truncated 
oligosaccharide is synthesised and linked to the glycoprotein has also been 
shown to be less invasive of Caco-2 cells and impaired in chick colonisation 
(Karlyshev et aI., 2004). A screen of 22 C. jejuni 81-176 glycoprotein mutants 
revealed one gene that led to a loss of invasiveness of INT 407 cells if mutated 
(Cj1496) (Kakuda et ai., 2006). However, the role of the glycan in this 
phenotype is still unclear, as complementation with an unglycosylatable variant 
of the protein restored the phenotype. The same is true for the glycoprotein 
encoded by znuA, a component of a putative zinc ABC transport system (Davis et 
ai., 2009). Despite detailed knowledge of the N-glycosylation machinery, the role 
of glycoproteins in the biology of C. jejuni still remains to be fully elucidated. 
1.2.3.4 O-Iinked glycosylation 
As opposed to N-linked glycosylation, O-linked glycosylation of proteins in C. 
jejuni is more diverse and heterogenous, both genetically and phenotypically. 
Logan and co-workers first discovered the presence of post-translationally 
modified serine residues on the flagellin protein of C. coli (Logan et ai., 1989). 
The glycan most frequently attached to the flagellin proteins was determined to 
be pseudaminic acid, with added heterogeneity generated through substitution of 
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certain groups (Thibault et al., 2001). The biosynthesis of the flagellar glycans 
and their transfer to flagellin have since been analysed in some depth by 
investigation of strains mutated in genes coding for sugar modifying and 
transferring enzymes as well as by targeted metabolomics studies (McNally et 
al., 2006, Goon et al., 2003, Vijayakumar et al., 2006). Through a functional 
metabolomics study, a novel glycan moiety attached to the flagellin of C. coli, 
legionaminic acid, was discovered (McNally et al., 2007). Regarding the 
biological function of these modifications, it has been proposed that the O-linked 
glycosylation is required for efficient assembly and function of the flagella, as 
mutants unable to glycosylate their flagella either through site-directed 
mutagenesis of acceptor serine residues or through mutations of the glycan 
synthesis/transfer enzymes have been demonstrated to be non-motile (Ewing et 
al., 2009, Guerry et al., 2006). Flagellin glycosylation has also been shown to be 
involved in the colonisation of chickens (Howard et al., 2009). 
1.2.4 Cytolethal distending toxin (CDT) 
Bacterial CDTs belong to the AB2-type toxins and generally consist of three 
subunits, CdtA, CdtB and CdtC (Ge et al., 2008). CdtA and CdtC are binding 
proteins that act as carriers to deliver the catalytic subunit, CdtB, into host cells 
(Smith et al., 2006). Once inside the cells, CdtB exhibits DNase I-like activity 
and induces limited DNA damage such as double strand damage, leading to the 
activation of DNA repair responses and ultimately an arrest of the cell cycle at 
the GM2iM phase (Lara-Tejero et al., 2001, Whitehouse et al., 1998). The 
presence of a CDT in C. jejuni was determined relatively early on in C. jejuni 
research (Johnson et al., 1988) and the Campylobaeter CDT has in fact been 
useful in studying the function of this class of toxin (Lara-Tejero et al., 2000, 
Lara-Tejero et al., 2001). With regards to pathogenesis, C. jejuni CDT has been 
shown to be involved in mediating the release of interleukin 8 (IL-8) from lEes 
(Hickey et al., 2000, Zheng et al., 2008), to promote DNA repair responses in 
human cells (Hassane et al., 2003), to be involved in gastroenteritis in NFlCB-
deficient mice (Fox et al., 2004), and to induce cell death in human monocytic 
cells (Hickey et al., 2005). Additionally, the edtABC genes have been used as 
targets for multiplex PCR reactions aimed at detecting and identifying C. j~juni, 
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C. coli and C. fetus (Asakura et al., 2008, Fernandes et aI., 2009). Recently, the 
presence of eDT proteins in C. jejuni outer membrane vesicles (OMVs) has been 
demonstrated, suggesting that these vesicles may be one pathway utilised by C. 
jejuni to deliver the toxin to the host (Lindmark et al., 2009). 
1.3 Host response to C.jejuni infection 
1.3.1 Innate Immunity 
The epithelial lining of the intestine acts as the first physical barrier between any 
intestinal pathogen and the host. However, the cells of the epithelium have a 
further role in defence against pathogens; they are capable of sensing the 
presence of a pathogenic microorganism and transmitting this to other cells of the 
innate immune system. Epithelial cells possess mechanisms that can detect both 
extracellular pathogens as well as organisms that have gained entry into the cells 
through different sets of pathogen recognition receptors (PRRs) (Sanderson et 
al., 2007). Of the extracellular receptors, the Toll-like receptor (TLR) family is 
amongst the best described (Kumar et al., 2009). TLRs are grouped into families 
depending on the recognised microbe-associated molecular pattern (MAMP) and 
are at the beginning of signalling cascades, involving nuclear targeting of the 
transcription factor NF-KB. (Bryant et al., 2009) TLR4 for example recognises 
bacterial LPS or illS while TLRS detects the flagellar subunit protein flagellin 
(Vijay-Kumar et al., 2009). In the case of C. jejuni, it has been demonstrated that 
flagellin is a poor activator ofTLRS signalling (Watson et al., 2005, 10hanesen et 
al., 2006). The site recognised by TLRS has recently been identified and found to 
be absent from C. jejuni flagellin, thus leading to the lack of recognition 
(Andersen-Nissen et al., 2005). With regards to TLR4, recent work demonstrated 
that bone-marrow derived dendritic cells (BM Des) from mice from a TLR4-
deficient background were less responsive to C. jejuni challenge than wild type 
BM Des, suggesting a role for this receptor in the recognition of the pathogen 
(Rathinam et al., 2009). The same study also identified the involvement of TLR2 
which recognises bacterial lipoproteins in the BM De response to C. jejuni. 
Furthermore, the myeloid differentiation factor 88 (Myd88) protein, which is 
involved in most TLR-dependent signalling, has been implicated in innate 
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immune response to C. jejuni in mouse BM Des and in a Myd88 knockout 
mouse colonisation study (Rathinam et al., 2009, Watson et al., 2007). However, 
human IECs have been shown to respond to C. jejuni challenge in a Myd88-
independent way (Friis et al., 2009), suggesting that several pathways are utilised 
to trigger a response. 
Downstream of the PRRs, a variety of signalling cascades transmit and amplify 
the signal. These cascades are made up of a plethora of kinase proteins, and 
several of these have been implicated in signalling in response to C. jejuni 
challenge. As early as 1996, a role for the phosphatidylinositol-3 kinase (PI-3 
kinase) in IEC entry and signalling of C. jejuni was demonstrated (Wooldridge et 
al., 1996). The surface lipoprotein JlpA has been demonstrated to interact with 
the surface exposed heat shock protein 90alpha and lead to activation of the p38 
MAP kinase in IECs (Jin et al., 2001). A further study demonstrated that the 
ERK protein kinase was activated alongside the p38 MAP kinase in response to 
C. jejuni challenge (Watson et al., 2005). Additionally, the Jun N-Terminal 
kinase (JNK) was shown by two studies to be activated in response to C. jejuni 
challenge (MacCallum et al., 2005a, Chen et al., 2006). 
Receptors of the nucleotide oligomerization domain (NOD) family are 
specialised intracellular PRRs involved in regulation of an innate immune 
response (Franchi et aI., 2009). Similar to the TLR receptors, they stand at the 
head of a signalling cascade that involves NF-KB signalling. Recently, NODI, 
but not NOD2, was demonstrated to play an important role in the host 
recognition of C. jejuni in IECs (Zilbauer et al., 2007). When NODI was 
targeted with small interfering RNA (siRNA), an increase in the number of 
intracellular C. jejuni was detected, highlighting a role for NODI in the defence 
against the pathogen. 
Once a pathogen is detected by a PRR, in most cases, downstream signalling 
involves activation of the transcription factor NF-KB. This in turn leads to 
expression of several innate immunity genes. NF-KB activation in IECs has been 
shown to Occur in response to C. jejuni challenge by several studies (Zheng et 
al., 2008, Chen et al., 2006, Mellits et al., 2002, Jin et al., 2001, Johanesen et al., 
2006). Furthermore, an NF-KB deficient mouse has been demonstrated to exhibit 
gastroenteritis when infected with C. jejuni (Fox et al., 2004), and NF-KB 
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activation has been demonstrated in C. jejuni infected gnotobiotic and IL-lO 
deficient mice exhibiting gastroenteritis by promoter fusion (Lippert et al., 
2009). 
Once the pathogen has been detected by the epithelium, the information must be 
transmitted to other parts of the innate immune system. Small signalling peptides 
are the carriers of such signals; the chemokine Interleukin 8 (IL-8) for instance is 
a chemoattractant, recruiting immune cells such as neutrophils to a site of 
infection. IL-8 signalling has been clearly established as one of the responses of 
intestinal epithelia to C. jejuni infection (Hickey et al., 1999). The secretion of 
IL-8 has been shown to be dependent on the presence of CDT (Hickey et al., 
2000, Zheng et al., 2008) and requires contact between the bacteria and the IECs 
(Watson et al., 2005). It has also been demonstrated that the secretion of IL-8 by 
a polarised monolayer of IECs is directional, with most of the IL-8 found on the 
basolateral side of the monolayer (Chen et al., 2006). Furthermore, not all IEC 
lines respond alike to C. jejuni challenge, with some lines secreting high 
quantities of IL-8, whilst others only secrete low levels (MacCallum et al., 2006). 
Recently, IECs have been demonstrated to secrete Interleukin-6 (IL-6) (Friis et 
al., 2009) and tumour necrosis factor alpha (TNF-a) (Zheng et al., 2008) in 
response to C jejuni challenge. Additionally, the intestinal epithelium has been 
shown to not only sense the presence of C. jejuni and relay the signal to other 
immune cells; evidence demonstrated that IECs produced antimicrobial peptides 
of the defensin family in response to C. jejuni challenge (Zilbauer et al., 2005). 
Transcription as well as secretion of both hBD-2 and hBD-3 was demonstrated in 
IECs infected in vitro with C. jejuni, and both antimicrobial peptides exhibited 
potent bactericidal activity against C. jejuni. 
Once C. jejuni has crossed the epithelial barrier, the bacteria come into contact 
with other cells of the innate immune system such as dendritic cells (DCs), 
macrophages and neutrophils. Human DCs have been shown to undergo 
maturation and produce cytokines in response to C. jejuni challenge (Hu et al., 
2006). Furthermore, DCs in rectal mucosal biopsies of patients with acute 
Campylobaeter colitis showed higher prevalence of ultrastructural features of 
activation than control samples (Pulimood et al., 2008). Mouse DCs have also 
been shown to be activated by C. jejuni and to signal via the pathways mentioned 
above (Rathinam et al., 2008, Rathinam et al., 2009). Recently, the human 
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Macrophage Galactose-type lectin (MGL), which is mainly expressed on 
immature DCs and a specific subset of macrophages has been shown to bind to 
the C. jejuni N-glycan and has been implicated in possible immunosuppression 
(van Sorge et ai., 2009). 
Neutrophil infiltrates have been detected in biopsies of ferrets infected with C. 
jejuni (Fox et ai., 1987), in the cecum and colon of infected gnotobiotic pigs 
(Boosinger et ai., 1988), and in intestinal biopsies of infected Macacca 
nemestrina monkeys (Russell et ai., 1989). However, the exact role of 
neutrophils in C. jejuni infection remains to be elucidated and no in vitro data of 
neutrophil interactions with C. jejuni has been obtained to date. 
Unlike neutrophil-Co jejuni interactions, interactions between macrophages and 
C. jejuni have been studied in more depth. Macrophages from different 
organisms such as humans, mice, chickens and guinea pigs, as well as primary 
and "immortalised" macrophages have been used. Intriguingly, however, the 
reported results are not always consistent. The first report of an in vitro co-
culture of C. jejuni with a murine macrophage line, primary murine peritoneal 
macrophages as well as human peripheral blood monocytes demonstrated that C. 
jejuni was readily phagocytosed by all macrophages (Kiehlbauch et ai., 1985), 
with human macrophages ingesting "more rapidly and vigorously" than murine 
macrophages. The authors also demonstrated survival of the bacteria within the 
macrophages for up to 7 days. Co-culturing of chicken peritoneal macrophages 
and C. jejuni revealed that these cells were also able to phagocytose the bacteria 
and that phagocytosis was increased by pre-incubating the bacteria with an 
antiserum (Myszewski et ai., 1991). The authors reported that the chicken-
derived macrophages managed to kill all bacteria within the experimental period 
of maximum 6 h. However, another study using human peritoneal 
monocytes/macrophages implicated host factors in the killing of C. jejuni by the 
macrophages, as cells from 10% of the donors were able to phagocytose, but not 
kill the bacteria (Wassenaar et ai., 1997). A further study using the human 
monocytic cell line THP-1 demonstrated the occurrence of caspase-1 
independent apoptosis and induction of Interleukin 1 beta (IL-l P) (Siegesmund et 
ai., 2004). The most recent study using bone marrow-derived (BMDM) murin~ 
macrophages demonstrated complete killing of C. jejuni by the macrophages 
after 24 h (Watson et ai., 2008). 
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1.3.2 Adaptive immune response 
C. jejuni infection has been demonstrated to lead to an increase of serum titres of 
anti-Campyiobaeter IgG, IgM and IgA antibodies (Cawthraw et ai., 2000, Strid 
et ai., 2001). However, the kinetics of the three antibody classes differ. While 
IgM and IgA were detected during the acute phase of the infection (up to two 
months after infection) and then declined, IgG antibodies can persist for months 
or even years after an infection. Re-infection of previously infected adults has 
shown that the previous infection was able to protect from disease, but not from 
colonisation, suggesting a role for humoral immunity in determining the outcome 
of the disease (Black et ai., 1988). A further study demonstrated an age-
dependent rise in serum-specific antibodies in developing countries, where C. 
jejuni infections are common from an early age. This was shown to lead to 
Successively milder symptoms with each infection (Taylor et ai., 1993). 
1.4 Models used to study C.jejuni pathogenesis 
In order to understand how a pathogenic organism causes disease in humans, the 
availability of a good model of the disease is the most essential factor. Over the 
past decades, multiple pathogenic organisms have been studied using a variety of 
in vivo animal models such as rodents, combined with in vitro culturing models. 
In the case of C. jejuni, the search for convenient models of the disease has 
proven to be more difficult than for other organisms, which has in tum led to a 
lag in the knowledge regarding C. jejuni virulence factors and key host responses 
to infection compared to other enteric pathogens. 
There is a clear need for the development of new models to study C. jejuni in 
vivo as well as in vitro, to further understand the molecular pathogenesis of this 
important microorganism. 
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1.4.1 In vivo models used to study C.jejuni 
When developing an animal model to study a human pathogenic microorganism, 
a set of key points need to be met to determine whether the model will be 
suitable for the planned studies. These points are: 
• Reproduction of the disease found in humans 
• Commercial availability 
• Ease of laboratory handling 
• Good lifespan/generation time 
• Availability of genetic tools/mutants 
• Availability of other tools such as sera 
• Ethical agreement 
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1.4.1.1 Humans 
The best model of infection for a human pathogen would always be humans 
themselves. A few human experimental studies have been performed, 
demonstrating that humans can indeed be experimentally infected with C. jejuni 
(Black et al., 1988, Prendergast et al., 2004). However, the main concern 
regarding the use of a human challenge model is the possibility of GBS. The 
possibility that some of the volunteers may develop this serious post-infectious 
sequela renders the model ethically questionable. Recently, a set of C. jejuni 
strains that were found to lack the genes required to synthesise the LOS 
structures involved in inducing GBS were assessed as potential vaccination 
candidates (Poly et al., 2008). The strains were shown to lack the ganglioside 
mimicking glycans on their surface and one strain was evaluated in a human 
challenge study (Tribble et al., 2009). These strains may provide a novel, safer 
tool to study the complex interaction of the bacterium with the human host. 
However, whilst lowering the ethical constraints due to the inability to cause 
GBS, the strain still does not address the problems of generation time, "handling" 
and availability of genetic tools for the human model of C. jejuni infection. 
1.4.1.2 Non-human primates 
Non-human primates are considered good models for infection studies with 
human pathogens, as they are more closely related to humans than rodents or 
other mammals. A couple of studies have been performed using different species 
of rhesus monkey. A first study using young Macaca mulatta demonstrated a 
mild disease outcome, with short lasting diarrhoea, prolonged excretion of 
bacteria, and bacteraemia for the first 2 to 3 days after infection (Fitzgeorge et 
al., 1981). Another study with young Macaca nemestrina monkeys demonstrated 
a more severe outcome of the disease, including acute diarrhoeal illness, with 
fluid diarrhoea, bloody stools and faecal leukocytes (Russell et al., 1989). Re-
infection of the animals led to only mild diarrhoea, strengthening the hypothesis 
of a role for the adaptive immune system in protection towards disease caused by 
C. jejuni. However, despite the promising preliminary results, the rhesus monkey 
remains a suboptimal ideal model, mainly due to the fairly complicated handling 
and housing requirements and the absence of genetic tools. 
1.4.1.3 Dogs 
Two reports discuss dogs as a potential model to study C. jejuni mediated 
disease. In the first, gnotobiotic Beagle puppies were orally inoculated with C. 
jejuni from human and canine origin and displayed transient listlessness, lack of 
appetite and mild diarrhoea (Prescott et al., 1981). In the second, puppies were 
orally inoculated and displayed mild disease; however no penetration of IECs 
was detected (Macartney et al., 1988). However, as dogs have been reported to 
be natural carriers of C. jejuni, they are not an ideal model, and precautions such 
as keeping the animals germ-free are necessary (Moreno et al., 1993). 
1.4.1.4 Pigs 
As the digestive tracts of pigs and humans are not that different, pigs have been 
considered to be a potentially attractive model to study C. jejuni. It has been 
demonstrated that gnotobiotic piglets can be readily infected orally with C. jejuni 
(Boosinger et al., 1988, Vitovec et al., 1989). The cecum and colon of infected 
pigs showed oedema, neutrophil infiltration and sloughing of IECs from the 
mucosa. Furthermore, colostrum-deprived newborn piglets have also been 
successfully experimentally infected with C. jejuni. The animals developed 
clinical symptoms and histopathological lesions similar to humans infected with 
C. jejuni (Babakbani et al., 1993a). Pigs seem to constitute a reasonably good, 
reproducible model system to study C. jejuni. However, to date only a few 
studies have used pigs, most likely due to the complex housing and handling 
requirements. 
1.4.1.5 Ferrets 
Ferrets have been used by several groups as a potential model for C. jejuni. 
Weanling ferrets inoculated orally with C. jejuni became infected after 3 days 
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and had bile-tinged, liquid faeces with excessive mucous and blood (Fox et ai., 
1987). Another study using juvenile and adult animals demonstrated a disease 
spectrum similar to humans, with diarrhoea ranging from mild to moderate which 
was spontaneously resolved in a few days (Bell et ai., 1990). A recent study 
explored the pathology and immune response of C. jejuni infected ferrets in more 
detail, highlighting vigorous systemic and mucosal immune responses to C. 
jejuni challenge (Nemelka et ai., 2009). Taken together, these data suggest that 
ferrets are a plausible model for studying C. jejuni. However, similar to the pig 
model, only relatively few studies have been conducted using ferrets, most likely 
due to the laborious handling and lack of genetically defined mutants and 
reagents. 
1.4.1.6 Chickens 
Chickens as one of the natural hosts of C. jejuni, have been assessed for their 
potential as a model. There remains an ongoing discussion whether C. jejuni is a 
chicken commensal or a pathogen. Most studies conducted with chickens have 
been aimed to decipher factors relevant for colonisation rather than pathogenesis, 
potentially with the aim of lowering the burden of infected chickens on farms. A 
C. jejuni flaA and a C. coli sodB mutant have been demonstrated to exhibit 
defects in chicken colonisation, suggesting an involvement of the major flagellar 
protein FlaA and the superoxide dismutase SodB in the colonisation of chickens 
(Nachamkin et ai., 1993, Purdy et ai., 1999). A large signature tagged 
mutagenesis project led to the discovery of 22 genes involved in commensal 
colonisation of the chicken gastrointestinal tract (Hendrixson et ai., 2004). 
Recent evidence suggests that there may be a controlled inflammatory process 
occurring during colonisation of the chicken intestine (Smith et ai., 2008), and 
that C. jejuni differentially activates TLRs in chickens compared to humans (de 
Zoete et ai., 2009). However, as the chickens colonised with C. jejuni do not 
suffer from any symptoms similar to those encountered in humans, the feasibility 
of a chicken model remains questionable. 
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1.4.1.7 Mice 
Small rodents, particularly mice, are amongst the most widely used models of 
infection to study human pathogens. Successful mouse models have been 
developed for many bacteria, including Salmonella spp. (Hapfelmeier et al., 
2005), enteropathogenic E. coli using the related mouse pathogen Citrobacter 
rodentium (Mundy et al., 2005), Vibrio cholera (Klose, 2000) and Yersinia 
enterocolitica (Oellerich et al., 2007). The mouse has several major advantages 
over all of the other animal models described above. The generation time is low, 
handling is relatively simple, there are many knockout strains available, as well 
as a whole range of sera and other tools to study the host response to a pathogen. 
In 1983 a first mouse infection study with C. jejuni reported that the bacteria 
readily colonised mice, leading to a brief spike of bacteraemia 10 minutes after 
oral infection, but did not lead to any signs of illness, even though the challenged 
mice developed into chronic excretors (Blaser et al., 1983a). This finding was 
confirmed by several further studies, suggesting that C. jejuni rapidly colonised 
mice, but did not appear to lead to the development of disease (Lee et al., 1986). 
Another study further demonstrates the difficulties encountered when using mice 
as a model for C. jejuni. Although the authors succeeded in generating symptoms 
of disease in mice using C. jejuni, a very high infection dose of 108 to 109 eFUs 
injected intraperitoneally into mice pre-treated by injection with iron dextran was 
necessary for the development of disease (Stanfield et al., 1987). Mice that had 
not been pre-treated with iron dextran did not develop the disease. Furthermore, 
the levels of colonisation varied substantially between different replicate mice. 
More recently, several knockout mutant mouse strains have been tested for their 
suitability as a model for C. jejuni pathogenesis. Mice deficient in NFKB have 
been reported to develop moderately severe gastritis and duodenitis when 
challenged with C. jejuni, compared to mild gastritis in the wild type parental 
mice (Fox et al., 2004). Furthermore, the authors highlighted a role for the eDT 
as an important virulence factor in these mice. Another group reported the use of 
congenic interleukin-lO (IL-lO) deficient mice and demonstrated the 
development of severe typhocolitis in the mutant mice compared to the wild type 
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parent strain. However, as the wild type mice showed similar rates of 
colonisation but no symptoms, the authors hypothesised that colonisation of the 
gastrointestinal tract is necessary but not sufficient for the development of 
enteritis (Mansfield et al., 2007). The same year, Watson and co-workers 
reported the use of a MyD88 deficient mouse model (Watson et al., 2007). They 
demonstrated that the mutant mouse was readily colonised by C. jejuni, but not 
by bacterial strains deficient in known virulence factors. Furthermore, they 
hypothesised that Natural resistance-associated macrophage protein one 
(Nramp1)-deficiency leads to an increased mouse susceptibility to systemic 
infection, as Nramp1-deficient mice were less able to clear C. jejuni after 
intraperitoneal inoculation. This finding was confirmed by another study, further 
strengthening the hypothesis that Nramp1 is critical in host resistance to C. jejuni 
(Champion et al., 2008). The most recent finding using gnotobiotic IL-lO 
deficient mice demonstrated development of severe ulcerating colonic 
inflammation and bloody diarrhoea in response to C. jejuni infection (Lippert et 
al., 2009). Three other reports demonstrate disease and systemic spread of C. 
jejuni after intranasal challenge, although it is debatable whether a lung model is 
suited for an enteropathogen (Baqar et al., 1996, AI-Banna et al., 2008b, AI-
Banna et al., 2008a). Taken together, it can be stated that to date, even though 
several mouse models have been evaluated, there still remains the need for 
further development, as none of the models has led to any significant advances in 
our understanding of the molecular basis of pathogenicity of C. jejuni. 
Nevertheless, the mouse model remains the most promising in vivo model. 
1.4.2 In vitro models used to study C.jejuni 
An alternative to using in vivo models to understand how a pathogenic organism 
causes disease is the use of in vitro systems. As the intestinal epithelium is the 
part of the host with which the bacteria mainly interact whilst in the gut, there is 
a strong rationale to use a co-culture method of C. jejuni with IECs. These can 
either be primary IECs harvested from intestinal tissue sections or 
"immortalised" cell lines that have usually been derived from carcinomas. 
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1.4.2.1 Primary cells 
The advantage of primary cells is that they are freshly isolated from the host and 
are not cultivated and lab-adapted, thus representing the in vivo state much more 
closely than cell lines. On the other hand, isolation of primary cells can be 
difficult and it is not always easy to culture them long enough to perform 
experiments. Primary cells from different organisms have been assessed in in 
vitro co-culturing experiments. Babakhani and co-workers utilised primary swine 
IECs from 6 hour old piglets and demonstrated invasion of the IECs by C. jejuni 
(Babakhani et al., 1993b). Primary cells of chickens from different organs of the 
bird have been used in order to try to understand the differences between humans 
and chickens infected with C. jejuni. Using avian primary chick kidney cells, 
Smith and co-workers demonstrated expression of pro-inflammatory cytokines 
and chemokines in response to C. jejuni (Smith et al., 2005). Another study 
supported this finding by demonstrating the induction of IL-8 in primary 
intestinal chick cells (Borrmann et al., 2007). Two other studies showed that C. 
jejuni is capable of invading primary chick embryo IECs and primary adult 
chicken IECs (Li et al., 2008, Byrne et aI., 2007). Intriguingly, these studies 
suggest that C. jejuni interacts with avian cells in a very similar way to human 
cells and that the cells respond in turn. It remains to be fully elucidated why the 
outcome of colonisation/infection is so different in chickens and humans. 
Primary cells of human origin have been used in very few studies, most likely 
because they are more difficult to obtain than animal cells. Four studies used an 
ex vivo organ culturing (EVOC) model to co-culture C. jejuni with human 
intestinal biopsies. Using this model, it was demonstrated that C. jejuni was able 
to adhere to the biopsies in vitro (Grant et al., 2006) and IL-8 secretion as well as 
mitogen-activated kinase activation were reported in response to infection in 
human biopsies (MacCallum et al., 2006, MacCallum et al., 2005a). Recent data 
from the same group demonstrated the importance of flagella in the interaction of 
C. jejuni with human primary intestinal tissue and showed that the bacteria 
formed distinct microcolonies on the ileal tissue before spreading out and 
forming a biofilm (Haddock et al., 2010). 
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1.4.2.2 Immortalised epithelial cell line models 
The most common type of in vitro model used to study host-pathogen 
interactions is the epithelial cell line model. These cell lines are usually derived 
from a carcinoma and are available from a wide range of organisms and a wide 
range of tissues. The American Type Culture Collection (ATCC) for example 
offers approximately 1100 tumour cell lines from a variety of species 
(www.atcc.orglPortalsll!fumorLines.pdf). These cell lines have the advantage 
that they are readily available and often relatively easy to cultivate. The most 
common type of cells used for studying C. jejuni host-pathogen interactions are 
human cell lines stemming from the intestinal epithelium, although cells from 
other organs have also been used (Table 1.1). 
Table 1.1: Cell lines used to study C. jejuni in vitro. 
Cell line Organism Organ Forms 
polarised 
monolayer 
Caco-2 Human Colon Yes 
HeLa Human Cervix No 
HEp-2 Human Cervix No 
Int 407 Human Intestine No 
HT29 Human Colon Yes 
T84 Human Colon Yes 
MDCK Dog Kidney Yes 
.. Adapted from Frns et al. 2005 
The first evidence that C. jejuni invaded epithelial cells of intestinal and non-
intestinal origin in vitro was obtained around 1990 (Everest et al., 1992, De Melo 
et al., 1989), followed by demonstrations that the IECs responded to C. jejuni 
challenge (Hickey et al., 1999). Most of the findings summarised in section 1.2 
were elucidated using this type of model. However, the fact that several different 
cell lines have been used combined with contradictory results obtained by 
different research groups, suggests that the 2D monolayer model is not totally 
satisfactory. The cell line used represents a particular research group's preference 
rather than an established rationale for using that line. Furthermore, the rate of 
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interaction of the bacteria with the IECs is substantially lower than that of other 
enteropathogens such as Salmonella spp. In 2005, Friis and co-workers reviewed 
the use of "in vitro cell culture models for investigating Campylobaeter invasion 
mechanisms" (Friis et al., 2005). The authors highlighted several difficulties and 
variables encountered when using this type of model such as the multiplicity of 
infection (Mal) or the bacterial strain used. A number of suggestions were 
proposed to tackle these variables such as establishing the effects of different 
MOls for each cell line and mathematically evaluating these effects. Following 
these suggestions might lead to an optimisation of the classical 2D monolayer 
model of infection, increasing reproducibility and strengthening the model. 
However, as things stand to date, there is no generally accepted protocol for in 
vitro co-culturing of C. jejuni with epithelial cells. 
There is an additional fact that must be considered when using this model to 
study C. jejuni interactions with epithelial cells. In order to assure survival of the 
IECs, the co-culturing must be performed under aerobic conditions. This does 
not affect bacteria such as Salmonella or E. eoli, as these organisms are 
facultative anaerobes that thrive under atmospheric oxygen conditions. On the 
other hand, C. jejuni is a microaerophilic organism. Although C. jejuni has been 
shown to possess mechanisms to survive oxidative stress such as the superoxide 
dismutase (Pesci et al., 1994, Purdy et al., 1994), catalase (Day et al., 2000), 
polyphosphate kinase 1 (Candon et aI., 2007) and other stress response proteins, 
it is probable that the bacteria will behave differently under atmospheric oxygen 
conditions than in a micro aerobic or even anaerobic environment. Furthermore, 
the environment in the human intestine is probably almost anaerobic. There is 
therefore a strong possibility that the aerobic nature of the classical monolayer 
IEC culture model is not ideal to study the pathogenesis of the microaerophilic C. 
jejuni and may have effects on the pathogen's behaviour leading to contradictory 
observations. 
The interaction of Helieobaeter pylori, another microaerophilic bacterial species 
related to C. jejuni, was studied under micro aerobic and aerobic conditions 
(Cottet et al., 2002). This study was performed by using a Vertical Diffusion 
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Chamber (VDC) or Ussing Chamber (UC), which was originally developed by 
Grass and Sweetana to study the transport of substances across membranes 
(Grass et al., 1988). The design of this system was adapted such that when IECs 
grown on penneable plastic supports (Snapwells™) are inserted into the 
chamber, the cells act as a barrier, creating an apical and a basolateral 
compartment. The conditions in the two compartments can then be individually 
adjusted; both the content of the compartment (medium, bacteria and other 
substances) and the gas composition can be individually manipulated. H. pylori 
was demonstrated to adhere to the IECs in a greater number under micro aerobic 
conditions and the innate immune response of the IECs was increased due to this 
greater interaction. Furthennore, an increased expression of the H. pylori urease 
was detected under microaerobic conditions. As H. pylori and C. jejuni are both 
microaerophilic, we hypothesised that applying the VDC model to C. jejuni will 
analogously increase the interactions of the bacteria with the lEes. 
A further limitation of the classic IEC-bacteria co-culturing model is the 
presence of only one type of cells, the IECs. A polarised monolayer of IECs may 
represent a major part of the human intestine an invading pathogen encounters; 
however, the morphology of the gut wall as well as the cellular content is much 
more complex than a monolayer. Areas tenned Peyer's patches, aggregation of 
lymphoid tissue containing a type of cell called M cells, are present in the lowest 
portion of the small intestine, the tenninal ileum. Moreover, it has been shown 
that another type of immunomodulatory cell belonging to the DC class penetrates 
the epithelium and samples bacteria (Rescigno et al., 2001). As these types of 
cells are not present in the 2-D model but may be a point of interaction for C. 
jejuni with the intestine, this may partially limit the usefulness of the classical 2D 
model. 
An EVOC model has successfully been established to study the interaction of 
enteropathogenic and enterohaemorrhagic E. coli (EPEC and EHEC) with human 
intestinal biopsies (Hicks et al., 1996). The model has been used to highlight 
similarities as well as differences between the interactions of EHEC with a 
classical 2-D IEC monolayer and with the biopsies. For example, pedestal 
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formation and the formation of attaching and effacing lesions occur in both 
models (Hicks et al., 1998). However, certain differences between the two 
models regarding the molecular basis of the interactions have also been 
discovered (Schuller et al., 2007). For C. jejuni, four studies have utilised human 
intestinal biopsies. As the tissue is relatively difficult to obtain, these remain the 
only studies to date. 
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1.5 Aims 
Although some progress has been made over the past decade, the knowledge 
about how C. jejuni causes disease in humans still lags behind that for other 
pathogenic enteric bacteria. The aims of this research project were to further 
develop and assess two alternative in vitro models to study the interactions of 
this important bacterial pathogen with the host. 
1.5.1 The Ex Vivo Organ Culture (EVOC) model 
One of the drawbacks of IEC-bacterial co-culture is the absence of cell types 
other than the IECs. Co-culturing whole human intestinal biopsies with C. jejeni 
will address this, as these tissues contain all cell types present in the human 
intestinal lining, including DCs, macrophages and neutrophils. The innate 
immune response mounted by the tissue in response to ex vivo infection with C. 
jejuni will be studied. Furthermore, the effect of loss of bacterial surface 
structures on the response will be addressed by using different C. jejuni mutants. 
1.5.2 The Vertical Diffusion Chamber (VDC) model 
Another major drawback of IEC co-culturing with C. jejuni is the aerobic 
conditions that such experiments are performed under. The VDC model aims to 
overcome this problem by co-culturing C. jejuni with IECs under microaerobic 
conditions, thus more closely mimicking the conditions encountered by C. jejuni 
in vivo in the human intestine. Initially, survival of the IECs under microaerobic 
conditions will be analysed using different methodologies. Subsequently, the 
effect of microaerobic co-culturing of C. jejuni with the IECs will be analysed, 
both with regards to the numbers of interacting and invading bacteria as well as 
with regards to the host innate immune response mounted after microaerobic co-
culturing. Finally, different C. jejuni mutants will be tested using the VDC 
model. 
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Chapter 2 
Materials and Methods 
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2 Materials and Methods 
2.1 Bacterial strains 
Campyiobaeter jejuni strains used in this study are listed in Table 2.1. The two C. 
jejuni wild-type strains used were 11168H, a hypermotile derivative of the original 
sequenced strain NCTCl1168 (Jones et ai., 2004, Karlyshev et ai., 2001), and 81-
176, a strain isolated from a milk-borne outbreak in the USA (Korlath et ai., 1985). 
The defined C. jejuni 11168H mutants used in the study were obtained from Neveda 
Naz (ciaB), the LSHTM Campylobaeter jejuni mutant library (flaA) or Nick Dorrell 
(rpoN). All three mutants were constructed by insertion of a Kanamycin resistance 
cassette into the Open Reading Frame at the nucleotide position specified in Table 
2.1. (Karlyshev et al., 2001) 
Table 2.1: C. jejuni strains used in this study. 
Strain/M utant Origin/Reference Features 
11168H wild-type strain Karlyshev et ai., 2001, Hypermotile derivative 
Jones et ai., 2004 of the original 
sequenced strain 
NCTC11168 
11168H strain expressing Karlyshev and Wren, 2005 11168H strain modified 
enhanced Green Fluorescent to express eGFP 
Protein (eGFP) 
81-176 wild-type strain Korlath et ai., 1985 Wild-type laboratory 
~assaged strain 
11168H ciaB mutant Obtained from Neveda KanK cassette inserted 
Naz, LSHTM into the gene encoding 
CiaB at nucleotide 103 
11168HflaA mutant Obtained from LSHTM KanK cassette inserted 
mutant library into the gene encoding 
the major flagellin 
subunit protein FlaA at 
nucleotide 163 
11168H rpoN mutant Obtained from Nick KanK cassette inserted 
Dorrell, LSHTM into the gene encoding 
the alternative sigma 
factor 0-54 (RpoN) at 
nucleotides 127, 
removing nucleotides 
128 to 1036 
Complemented 11168H rpoN This study Functional copy of the 
mutant 11168H rpoN gene 
inserted into the Cj0223 
pseudogene locus 
(nucleotides 205297-
207475 inclusive) 
For cloning and plasmid propagation, library efficiency Escherichia coli DH5a 
chemically competent cells (Invitrogen, Paisley, UK) were used. 
2.2 Bacterial growth media and culturing conditions 
All bacterial growth media were prepared using Milli-RO (Reverse osmosis) pure 
water (Millipore, Billerica, USA). 
C. jejuni were routinely cultured on Blood Agar (BA) plates supplemented with 
Campylobacter selective supplement (Skirrow) (Oxoid, Basingstoke, UK) and 7% 
(v/v) horse blood (TCS Biosciences, Botolph Claydon, UK). BA was prepared by 
dissolving 21 g of Columbia Agar Base (Oxoid) in 465 ml of H20 and autoclaving at 
121°C for 15 min in a steam steriliser. To prepare agar plates, the agar base was 
melted in a microwave and cooled to approximately 50°C. 35 ml of horse blood and 
one vial of the selective supplement were added to the cooled agar and 25 ml of the 
mixture was poured into each sterile petri dish (Fisher Scientific, Leicestershire, 
UK). When required, kanamycin (Sigma. Gillingham, UK) (final concentration 50 
",glml) and chloramphenicol (Sigma) (final concentration 10 ",glml) were added to 
the cooled agar immediately before pouring. 
E. coli were routinely grown on Luria Bertani Agar (LBA) plates. LBA was prepared 
by dissolving 18.5 g of LB agar base (Oxoid» in 500 ml H20 and autoclaving at 
121°C for 15 min. To prepare agar plates, the agar base was melted in a microwave, 
cooled to approximately 50°C and 25 ml poured into each sterile petri dish. When 
required, ampicillin (Sigma)( final concentration 50 ",glml), kanamycin (Sigma) 
(final concentration 50 ",glml) or chloramphenicol (Sigma) (final concentration 30 
",glml) were added to the cooled agar immediately before pouring. 
C. jejuni motility medium was prepared by dissolving 5.6 g of Brucella broth base 
(Oxoid) and 0.8 g bacto-agar (Oxoid) (final agar concentration 0.4% (w/v» in 200 
ml H20 and autoclaving at 121°C for 15 min. To prepare motility plates, the agar 
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was melted in a microwave, cooled to approximately 50°C and 20 ml poured into 
each sterile petri dish. 
e. jejuni cultures were grown in Brucella broth. Brucella broth was prepared by 
dissolving 5.6 g of Brucella broth base in 200 ml H20 and autoclaving at 121°C for 
15 min. 
E. coli cultures were routinely grown in LB broth. LB broth was prepared by 
dissolving 5 g of LB broth base (Oxoid) in 200 ml H20 and autoclaving at 121°C for 
15 min. 
e. jejuni were routinely grown at 37°C in a Variable Atmosphere INcubator (V AlN) 
(Don Whitley Scientific, Shipley, UK) filled with a mixture of 85% N2, 10% CO2 
and 5% 02. e. jejuni cultures were grown in vented 75 cm2 tissue culture flasks 
(Coming NY, USA) at 75 revolutions per minute (RPM) on an SSM-1 orbital shaker 
(StuartlBibby Scientific, Stone, UK) inside the V AlN. 
E. coli strains were routinely grown on LBA plates at 3rC in a MIR microbiological 
incubator (Sanyo, Loughborough, UK). E. coli cultures were grown at 37°C in a 
shaking incubator (Gallenkamp/Sanyo, Loughborough, UK) at 200 RPM. 
2.3 Preparation of frozen bacterial stocks 
To prepare frozen stocks of e. jejuni, bacteria were grown for 24 h on a BA plate. 
Bacteria were harvested with a sterile 10 t-tl plastic loop (VWR, Lutterworth, UK), 
resuspended in Brucella broth supplemented with 10% (v/v) foetal calf serum (FCS) 
(Sigma) and 10% (v/v) Glycerol (Sigma), aliquotted into 1.5 ml Eppendorf tubes 
(Eppendorf, Histon, UK) and snap-frozen by immersion into an ethanol-dry-ice mix 
for 1 min. Frozen stocks were stored at -80°C in a New Brunswick Scientific Innova 
ultra-low freezer (Eppendort) 
To prepare frozen stocks of E. coli, the bacteria were grown overnight in LB broth, 
800 t-tl of bacterial culture mixed with 200 t-tl of sterile Glycerol in a Cryovial 
(NUNC Roskilde, Denmark) and the vial frozen down directly to -80°C in a New 
Brunswick Scientific Innova ultra-low freezer. 
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2.4 Resuscitation of bacteria from frozen stocks 
To resuscitate C. jejuni from frozen stocks, an Eppendorf tube containing the desired 
bacterial strain was slowly thawed on ice. 25 ~l of stock suspension were streaked 
onto a BA plate with the aim of obtaining single colonies. After 24 h of growth, one 
or more CFUs were re-streaked onto a fresh BA plate; this was termed passage 
number l. 
Resuscitation of E. coli from frozen stocks was performed as above but using LBA 
instead of BA plates. 
2.5 Passaging of C.jejuni strains 
C. jejuni strains were routinely passaged onto a fresh BA plate every 72-96 h up to a 
maximum passage number of 10. Passages were routinely checked for contamination 
by streaking in a fashion aimed at obtaining single CFUs and the morphology of the 
CFUs examined, as extended passage can lead to the development of a mucoidy 
colony phenotype. If a mucoidy phenotype was observed, the line was discontinued, 
and fresh bacteria resuscitated from the stocks as described in section 2.4. 
E. coli strains were not routinely passaged. Instead, plates were kept at 4°C for up to 
4 weeks after resuscitation and single colonies inoculated into fresh LB broth when 
new liquid cultures were required. After 4 weeks of storage, a fresh plate was 
prepared as described in section 2.4. 
2.6 Preparation of a C.jejuni suspension for assays 
To prepare suspensions of C. jejuni for assays, bacteria were grown for 24 h on a BA 
plate, collected from the plate using a sterile 10 ~l loop and resuspended in the 
desired medium. 
2.7 Quantification of bacteria 
Two methods were used to quantify the number of bacteria in a suspension:-
2.7.1 Quantification by optical density 
For rapid quantification of bacteria in a suspension, the optical density (OD) at a 
wavelength of 600 nm was determined. Bacteria were suspended in the required 
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medium as described in section 2.6 and diluted 1: 10 in fresh medium in a cuvette (10 
mm path length, Kartell, Noviglio, Italy). The spectrophotometer (WPA, Cambridge, 
UK) was zeroed with a sample of pure medium and the OD6oo of the bacterial 
suspension determined. This method allows for rapid quantification of different 
bacterial suspensions such as for inoculation of a co-culture assay with different 
strains/mutants with approximately the same number of bacteria. However, this 
method is only an approximation and requires the OD600/CFU ratio to be similar for 
every strain and mutant. This was assessed using the CFU count method of bacterial 
quantification. 
2.7.2 Quantification by CFU count 
For absolute quantification of bacterial numbers in a suspension, such as for 
determination of the OD600/CFU ratio for different C. jejuni strains and mutants, a 
bacterial suspension was adjusted to an OD600 of 1. The suspension was serially 
diluted 1:10 in phosphate buffered saline (PBS) (Sigma) up to a dilution factor of 10-
6 and 100 ~l aliquots of each dilution plated in triplicate on BA plates and incubated 
for 72 h. For dilutions with 20-200 CFUs per plate, the number of CFUs was counted 
and used to calculate total CFUs in the initial suspension. Using this method, a 
concentration of 1-2 x 109 C. jejuni / ml was determined for a suspension of OD600 = 
1. This was confirmed to be the case for both wild-type strains as well as all mutants 
used in this study. 
2.8 Mammalian cell culture 
2.8.1 Human intestinal epithelial cell lines 
Two human intestinal epithelial cell (IEC) lines were used in this study: Caco-2 
(ATCC® number HTB-37™) and T84 (ATCC® number CCL-248™). Both lines 
are derived from a colorectal adenocarcinoma and exhibit characteristics of a 
polarised epithelium such as tight junctions and desmosomes when grown to 
confluence. Both lines were routinely cultured at 37°C in a MC015-AC humidified 
tissue culture incubator (Sanyo) in air enriched with 5% CO2• 
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2.8.2 Cell culture media 
Caco-2 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) (Sigma) 
supplemented with 10% (v/v) heat-deactivated FCS, 1% (v/v) MEM non-essential 
amino acids (Sigma), 100 units/ml penicillin and 100 J.lg/ml streptomycin (Sigma). 
T84 cells were grown in 1:1 DMEMIHam's F12 medium containing GlutaMAXTM 
and supplemented with 10% (v/v) heat inactivated FCS, 100 units/ml penicillin and 
100 J.lg/ml streptomycin. These two media are referred to as complete growth 
medium in this study. 
2.8.3 Resuscitation of IECs from frozen stocks 
Frozen stocks of both IEC lines were stored in the vapour phase of a Statebourne 
Biosystems24 liquid nitrogen storage tank (Statebourne, Washington Tyne & Wear, 
UK). To resuscitate the IECs, a vial was thawed at 37°C and the contents added to 
10 ml of the appropriate complete growth medium in a 25 cm2 tissue culture flask 
(Corning). Mter 24 h, the medium was removed, the cells washed once with sterile 
PBS (Sigma) and 10 ml of fresh complete growth medium added. Once the cells 
reached 80-90% confluence as judged by eye using an inverted microscope (Leica, 
Wetzlar, Germany), the cells were detached by immersion in Trypsin-EDTA solution 
(Sigma) for 5-10 min and seeded into a new 75 cm2 tissue culture flask (Corning) 
containing 25 ml of fresh complete growth medium. 
2.8.4 Passaging of lEes 
IECs were routinely subcultured (split) when 80-90% confluence was reached. The 
cells were briefly washed with 10 ml of sterile PBS and then with 1.5 ml of Trypsin-
EDTA solution. 4 ml of fresh Trypsin-EDTA was added to the cells and incubated 
for 5-10 min at 37°C in the tissue culture incubator to detach the cells. The Trypsin 
was then deactivated by addition of 46 ml of fresh complete growth medium 
containing 10% (v/v) FCS. The cell suspension was centrifuged at 200 x g for 10 
min at 4°C. The cell pellet was resuspended in fresh culture medium by gentle 
pipetting and one third (T84) or one eighth (Caco-2) of the suspension transferred to 
a fresh 75 cm2 flask containing 25 ml of complete growth medium (Split ratio 1:3 or 
1:8 respectively). 
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2.8.5 Enumeration of IECs using a haemocytometer 
100 !J.I of cell suspension was mixed with BOO !J.I of complete growth medium and 
100 !J.I of Trypan Blue dye (Sigma). Approximately 10 !J.I was loaded into both 
chambers of a haemocytometer (Weber Scientific, Teddington, UK) and the average 
number of cells per square determined using an inverted microscope. The cell 
density was calculated as described in Figure 2.1. 
N x 9 X 
" 
1000 X 10 = number of cells per ml 
I 
Average 
number of cells 
per square 
Volume over 
one square = 
1/9 of a !J.I 
r 
Multip lica tion 
factor to 
convert "cells 
per /ll"to 
"cells per ml" 
\ 
Dilution factor 
of original cell 
suspension for 
counting 
Figure 2.1: Formula used to calculate the cell density of a suspension when N cells 
were counted using the haemocytometer. 
Suspensions of the required density were obtained by diluting the original 
suspension with fresh complete growth medium. 
2.8.6 Preparation of frozen IEC stocks 
lEes were grown in 75 cm2 tissue culture flasks, detached with Trypsin-EDTA, 
washed and counted as described in section 2.B.4 and 2.B.5. The cells were pelleted 
again and resuspended in complete growth medium without antibiotics but 
supplemented with 5% (v/v) dimethyl sulfoxide (DMSO) as a cryoprotectant at a 
density of 2-4 x 106 cells/ml. 1 ml aliquots of the suspension were added to cryovials 
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(NUNC) and gradually cooled down to -80°C overnight (OIN) using a Mr FrostyTM 
freezing box (NUNC) in a New Brunswick Scientific Innova ultra-low freezer. The 
vials were then transferred to the vapour phase of a Statebourne Biosystems24 liquid 
nitrogen storage tank. 
2.8.7 Culturing of IECs on Snapwell™ filters for co-culturing 
experiments in a Vertical Diffusion Chamber (VDC) 
For subsequent IEC-bacterium co-culture studies in a VDC, IECs were seeded onto 
permeable polycarbonate Snapwell™ filters (Pore size 0.4 Jlm) (Coming) suspended 
from hanging supports at a density of 4 x 105 cells/filter. The IECs were grown on 
the Snapwell™ filters in a MC015-AC humidified tissue culture incubator for a 
minimum of 21 days, during which the medium was changed every three days. 
2.8.8 Measurement of the Trans-Epithelial Electrical Resistance (TEER) 
of IECs growing on Snapwell™ filters 
The TEER of IECs growing on Snapwell™ filters was measured using a Millicell 
ERS-2 resistance meter using chopstick electrodes (Millipore). 
2.9 Recombinant DNA techniques 
Ultra-pure Milli-Q H20 (Millipore) was used for all molecular biology techniques. 
2.9.1 Isolation of C.jejuni genomic DNA 
C. jejuni genomic DNA was isolated from bacteria grown for 24 h on BA plates 
using a Gentra Puregene Bacterial Kit (Qiagen, Crawley, UK) according to the 
manufacturer's instructions. 
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2.9.2 Polymerase chain reaction (peR) 
PCR was routinely performed using GoTaq DNA polymerase (Promega, 
Southampton, UK). If high fidelity amplification was desired, either for large 
amplicons or for recombinant protein expression, Accuprime Pfx supermix 
(Invitrogen) was used. The PCR mixtures were set up as follows: 
10 X PCR Buffer (200 mMTris-HCI (PH 8.4), 500 mM KCI) 
50mM MgClz 
10 mM dNTP mix (each dNTP at 10 mM) 
Oligonucleotide primers (10 pmol) 
0.5 units DNA polymerase 
Template DNA (10 pg to 200 ng) 
H20 
5 ~l 
1.5 ~l 
1 ~l 
2 ~l 
0.2 ~l 
1-5 ~l 
to 50 ~l 
The reaction mixture was scaled up for reactions aimed at obtaining large yields of 
PCR product for downstream applications and scaled down to 25 ~l for screening 
PCRs. 
PCR reactions were routinely performed on a Tetrad-2 thermocycler (BioRad, 
Hemel Hempstead, UK). A representative PCR program using GoTaq DNA 
polymerase is shown below: 
95°C for 10 min initial denaturation 
95°C denaturation for 30 s 
55°C annealing for 30 s 
72°C extension for 1 mini kb 
72°C for 10 min 
- 1 cycle }-35 cycles 
- 1 cycle 
The annealing temperature was adjusted depending on the characteristics of the 
primer pair. If Pfx supermix was used, the extension temperature was changed to 
68°C and the extension time adjusted to 1 min/500 bp. 
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2.9.3 Purification of peR products and purification of DNA after 
enzymatic reactions 
DNA fragments were purified after PCR and after digestion with restriction 
endonucleases using the QIAquick PCR purification kit (Qiagen) according to the 
manufacturer's instructions. 
2.9.4 DNA digestion using restriction endonucleases 
Restriction endonucleases were purchased from New England Biolabs (NEB, 
Hitchin, UK). Restriction digests were routinely set up as follows: 
10 X Reaction buffer (NEB) 
Restriction endonuclease 
DNA 
H20 
5 ~l 
5U 
0.5 ~g to 5 ~g 
to 50 ~l 
Digests were routinely performed at 37°C for 1 h. Double digests were performed as 
required if the two enzymes shared a common reaction buffer. DNA was purified 
after digestion as described in section 2.9.3. 
2.9.5 Antarctic phosphatase treatment of digested DNA vectors 
To prevent self-ligation of digested vectors, 5' phosphate groups were removed by 
treatment with Antarctic phosphatase (NEB) at 37°C for 15 min according to the 
manufacturer's instructions. 
2.9.6 Ligation of DNA fragments 
T4 DNA ligase was purchased from NEB. Insert-vector ligation reactions were as 
follows: 
10 X Reaction buffer 
T4 DNA ligase (400,000 cohesive end units/ml) 
Vector backbone DNA 
Insert DNA 
H20 
1~1 
1 ~l 
2 ~l 
6 ~l 
to 10 ~l 
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Insert to vector ratios of 3:1 were used. Ligations were mixed by gentle pipetting and 
incubated at 4°C DIN. 
2.9.7 Transformation ofE. coli with ligation products/plasmids 
E. coli DH5a cells were transfonned with ligation products or plasmids using a heat 
shock protocol. Briefly, 100 I-tl of chemically competent E. coli DH5a cells were 
thawed on ice and gently mixed with 1 I-tl of plasmid or 5 I-tl of ligation product. The 
mixture was incubated on ice for another 30 min followed by heat shocking at 42°C 
for 45 seconds. The cells were cooled on ice for 2 min before 900 I-tl of SOC broth 
(Invitrogen) was added and the cells recovered by incubation for 1.5 h at 3rC with 
agitation at 200 RPM. The bacteria were harvested by centrifugation at 13,000 x 
RPM for 2 min, the supernatant removed by decanting, the cells resuspended in the 
residual supernatant, plated on selective agar plates and incubated OIN at 37°C. 
2.9.8 Isolation of plasmid DNA from E. coli Strains 
Plasmid DNA was isolated from overnight cultures of E. coli using the QIAprep 
Spin Miniprep Kit (Qiagen) according to the manufacturer's instructions. 
2.9.9 Agarose gel electrophoresis (AGE) of DNA fragments 
50 X concentrated tris-acetic acid EDT A buffer (T AE) was prepared as follows: 
Trizma-base (Sigma) 
0.5 M EDTA pH 8.0 (Sigma) 
Glacial Acetic Acid (Sigma) 
H20 
242g 
100ml 
57.2 ml 
to 11 
To prepare a 1% (w/v) agarose gel for DNA electrophoresis, 1 g of agarose powder 
(Bioline, London, UK) was added to 100 ml of 1 X T AE buffer. The agarose was 
dissolved by microwaving the suspension at a low setting to avoid evaporation and 
superheating. Once the agarose was dissolved, the suspension was cooled to 50°C, 
Ethidium Bromide (stock 10 mg/ml) (Promega) that had been stored in the dark at 
4°C was added at a final concentration of 0.5 I-tg/ml, the gel poured into an 
electrophoresis tray (BioRad), the comb (BioRad) inserted and the gel left to set at 
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room temperature. The DNA fragments were mixed with 6 X concentrated loading 
buffer (Bioline) in a ratio of 6:1, loaded into the wells, separated by electrophoresis 
at 100 V for 45 min in an AGE tank (BioRad) and the separated fragments visualised 
by UV-illumination of the EtBr-DNA complex in a Gene Genius Gel imager (UVP, 
Cambridge, UK). 
2.9.10 Transformation ofC.jejuni with plasmid DNA 
Electrocompetent C. jejuni for transformation with plasmid DNA by electroporation 
were prepared as follows. C. jejuni were grown on BA plates for 24 h. The bacteria 
were harvested with a sterile loop and thoroughly resuspended in 1 ml of ice cold 
EBF solution (10% (v/v) glycerol, 10% (w/v) sucrose in H20). The bacteria were 
pelleted by centrifugation at 13,000 x RPM for 10 min and resuspended in 1 ml of 
ice cold EBF solution. This step was repeated twice. The bacteria were then 
resuspended in 200 ",1 of ice cold EBF and 50 ",1 aliquots placed into sterile 
microcentrifuge tubes. 5 ",1 of plasmid DNA was added to the bacterial suspension, 
mixed by gently flicking the tube and incubated for 15 min on ice. The mixture was 
transferred to a pre-cooled electroporation cuvette (BioRad) (2 mm diameter) and 
placed into a Gene Pulser XCell electroporator (BioRad). The suspension was 
electroporated with the following settings (2.5 kV, 25 ",F, 2000), after which 100 ",1 
of prewarmed SOC broth (Invitrogen) was added and thoroughly mixed. The 
suspension was plated onto non-selective BA plates and incubated microaerobically 
for 24 h. The resultant lawn was collected with a sterile loop, streaked onto a BA 
plate containing the appropriate antibiotic and incubated microaerobically for up to 
72 h. Colonies were restreaked onto fresh selective BA plates and checked by PCR 
to verify the homologous recombination of the desired construct. 
2.9.11 Complementation of the C.jejuni rpoN mutation 
The complementation vector described in (Hitchen et ai., 2010) was used to 
complement the rpoN mutation in the 11168H rpoN mutant. The vector had been 
engineered to carry a 2179 bp fragment corresponding to nucleotides 205297-
207475 of the C. jejuni 11168H genome. This stretch of nucleotides is annotated as a 
pseudogene, Cj0223 (Gundogdu et ai., 2007). A chloramphenicol resistance cassette 
lacking a transcriptional terminator, followed by a multiple cloning site (MCS) 
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comprised of recognition sites for the restriction endonucleases Neol and Nhel was 
cloned into the centre of the 2179 bp fragment. The C. jejuni gene to be 
complemented can therefore be directionally cloned into the MCS and will be 
expressed from the constitutively active CamR promoter. 
A forward primer was designed to anneal 30 bp upstream of the ATG start codon of 
the rpoN gene in order to include the ribosomal binding site (RBS), as no RBS is 
present on the complementation vector (Figure 2.2). An Neol restriction enzyme 
recognition site was included at the 5' end of the primer for directional cloning of the 
PCR product into the complementation vector. 
5' -ccccatggtaggagcggagtttaaactccttgattgatg-3' 
.--------,/ r / 
Recognition 
sequence for 
Neol 
Ribosomal 
binding site 
Methionine 
start codon 
Figure 2.2: Forward primer used to amplify the rpoN gene from genomic DNA of C. jejuni 
11168H wild-type strain. 
A reverse primer was designed to anneal at the 3' end of the rpoN gene .An Nhel 
restriction enzyme recognition site was included at the 5' end of the primer for 
directional cloning of the PCR product into the complementation vector (Figure 2.3). 
5' -cc7tagctt\agttcatataatttttttctatc-3 ' 
Recognition Stop Co dOll 
sequell ce for (reverse 
NheI cowplemellt) 
Figure 2.3: Reverse primer used to amplify the rpoN gene from genomic DNA of C. jejuni 
11168H wild-type strain. 
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The rpoN gene was amplified by PCR from genomic DNA isolated from the C. 
jejuni 11168H wild-type strain using the two primers shown above. The PCR 
product was digested with Ncol and Nhel, purified, ligated into the Ncol/Nhel site of 
the complementation vector and transformed into chemically competent E. coli as 
described in sections 2.9.4-5 and 2.9.6-7. Successful cloning of the PCR product was 
confirmed by purifying plasmid prpoNcomp from E. coli and performing restriction 
analysis on the plasmid DNA using Ncol and Nhel. Analysis of the restriction 
products by AGE demonstrated the release of a DNA fragment of the correct size 
from both plasmids, but not from the original empty vector used for cloning, 
confirming the successful cloning of a DNA fragment of the correct size for rpoN 
into the complementation vector. 
2.10 Host-pathogen interaction methods 
2.10.1 Assembly of the Vertical Diffusion Chamber (VDC) 
Prior to assembly, the two compartments of the VDC (Harvard Apparatus, Kent, 
UK) were sterilised by immersion into Chloros (Sigma) solution for a minimum of 3 
h, followed by three washes with Milli-RO water. A Snapwell™ filter carrying a 
monolayer of Caco-2 cells differentiated for at least 21 days was removed from a 
culture plate, washed three times with PBS and inserted between the two 
compartments of the VDC. The apical compartment was filled first to avoid removal 
of the IECs from the Snapwell™ filter due to liquid pressure from the basolateral 
compartment. The apical compartment was filled with either DMEM supplemented 
with 1% (v/v) PCS and 1 % (v/v) non-essential amino acid solution when using 
Caco-2 IECs, 1:1 DMEMIHam's PI2 medium containing GlutaMAXTM 
supplemented with 1 % (v/v) heat inactivated PCS when using T84 IECs or with 4 ml 
of Brucella broth. The basolateral compartment was filled with 4 ml of DMEM 
supplemented with 1% (v/v) PCS and 1% (v/v) non-essential amino acid solution 
when using Caco-2 IECs, 1:1 DMEMIHam's PI2 medium containing GlutaMAXTM 
supplemented with 1% (v/v) heat inactivated PCS when using T84 IECs. For co-
culturing experiments, C. jejuni were harvested from a BA plate grown for 24 h, 
adjusted to approximately 1 x 108 CFU/ml in either DMEM or Brucella broth as 
described in section 2.6 and 4 ml added into the apical compartment. Por aerobic co-
59 
incubation, the VDC was maintained at 37°C in 5% C02 and 95% air in the 
humidified tissue culture incubator. For microaerobic co-incubation, the VDC was 
maintained under microaerobic conditions (85% N2, 10% C02, and 5% O2) in a 
VAIN. During microaerobic co-culturing, a gas mixture of 95% O2, 5% CO2 was 
perfused through the basolateral compartment using a 12-channel gas manifold 
(Harvard Apparatus) at a flow rate of 1 bubble every 2 to 3 seconds, while the apical 
compartment was left open to the microaerobic atmosphere of the VAIN. 
2.10.2 Measurement of the TEER oflEC monolayers in the VDC 
The TEER of an IEC monolayer on a Snapwell™ filter in a VDC was measured 
using a DVC-1000 voltage clamp (World Precision Instruments, Stevenage, UK). 
This was performed by placing two voltage sensing AgCl electrodes close to the cell 
monolayer on each side of the Snapwell™ filter, passing a current through two 
further electrodes placed at the two distal ends of the VDC and reading the voltage 
necessary to keep the current flowing. Resistance was calculated according to Ohm's 
law (Resistance equals Voltage divided by Current (R = VII», and multiplied by the 
surface area of the monolayers (1.12 cm2), to give the TEER in n cm2. 
2.10.3 Enumeration of bacteria interacting (adherent and invaded) with 
the IECs 
At specific time points, the apical and basolateral supernatants were removed from 
the VDC and stored at -80°C for subsequent analysis of the host immune response 
(see section 2.10.5). Alternatively, for microarray analysis of the gene expression of 
C. jejuni after co-culturing with the IECs in the VDC, the apical supernatant was 
removed, mixed 1:2 with RNAProtect (Qiagen) and stored at -80°C. The Snapwell™ 
filter was removed from the VDC, washed three times with sterile PBS and placed 
into a 6-well tissue culture dish (Coming). The Caco-2 cells were lysed by addition 
of 0.5% (v/v) Triton X-100 (Sigma) in PBS for 20 min at 37°C. The lysates were 
serially diluted in PBS, plated on BA and incubated for 72 h. CFU counts were 
determined and the number of bacteria interacting with the IECs calculated. 
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2.10.4 Enumeration of intracellular bacteria 
Enumeration of intracellular bacteria was essentially performed as above, with one 
modification. Before lysis with Triton X-lOO, the Caco-2 cells were incubated with 
150 Ilglml Gentamicin (Sigma) in DMEM for 2 h at 37°C. This level of Gentamicin 
has been shown to kill C. jejuni whilst not permeating epithelial cells This step 
therefore kills extracellular, adherent bacteria and allows for the enumeration of the 
intracellular bacteria present after co-incubation. 
2.10.5 Analysis of the host innate immune response 
Co-incubation supernatants were probed for the presence of chemokines, cytokines 
and defensins with the appropriate human cytokine/defensin ELISA Development 
Kit (Peprotech, London, UK), according to the manufacturer's instructions. Briefly, 
a 96-well microtitreplate (NUNC) was coated overnight with anti-human 
cytokine/defensin capture antibody at room temperature. The plate was washed three 
times with 0.1% (v/v) Tween 20 (Sigma) in PBS (pBS-Tween) and blocked for 2 h 
with 1% (w/v) Bovine Serum Albumin (BSA) (Sigma) in PBS. Standards containing 
known concentrations of chemokine/cytokine/defensins were prepared, loaded with 
the samples in duplicate and incubated at room temperature for 2 h. The plate was 
washed three times with PBS-Tween and the wells incubated with biotinylated anti-
human chemokine/cytokine/defensin detection antibody at room temperature for 1 h 
(concentration according to the manufacturer's instructions). The plate was washed 3 
times with PBS-Tween and the wells incubated with Horseradish Peroxidase (HRP) 
conjugated avidin at room temperature for 30 min (concentration according to the 
manufacturer's instructions). The plate was then washed three times with PBS-
Tween and 100 III of 2,2'-azino-bis-(3-benzthiazoline-6-sulfonic acid) (ABTS) 
substrate solution (Sigma) was added. The absorbance of each well at 405 nm was 
measured on a Dynex MRX II 96-well plate reader (Dynex, Worthing, UK). The 
data was processed with Revelation software (Revelation, Ealing, UK) and the 
chemokine/cytokine/defensin concentration of each sample calculated using a 
standard curve generated from the standard calibration samples. 
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2.10.6 Immunofluorescence analysis ofCaco-2 cells on Snapwell™ filters 
After disassembly of the VDC post-infection, the Caco-2 cells were fixed with 2% 
(w/v) paraformaldehyde (Sigma) for 1 h at 4°C. The fixed cells were permeabilised 
with 0.1% (v/v) Triton X-100 in PBS for 20 min at room temperature and blocked 
with 1% (w/v) BSA in PBS for 1 h at room temperature. The filter was then excised 
from the carrier and placed in a 12-well dish. For actin staining, the cells were 
incubated with Alexa Fluor 555 conjugated phalloidin (Invitrogen) (stock diluted 
1:1000 in PBS) for 1 h in the dark. For staining of occludin, the cells were incubated 
with mouse anti-occludin primary antibody (stock diluted 1:100 in PBS) (Invitrogen) 
for 1 h at room temperature followed by an Alexa Fluor 488 conjugated goat anti-
mouse (Invitrogen) (stock diluted 1:200 in PBS) for 1 h at room temperature in the 
dark. Stained filters were mounted in Vectashield mounting medium containing 4',6 
diamidino-2-phenylindole (DAPI, final concentration 1.5 ~g/ml) (Vector 
Laboratories, Peterborough, UK) on a coverslip (Fisher) and examined with a Zeiss 
LSM510 Confocal microscope (Carl Zeiss AG, Jena, Germany). 
2.10.7 Fluorescent dextran diffusion assay 
IECs on Snapwell™ filters were washed three times with sterile PBS, placed back 
into the hanging support and 500 ~l of 100 ~M FITC-Iabelled dextran (Sigma) with 
an average molecular weight of 4 kilodaltons (kDa) in Ringer's solution (115 mM 
NaCl, 1 mM KCI, 1 mM CaCh in H20) added to the apical side of the monolayer 
and incubated for 3 h at room temperature, with the basolateral side of the monolayer 
immersed in Ringers solution. The amount of fluorescently labelled dextran on the 
basolateral side of the monolayer was determined post-incubation by removal of the 
basolateral solution and measurement of the fluorescence intensity at 488 nm using a 
Gemini XPS Fluorescence Microplate Reader (Molecular Devices, Sunnyvale, 
USA). 
2.10.8 Preparation of media for ex vivo organ culture 
EVOC medium was prepared by adding 0.95 g powdered NCTC-135 media (Sigma) 
to 100 ml H20. The pH was adjusted to 7.4 by adding 0.22 g sodium bicarbonate 
(Sigma). Finally, 100 ml of DMEM (Sigma) and 20 ml FCS (Sigma) were added and 
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the medium filter sterilised using a 0.22 Jlm filter (Millipore) to make up complete 
EVOC medium. 
2.11 Bacteriological assays 
2.11.1 Swimming motility assay 
To assess the motility of a C. jejuni strain, the ability of the bacteria to swim though 
0.4% (w/v) soft agar plates was determined. Motility plates were prepared as 
described in section 2.2. Two different methods for inoculating the bacteria into the 
agar were used. For a quick check of motility, a culture growing on a BA plate was 
touched with a sterile loop, stabbed into the motility plate and the motility monitored 
over 72 h. For a more quantitative comparison between strains, a bacterial 
suspension of 1 OD600 was prepared in sterile PBS as described in section 2.6, then 1 
Jll stabbed into the motility plate using a pipette and the motility monitored by 
measuring the diameter of the bacterial halo every 24 h over a period of 72 h. 
2.11.2 Autoagglutination assay 
To assess the autoagglutination properties of a C. jejuni strain or mutant, 2 ml of a 
suspension at an OD6oo of 1 was prepared in sterile PBS as described in section 2.6. 
The suspension was incubated in a 5 ml plastic tube (Fisher) at 37°C under 
microaerobic conditions for 24 h and the OD6oo of the top 1 ml of the suspension was 
determined as described in section 2.6. If the bacteria tested had autoagglutinated, 
the OD would be substantially lower, as most of the bacteria would have pelleted to 
the bottom of the tube. 
2.12 Microarray analysis 
2.12.1 Total RNA isolation 
Total bacterial RNA was isolated using the RNEasy kit (Qiagen) according to the 
manufacturer's instructions from apical supernatants of VDC co-culturing 
experiments that had been stored in RNAProtect. 
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2.12.2 Microarray experimental design, template labelling and 
hybridisation 
Gene expression profiling of C. jejuni 11168H wild-type strain co-cultured with 
Caco-2 IECs for 6 and 24 h in the VDC under either aerobic or microaerobic 
conditions was performed using an indirect comparison method or type 2 
experimental design (Kamal et al., 2007). In this experimental design, replicate test 
sets of Cy5-labelled C. jejuni 11168H wild-type strain total RNA samples were 
combined with a common reference sample (Cy3-labelled C. jejuni 11168H wild-
type strain genomic DNA). The microarrays used in this study were whole genome 
C. jejuni NCTC11168 arrays printed on Ultragaps glass slides (Corning), produced 
by the BJlG@S Group (www.bugs.sghms.ac.uk). 
50 ml of pre-hybridisation solution was prepared as stated below and placed into a 
Coplin jar (Fisher). Reagents were added in the following order:-
Sodium Dodecyl Sulphate (SDS) 20% (v/v) (Sigma) 
H20 
20 X Saline Sodium Citrate (SSC) (Sigma) 
Bovine Serum Albumin (BSA) (100 mg!ml in H20) 
250/-l1 
36.0 ml 
8.75 ml 
5 ml 
The pre-hybridisation solution was incubated at 65°C for 1 h before beginning the 
experiment. 
2.12.2.1 Cy3-labelling of control C.jejuni 11168H wild-type strain 
genomic DNA 
To label the control genomic DNA, the following reaction was set up:-
Genomic DNA 
Random primers (3 /-lg!/-ll) (Invitrogen) 
H20 
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Reactions were heated at 95°C for 5 min followed by snap cooling on ice and brief 
pulse centrifugation. The following reagents were added to the reactions:-
10 X REact 2 buffer (Invitrogen) 5 J..lI 
dNTPs (5 mM dATP, dGTP dTTP, 2 mM dCTP) (Invitrogen) 1 J..lI 
25 nM Cy3-labelled dCTP (GE Healthcare, Chalfont St. Giles, UK)1.5 J..lI 
Klenow fragment (10 U/J..ll) (Invitrogen) 1 J..lI 
The reaction was incubated at 37°C for 90 min. 
2.12.2.2 Cy5-labelling of test C.jejuni 11168H wild-type total RNA 
To label the test RNA, the following reaction was set up. 
Total RNA 
Random primers (3 J..lg/J..lI) (Invitrogen) 
2.5 ng 
1 J..lI 
Reactions were heated at 95°C for 5 minutes followed by snap cooling on ice and 
brief pulse centrifugation. Test reactions were prepared, adding reagents in the 
following order:-
5 X first strand buffer (Invitrogen) 5 J..lI 
DTT (100 mM) (Sigma) 2.5 J..lI 
dNTPs (5 mM dATP, dGTP dTTP, 2 mM dCTP) (Invitrogen) 2.3 J..lI 
25 nM Cy5-labelled dCTP (GE Healthcare) 1.7 J..lI 
Reverse transcriptase (Superscript II 200 U/J..lI) (Invitrogen) 2.5 J..lI 
The Test Cy5-labelled reaction was incubated at 25°C for 10 min, followed by 
incubation at 42°C for 90 min. 20 min prior to completion of this incubation, 
microarray slide(s) were placed into the pre-hybridisation solution in the Coplin jar 
and incubated at 65°C, 
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2.12.2.3 Combination and purification of the labelled test and control 
samples 
Both control and test reactions were combined in a 1.5 ml microcentrifuge tube. The 
reaction was purified using a MinElute PCR purification kit (Qiagen) according to 
the manufacturer's instructions. The cDNA was eluted from the column by adding 
14 fJ.I H20 to the spin column. Samples were incubated on ice. Pre-hybridized 
microarray slides were rinsed in H20 for 1 minute using a trough and holder 
(Fisher). Slides were then rinsed in 100% isopropanol for 1 minute. Microarray 
slides were dried by placing into 50 ml Falcon tubes and centrifuging at 1500 x RPM 
for 5 min. The Hybridisation solution was prepared as follows in a 1.5 ml 
microcentrifuge tube:-
Eluted sample 
H20 
20XSSC 
2% (v/v) SDS 
This hybridisation solution was heated at 95°C for 2 min, allowed to cool to room 
temperature and briefly centrifuged. 
A microarray slide was placed in a humidified hybridisation cassette (Telechem 
International, Sunnyvale, USA) and covered with a LifterSlipTM (Erie Scientific, 
Portsmouth, USA) glass coverslip (22 mm x 25 mm) over the array section. The 
hybridisation solution was carefully pipetted under the LifterSlipTM. The microarray 
chamber was sealed and incubated in a water bath at 65°C overnight without 
shaking. Wash A solution was also prepared and incubated at 65°C overnight along 
with troughs and holder. 
Wash A 
20XSSC 
20% (v/v) SDS 
H20 
20ml 
1 ml 
379 ml 
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Wash A was dispensed into a single trough. Prior to commencing the wash protocol, 
Wash B solution was prepared as follows; 
WashB 
20XSSC 
H20 
Wash B was dispensed into two troughs. 
2.4ml 
797.6 ml 
The micro array slides were removed from the cassettes, placed into the holder in 
Wash A and gently agitated for 5 min. The micro array slides were transferred to a 
clean rack and rinsed with gentle agitation in Wash B for 2 min. This was followed 
by another 2 min in the second Wash B trough. The microarray slides were placed 
into 50 ml Falcon tubes (Fisher) and spun at 1500 x RPM for 5 min to dry the slides, 
with the labels facing away from the tube lid to ensure any liquid was centrifuged 
away from the printed array area. 
2.12.3 Data analysis 
The microarray slides were scanned with an Affymetrix 418 array scanner (MWG 
Biotech, Acton, UK) according to the manufacturer's instructions. Signal and local 
background intensity readings for each spot were quantified using ImaGene software 
v8.0 (BioDiscovery, EI Segundo, USA). Quantified data were analysed using 
GeneSpring GX software v7.2 (Agilent, Santa Clara, USA). Expression analysis was 
performed using a DNA versus RNA experimental set-up. To determine which genes 
were differentially expressed under the microaerobic test conditions, a P-value of < 
0.05 was used for testing whether the normalised expression of each gene 
statistically differed from 1.0 by ANOVA (Analysis Of Variance) using a Benjamini 
& Hochberg False Discovery Rate as the Multiple Testing Correction within the 
GeneSpring software. As many of the fold changes between the gene expression 
levels under the two experimental conditions were small, this correction method was 
used as it is the least stringent method and therefore least likely to call a gene non-
significant when in fact it is. 
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Chapter 3 
Development of an ex vivo organ culture 
model to study C. jejuni interactions with 
human intestinal biopsies 
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3.1 Introduction 
One advantage of animal models for infectious diseases over most in vitro models is 
the complexity of the in vivo system, despite the fact that such complexity may 
complicate the monitoring of the interaction between pathogen and host. In the case 
of the intestinal pathogen C. jejuni, it is assumed that the bacteria interact with 
numerous host cells types such as epithelial cells, DCs sampling the intestinal lumen 
and also with macrophages and other cells of the innate and adaptive immune 
system. The commonly used in vitro models generally utilise only one cell type, 
which therefore do not take into account the complexity of the interactions between 
the pathogen and the host or the interactions between host cells after encountering 
the pathogen, resulting in a simplification of the interactions occurring in vivo. This 
may in tum lead to an incomplete understanding of the host-pathogen interactions 
involved in pathogenesis. Small animal models can be used to overcome the 
simplicity of single cell type in vitro models, as they offer a more complex basis for 
investigating host-pathogen interactions. However no robust, reproducible and 
routinely usable small animal model has been established to date for C. jejuni 
infection. So far, most advances in the understanding of C. jejuni pathogenesis have 
been achieved using in vitro models with either immortalised cell lines or primary 
tissue. 
An ex vivo organ culture (EVOC) model, where human primary tissue is co-cultured 
with a pathogen, is one way of overcoming the absence of an animal model whilst 
not compromising the complexity of the tissue. The major drawback with the EVOC 
model is that the timeframe of such experiments is limited due to the problems with 
viability of the tissue over a prolonged period of time ex vivo. An EVOC model has 
successfully been utilised to study the interaction of enteroaggregative, 
enteropathogenic and enterohaemorrhagic Escherichia coli with human intestinal 
tissue (Hicks et al., 1996, Hicks et al., 1998, Mousnier et al., 2008). An example of 
the advantage of using primary human intestinal tissue was a study that 
demonstrated differences between Tir phosphorylation and Nck/N-WASP 
recruitment in an EVOC model for enterohaemorrhagic and enteropathogenic E. coli 
compared to those observed in cell culture models (Schuller et al., 2007). For C. 
jejuni, the first report of an EVOC model demonstrated activation of ERK, JNK and 
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p38 MAPK kinases in an EVOC model (MacCallum et ai. , 2005a). A second study 
demonstrated the secretion of IL-8 from C. jejuni infected human intestinal tissue 
(MacCallum et ai. , 2006). Initial microscopical studies of the interaction between C. 
jejuni and human intestinal tissue ex vivo have demonstrated micro-colonies of 
bacteria interacting with the tissue and with other bacteria, preferentially via the 
flagella (Grant et ai., 2006). This observation has been confirmed recently with the 
demonstration that C. jejuni form microcolonies on ex vivo infected human ileal 
tissue (Haddock et al., 2010). 
The aim of this study was to expand the use of the EVOC model for studying the 
host innate immune response to C. jejuni infection using different C. jejuni wild-type 
strains as well as defined isogenic mutants. 
3.2 Setting up the EVOC model 
Human intestinal biopsies were co-cultured with C. jejuni as described previously 
(Hicks et ai., 1996). In brief, histologically normal mucosal samples from terminal 
ileum and colon were obtained courtesy of Dr Keith J Lindley from paediatric 
patients undergoing routine endoscopic examination at Great Ormond Street 
Hospital for Children. Institutional ethical approval (ICH/Great Ormond Street 
Hospital for Children Research Ethics Committee: REC: 06/00508/26-05/07/2006 
and LSHTM Ethics Committee: EC:5016-19/09/2006) was obtained in advance and 
parental consent obtained at the time of the procedure. The patients ' age varied 
between 2 and 16 years, with a median of 11 years of age. Routinely, around 2-4 
biopsies from the colon were obtained. If the patient was undergoing upper 
endoscopy, around 1-3 additional ileal biopsies were received. An experimental day 
usually encompassed working with biopsies from between 1 and 3 patients. The 
tissue was placed into EVOC medium (see section 2.10.8) immediately after removal 
of the tissue from the patient and transported to the lab. The biopsies were 
microscopically examined for integrity such as presence of villi for ileal samples or 
intact crypts for colonic samples. If satisfactory, biopsies were mounted with the 
mucosal side upwards on sterile foam blocks in a 12 well plate (Figure 3.1). EVOC 
medium was added to the wells to a level that allowed partial covering of the 
biopsies. Preliminary studies had demonstrated that tissue stayed intact under these 
conditions for at least 12 hours (Matthias Zilbauer, PhD thesis, University of 
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London, 2007). C. jejuni were harvested from a 24 h plate into sterile PBS and 
adjusted to approximately 1 x 109 CFU/ml. 20 I .. d of this suspension was inoculated 
onto the tissue and incubated in a tissue culture incubator at 37°C with agitation on a 
rocker (30 motions per min). The EVOC medium was changed after 4 hours and 
another 20 ~l of the same bacterial suspension inoculated onto the biopsies. 8 hours 
after the initial set up, the medium (containing secreted proteins from time point 4 h 
to time point 8 h) was removed and stored at - 80°C for subsequent analysis. 
A B 
Figure 3.1: Microscopically intact biopsies were mounted mucosal side up on sterile foam 
blocks and covered with ex vivo organ culture medium. Biopsies were inoculated with either 
sterile PBS as a negative control or with 20 ~I of a suspension of a C. jejuni wild-type strain 
or mutant in PBS containing approximately I x 109 CFUlml and incubated on a rocker at 
37°C in a tissue culture incubator containing air enriched with 5% CO2• 
3.3 Co-incubation of human intestinal tissue with C.jejuni 11168H 
wild-type strains ex vivo does not lead to increased secretion of 
Interleukin 8 (IL-8) 
Previous studies have shown that the secretion of the proinflammatory chemokine 
IL-8 by adult human intestinal tissue was increased in response to ex vivo infection 
with C. jejuni wild-type strains NCTCll168 and L115 (MacCallum et ai. , 2006). 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain for 8 h ex vivo. The 
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supernatants were analysed by ELISA for the presence of IL-8 (Figure 3.2). No 
difference in IL-8 levels in the supernatants of infected and uninfected tissue was 
observed, in contrast to the previously reported study. The basal levels of IL-8 
secretion from uninfected tissue was similar for the ileal samples, 500 pglml in the 
previously published study (MacCallum et ai., 2006) and 380 pglml in this study. 
However, the basal levels of IL-8 secreted from the uninfected colonic samples 
differed markedly, approximately 2000 pglml in the previously published study and 
360 pglml in this study. Possible reasons for this finding are discussed in section 
3.11. 
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Figure 3.2: Human intestinal biopsies from the ileum (circles, N = 6) and the colon 
(squares, N = 7) were either mock infected with PBS (open symbols) or infected with C. 
jejuni 1116SH wild-type strain (black symbols) for S h ex vivo. The supernatants were 
probed by ELISA for the presence of IL-S. 
3.4 Co-incubation of human intestinal tissue with C.jejuni 81-176 
wild-type strains ex vivo does not lead to increased secretion of 
IL-8 
The previously published study demonstrated different levels of IL-8 secretion by 
human intestinal tissue in response to infection with two different C. jejuni wild-type 
strains (MacCallum et ai., 2006), with wild-type strain NCTCl1168 inducing lower 
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levels of IL-8 secretion than strain L115. To investigate the possibility that the C. 
jejuni 11168H wild-type strain only induces a minimal IL-8 response in this EVOC 
model and that a different C. jejuni wild-type strain might induce higher levels of IL-
8 secretion, human intestinal biopsies from the ileum and the colon were either mock 
infected with PBS or infected with C. jejuni 81-176 wild-type strain for 8 h ex vivo. 
The supernatants were analysed by ELISA for the presence of IL-8. 
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Figure 3.3: Human intestinal biopsies from the ileum (circles, N = 6) and the colon (squares, 
N = 7) were either mock infected with PBS (open symbols) or infected with C. jejuni 81-
176 wild-type strain (black symbols) for 8 h a vivo. The supernatants were probed by 
ELISA for the presence of IL-8. 
As with infection with the C. jejuni 11168H wild-type strain, no difference was 
detected between the levels of IL-8 secreted from uninfected biopsies compared to 
biopsies infected ex vivo with the C. jejuni 81-176 wild-type strain (Figure 3.3). 
3.5 Co-incubation of human intestinal tissue with C.jejuni 11168H 
or 81-176 wild-type strains ex vivo results in increased secretion 
of human beta defensins (hBDs) 
hBDs are antimicrobial peptides involved in innate immune defences against 
pathogenic bacteria. Infection with C. jejuni leads to increased transcription, 
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translation and secretion of human beta defensins 2 and 3 (hBD-2 and hBD-3) from 
Caco-2 and HT-29 human IECs (Zilbauer et aI., 2005). This in vitro data suggested 
an important role for hBDs in responding to C. jejuni infection. As no increased 
secretion of IL-8 had been detected from either colonic or ileal human tissue in 
response to infection with either C. jejuni 11168H or 81-176 wild-type strains 
(Figure 3.2 and Figure 3.3), the effect of infection with the same two wild-type 
strains on the secretion of hBD-2 and hBD-3 was analysed. To determine whether a 
hBD response was elicited in ex vivo infected human primary tissue, the co-culture 
supernatants were probed for the presence of hBD-2 and hBD-3 by ELISA following 
ex vivo infection with the two different C. jejuni wild-type strains 11168H and 81-
176 for 8 h. 
3.5.1 hBD-2 
hBD-2 is a cysteine-rich cationic low molecular weight antimicrobial peptide, which 
has been shown to be produced by a number of epithelial cells and exhibits potent 
antimicrobial activity against Gram-negative bacteria (Schroder et al., 1999). hBD-2 
showed potent bactericidal activity against C. jejuni 11168H wild-type strain in 
vitro, with> 99% of all bacteria in an initial suspension of 1 x 10 5 CFU killed within 
30 min of exposure (Zilbauer et al., 2005). 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H or 81-176 wild-type strains for 8 h ex 
vivo. The supernatants were probed by ELISA for the presence of hBD-2 (Figure 
3.4). 
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Figure 3.4: Human intestinal biopsies from the ileum (circles, N = 6) and the colon 
(squares, N = 6) were either mock infected with PBS (open symbols) or infected with C. 
jejuni 11168H (black symbols) or 81-176 (grey symbols) wild-type strains for 8 h ex vivo. 
The supernatants were probed for the presence of hBD-2. * = p < 0.05 
Basal levels of hBD-2 were detected in the supernatants of uninfected biopsies from 
the ileum and the colon. (Figure 3.4, open circles and squares, respectively). 
Increased levels of hBD-2 were detected in supernatants of both ileal and colonic 
biopsies infected with C. jejuni 11168H wild-type strain (Figure 3.4, black circles 
and squares) with the numbers reaching statistical significance for colonic tissue. 
The supernatants of biopsies infected with C. jejuni 81-176 wild-type strain also 
contained increased levels of hBD-2 compared to the uninfected samples (grey 
circles and squares), however the differences did not reach statistical significance. 
Taken together, the results demonstrate that infection of human intestinal tissue with 
C. jejuni 11168H and 81-176 wild-type strains ex vivo leads to induction of hBD-2, 
supporting previous evidence indicating a role for the hBD-2 in the defence against 
the pathogen. The data also indicates that a host response is induced by C. jejuni 
with this EVOC model, in contrast to the data obtained for IL-8. 
75 
3.5.2 hBD-3 
hBD-3 is a small, cationic antimicrobial peptide that has been shown to be active 
against Gram-negative as well as Gram-positive bacteria (Schneider et ai. , 2005). 
Similar to hBD-2, hBD-3 expression has been demonstrated to be upregulated in 
IECs in vitro and to exhibit bactericidal effects against C. jejuni 11168H wild-type 
strain in vitro similar to hBD-2, with> 99% of all bacteria in an initial suspension of 
1 x 10 5 CFU killed within 30 min of exposure (Zilbauer et aI., 2005). Human 
intestinal biopsies from the ileum and the colon were either mock infected with PBS 
or infected with C. jejuni 11168H or 81-176 wild-type strains for 8 h ex vivo. The 
supernatants were probed by ELISA for the presence of hBD-3 (Figure 3.5) 
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Figure 3.5: Human intestinal biopsies from the ileum (circles, N = 7) and the colon 
(squares, N = 6) were either mock infected with PBS (open symbols) or infected with C. 
jejuni 11168H (black symbols) or 81-176 (grey symbols) wild-type strains for 8 h ex vivo. 
The supernatants were probed for the presence of hBD-3. * = p < 0.05, ** = P < 0.01, *** = 
p < 0.001. 
Basal levels of hBD-3 were detected in the supernatants of uninfected tissue (Figure 
3.5, open circles and squares). Compared to hBD-2, the levels of hBD-3 detected in 
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uninfected samples were considerably higher, with an average of 240 pglml and 230 
pglml for ileal and colonic tissue respectively compared to approximately 14 pglml 
and 13 pglml for hBD-2. As with hBD-2, increased levels of hBD-3 were detected in 
both the ileal and the colonic supernatants from biopsies infected with either C. 
jejuni 11168H (Figure 3.5, black circles and squares) or 81-176 wild-type strain 
(Figure 3.5, grey circles and squares). Furthermore, all differences between infected 
and uninfected biopsy supernatants reached statistical significance. 
Taken together, these results demonstrate that hBD-2 and hBD-3 are induced from 
human intestinal biopsies in response to infection with C. jejuni wild-type strains ex 
vivo. This supports the previously published in vitro data (Zilbauer et al., 2005) and 
suggests that both defensins play an important part in the host innate immune 
defence against C. jejuni. This is the first time that secretion of hBD-2 and hBD-3 
has been demonstrated in response to challenge of human intestinal tissue ex vivo 
with C. jejuni. Furthermore, as no significant difference was detected between the 
innate immune response induced by the two C. jejuni wild-type strains tested and in 
light of the limited availability of primary tissue, combined with the necessity for at 
least 5 replicate data points per experiment, the decision was taken to use only the C. 
jejuni 11168H wild-type strain in future experiments. 
3.6 Co-incubation of human intestinal tissue with C.jejuni 111688 
wild-type strain ex vivo results in increased secretion of IL-IJJ 
IL-I P is a pro-inflammatory cytokine that is secreted upon recognition of pathogenic 
microorganisms. 11-1 P has been shown to induce the release of other pro-
inflammatory cytokines such as tumor necrosis factor (TNF) and IL-6. IL-I P has 
also been implicated in inducing a Th17 bias in the cellular adaptive immune 
response (Netea et al., 2010). IL-IP release from human Des and macrophages in 
response to C. jejuni has previously been demonstrated (Hu et al., 2006, Siegesmund 
et at., 2004). 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain for 8 h ex vivo. The 
supernatants were probed by ELISA for the presence of IL-I P (Figure 3.6). 
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Figure 3.6: Human intestinal biopsies from the ileum (circles, N =7) and the colon (squares, 
N = 16) were either mock infected with PBS (open symbols) or infected with C. jejuni 
11168H wild-type strain (black symbols) for 8 h ex vivo. The supernatants were probed by 
ELISA for the presence ofIL-lf3. ** = p < 0.01, ***p < 0.001 
Significantly more IL-I ~ was detected in the supernatants of C. jejuni 11168H wild-
type strain infected biopsies compared to the uninfected controls (Figure 3.6). The 
secreted quantities were relatively low, however as only macrophages and DCs have 
been implicated in IL-I ~ secretion, this was not surprising. No striking difference 
was observed between the ileal and the colonic samples. This data suggests a role for 
IL-I ~ in the host defence against C. jejuni and supports previous data Furthermore, 
this is the first time that secretion of IL-I ~ has been demonstrated in response to 
challenge of human intestinal tissue ex vivo with C. jejuni 
3.7 Co-incubation of human intestinal tissue with C.jejuni 11168H 
wild-type strain ex vivo results in increased secretion of IL-6 
IL-6 is involved in maintaining the intestinal epithelium, but is also a pro-
inflammatory cytokine secreted by epithelial cells as well as macrophages and T-
cells in response to pathogens (Jones, 2005). 11-6 has been shown to be produced by 
DCs as well as intestinal epithelial cells in response to C. jejuni infection in vitro 
(Friis et al., 2009, Rathinam et al., 2008). 
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Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain for 8 h ex vivo. The 
supernatants were probed by ELISA for the presence of IL-6 (Figure 3.7). 
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Figure 3.7: Human intestinal biopsies from the ileum (circles, N =8) and the colon (squares, 
N =15) were either mock infected with PBS (open symbols) or infected with C. jejuni 
11168H wild-type strain (black symbols) for 8 h ex vivo. The supernatants were probed by 
ELISA for the presence of IL-6. ** = P < 0.01, ***p < 0.001. 
Significantly higher levels of IL-6 were detected in the supernatants of biopsies that 
had been infected with C. jejuni 11168H wild-type strain compared with the 
uninfected controls (Figure 3.7). The supernatants of infected colonic samples 
contained on average more IL-6 than the ileal samples (31 pglml compared to 23 
pglml), however this was also the case for the uninfected samples. 
This data confirms previous evidence from cell culture assays (Friis et al., 2009) and 
Des (Rathinam et al., 2008) and highlights a role for IL-6 in the host innate immune 
response to C. jejuni. Furthermore, this is the first time that secretion of IL-6 has 
been demonstrated in response to challenge of human intestinal tissue ex vivo with C. 
jejuni 
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3.8 Co-incubation of human intestinal tissue with C.jejuni 111688 
wild-type strain ex vivo results in increased secretion of IL-12 
and IL-23, suggesting a possible involvement of a Th17 
adaptive immune response in combating C.jejuni infection 
Data obtained with collaborators at the ICH demonstrated that in vitro co-culturing 
of C. jejuni 11168H wild-type strain with human blood derived DCs led to secretion 
of IL-l ~ and IL-6, supporting the findings reported in the previous sections. 
Additionally, IL-12 and IL-23, two hallmarks of a Th17 pro-inflammatory immune 
response, were detected in the supernatants. Furthermore, incubation of the co-
culturing supernatants with human T -cells led to the production of Interferon 
Gamma (IFN-y) and IL-17, suggesting that C. jejuni modulates the Th17 type 
adaptive immune response (Edwards et al., 2010). 
As DCs are most likely present in the biopsies, supernatants of C. jejuni infected 
intestinal biopsies were analysed for the presence of IL-12 and IL-23. 
3.8.1 IL-12 
The IL-12 family of cytokines are important players in the regulation of T-cell 
responses, and are produced by monocytes, macrophages and DCs in response to 
infection (Gee et al., 2009). IL-12 has been demonstrated to be secreted by both 
human and murine DCs in response to C. jejuni challenge in vitro (Hu et al., 2006). 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain for 8 h ex vivo. The 
supernatants were probed by ELISA for the presence of IL-12 (Figure 3.8) 
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Figure 3.8: Human intestinal biopsies from the ileum (circles, N = 7) and the colon 
(squares, N = 13) were either mock infected with PBS (open symbols) or infected with C. 
jejuni 11168H wild-type strain (black symbols) for 8 h ex vivo. The supernatants were 
probed by ELISA for the presence ofIL-12. *** p < 0.001. 
Significantly higher levels of IL-12 were detected in the supernatants of tissue that 
had been incubated with C. jejuni 11168H wild-type strain compared to the 
uninfected controls (Figure 3.8). In contrast to what had been observed previously 
for IL-8, hBD-2, hBD-3, IL-I P and IL-6, no basal levels of IL-12 secretion were 
detected in the uninfected controls. 
3.8.2 IL-23 
IL-23, is a recent addition to the ever increasing number of signalling molecules that 
regulate the host adaptive immune system (Monteleone et al., 2009). Similar to IL-
12, IL-23 has been shown to act as a link between innate and adaptive immunity. 
Together with IL-12, IL-23 has been postulated to lead to the differentiation of naIve 
T cells into a novel class of T-helper cells, termed Th17, for the ability to secrete the 
cytokine IL-17. By stimulating the production of pro-inflammatory cytokines, the 
IL-17 secreting T cells are then involved in mediating inflammation (Mills, 2008). 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain for 8 h ex vivo. The 
supernatants were probed by ELISA for the presence of IL-23 (Figure 3.9). 
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Figure 3.9: Human intestinal biopsies from the ileum (circles, N = 7) and the colon 
(squares, N = 16) were either mock infected with PBS (open symbols) or infected with C. 
jejuni 11168H wild-type strain (black symbols) for 8 h ex vivo. The supernatants were 
probed by ELISA for the presence of IL-23. ** = P < 0.01, ***p < 0.001. 
Significantly higher levels of IL-23 were detected in the supernatants of tissue that 
had been incubated with C. jejuni 11168H wild-type strain compared to the 
uninfected controls (Figure 3.9). 
This supports recent data obtained by in vitro culturing of human blood-derived Des 
with C. jejuni where secretion of IL-lP, IL-6, IL-12 and IL-23 was detected after the 
Des were exposed to C. jejuni. Furthermore, the relative abundance of the four 
cytokines (IL-IP < IL-6 < IL-12 < IL-23) that was observed for the infected biopsies 
also held true for the Des (Edwards et al., 2010). Whether this finding is a result of 
the different relative numbers of cytokine producing cells remains unclear. 
3.9 Co-incubation of human intestinal tissue with C.jejuni 111688 
wild-type strain ex vivo results in increased secretion of IFN-y 
and IL-17 
The presence of both IL-12 and IL-23 in the supernatants of both infected Des as 
well as infected human intestinal biopsies suggests that C. jejuni infection triggers 
the IL-12/IL-23 immune axis. This axis has been proposed to further modulate 
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downstream T-cell responses, in particular the recently identified novel acute 
neutrophilic Th17 response, characterised by the differentiation of IL-17 -producing 
Th17 cells (van de Veerdonk et al., 2009). When naIve T cells were cultured in vitro 
with supernatants from DC-C. jejuni co-cultures, both IFN-y and IL-17 were 
detected, suggesting that C. jejuni triggered both a Thl and a Th17 response 
(Edwards et al., 2010). 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain for 8 h ex vivo. The 
supernatants were probed by ELISA for the presence of IFN-y (Figure 3.10). 
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Figure 3.10: Human intestinal biopsies from the ileum (circles, N = 6) and the colon 
(squares, N = 8) were either mock infected with PBS (open symbols) or infected with C. 
jejuni 11168H wild-type strain (black symbols) for 8 h ex vivo. The supernatants were 
probed by ELISA for the presence of IFN-y. * = P < 0.05. 
Higher levels of IFN-y were detected in the supernatants of C. jejuni infected tissue 
compared to the uninfected controls (Figure 3.10). However, the data only reached 
statistical significance for the colonic samples. Interestingly, the absolute values of 
detected IFN-y were approximately 3-fold higher in the ileal samples than in the 
colonic samples (65 pglml for the ileum compared to 18 pglml for the colon), a trend 
that was not observed with any of the other cytokines tested. As the source of the 
cytokines detected in the EVOC model cannot be easily traced back to the cell type 
involved in secretion, it is unclear whether this difference is the result of a different 
relative abundance of IFN-y secreting cells. 
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Data obtained with the ICH collaborators demonstrated increased levels of IL-17 in 
supernatants of ex vivo infected human intestinal biopsies (Figure 3.11). 
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Figure 3.11: Human intestinal biopsies from the ileum (circles, N = 5) and the colon 
(squares, N = 5) were either mock infected with PBS (open symbols) or infected with C. 
jejuni 11168H (black symbols) wild-type strain for 8 h ex vivo. The supernatants were 
probed by ELISA for the presence of IL-17. * = P < 0.05, *** = P < 0.001. Adapted from 
Edwards et al. 2010. 
Taken together, the presence of IFN-y and IL-17 suggests that the C. jejuni 11168H 
wild-type strain initiates a Th17 response in ex vivo infected human intestinal 
biopsies, supporting in vitro data obtained with the ICH collaborators. 
3.10 Investigating the role of C.jejuni surface structures involved in 
eliciting the secretion of hBD-2 and hBD-3 from ex vivo infected 
human intestinal biopsies. 
In addition to the investigation of the host innate immune response induced by ex 
vivo infection of human intestinal biopsies with C. jejuni wild-type strains, a further 
study was undertaken to analyse the role of two C. jejuni surface structures in 
inducing the host innate immune response during ex vivo infection. 
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The identification of pathogenic bacteria by the host via recognition of bacterial 
surface structures is well established (Heine et al., 2005). The bacterial surface 
structures recognised include flagellins, LPS/WS, lipoproteins and peptidoglycan. 
In order to identify which C. jejuni MAMPs are recognised by the host and lead to 
the induction of an innate immune response in the EVOC model, the induction of 
hBD-2 and hBD-3 by a C. jejuni 11168H flaA mutant lacking the major flagellar 
filament protein FlaA and a C. jejuni 11168H neuBl mutant lacking the sialic acid 
residue on the WS were analysed in ex vivo infected human intestinal biopsies. 
3.10.1 Absence of the major flagellar filament protein FlaA does not 
abrogate the hBD-2 and hBD-3 response of ex vivo infected human 
intestinal biopsies to C.jejuni 11168H 
Flagellin proteins have been demonstrated to be one of the bacterial MAMPs 
recognised by the host for several pathogenic microorganisms (Smith et al., 2002). 
Toll-like receptor 5 (TLRS) has been demonstrated to be the host receptor 
responsible for recognition of flagellin from both Gram-positive as well as Gram-
negative bacteria (Hayashi et al., 2001). The amino acid residues responsible for 
flagellin-TLR5 binding have been mapped for both the human TLRS receptor (Mizel 
et al., 2003) as well as the flagellin protein (Smith et al., 2003). However, sequence 
analysis demonstrated that C. jejuni flagellin lacks the amino acids recognised by 
TLRS and subsequent experimental data has shown that C. jejuni flagellin is not 
recognised by TLRS (Andersen-Nissen et al., 2005, Watson et al., 2005). 
Recombinant insertion of defined regions of Salmonella flagellin into the C. jejuni 
flagellin restored recognition of C. jejuni flagellin by TLR5 (de Zoete et al., 2010). 
A C. jejuni flaA mutant has been shown to be non-motile, to be less able to invade 
IECs in vitro compared to the wild-type strain, but to still be able to secrete the Cia 
proteins from the stunted flagellum (Wassenaar et al., 1991, Konkel et al., 2004). 
Recent evidence has suggested that a C. jejuni 81-176 flaA mutant is unable to 
adhere to and form biofilms on ex vivo infected human intestinal tissue as assessed 
by microscopy (Haddock et al., 2010). In Salmonella, the flagella have not only been 
demonstrated to be an important MAMP for the pro-inflammatory host response, but 
have also been indicated to be involved in dampening apoptotic processes in infected 
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intestinal epithelium (Vijay-Kumar et al., 2006). As such the ability of a C. jejuni 
11168HflaA mutant to elicit an hBD response from ex vivo infected human intestinal 
biopsies was analysed. 
3.10.2 Absence of the major flagellar filament protein FlaA does not 
abrogate the hBD-2 response of ex vivo infected human intestinal 
biopsies to C.jejuni 11168H 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain or the 11168H flaA 
mutant for 8 h ex vivo. The supernatants were probed by ELISA for the presence of 
hBD-2 (Figure 3.12) 
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Figure 3.12: Human intestinal biopsies from the ileum (circles, N = 4 and 6) and the colon 
(squares, N = 6) were either mock infected with PBS (open symbols) or infected with C. 
jejuni 11168H wild-type strain (black symbols) or the 11168H flaA mutant (grey symbols) 
for 8 h ex vivo. The supernatants were probed for the presence of hBD-2. 
No statistically significant difference between the amount of hBD-2 secreted in 
response to either C. jejuni 11168H wild-type strain or the 11168H flaA mutant was 
detected, indicating that the presence of the major flagellar filament protein FlaA is 
not required to trigger an hBD-2 response from the ex vivo infected human intestinal 
tissue (Figure 3.12). 
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3.10.3 Absence of the major flagellar filament protein FlaA does not 
abrogate the hBD-3 response of ex vivo infected human intestinal 
biopsies to C.jejuni 11168H 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain or with the 11168HfiaA 
mutant for 8 h ex vivo. The supernatants were probed by ELISA for the presence of 
hBD-3 (Figure 3.13) 
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Figure 3.13: Human intestinal biopsies from the ileum (circles, N = 7 and 5) and the colon 
(squares, N = 6 and 7) were either mock infected with PBS (open symbols) or infected with 
C. jejuni 11168H wild-type strain (black symbols) or the 11168HflaA mutant (grey 
symbols) for 8 h ex vivo. The supernatants were probed for the presence of hBD-3 
No statistically significant difference between the amount of hBD-3 secreted in 
response to either C. jejuni 11168H wild-type strain or the 11168HfiaA mutant was 
detected, indicating that the presence of the major flagellar filament protein FlaA is 
not required to trigger an hBD-3 response from the ex vivo infected human intestinal 
tissue (Figure 3.13). Intriguingly, the reported reduced interactions of a C. jejuni 81-
176 fiaA mutant with human intestinal tissue (Haddock et ai., 2010) does not appear 
to have an effect on the induction of a defensin response. 
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3.10.4 Absence of the sialic acid residue on C.jejuni 11168H LOS does not 
abrogate the hBD-2 and hBD-3 response of ex vivo infected human 
intestinal biopsies 
Bacterial LPS or LOS has been shown to be a potent mediator of host innate 
immunity. Furthermore, the LOS of certain C. jejuni strains has been shown to 
mimic ganglioside sugars found in humans. This has been implicated in the 
development of post-infectious sequelae, the most important being GBS (see section 
1.1.6.2). An important feature of the LOS of certain C. jejuni strains is the presence 
of a sialic acid residue. The presence of this residue has recently been shown to 
mediate TLR4-dependent sensing of C. jejuni by Des (Kuijf et al., 2010). 
To investigate whether the presence of the sialic acid residue in the C. jejuni 11168H 
wild-type strain LOS was important for induction of an hBD response from ex vivo 
infected human intestinal biopsies, EVOC experiments were performed using a C. 
jejuni 11168H neuB1 mutant. NeuBI has been shown to act as a sialic acid 
synthetase in sialation of WS and the neuB1 mutant has been shown to produce a 
truncated LOS lacking the sialic acid residue (Linton et al., 2000b). 
3.10.5 Absence of the sialic acid residue on C.jejuni 11168H LOS does not 
abrogate the hBD-2 response of ex vivo infected human intestinal 
biopsies 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain or with the 11168H 
neuB1 mutant for 8 h ex vivo. The supernatants were probed by ELISA for the 
presence of hBD-2 (Figure 3.14). 
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Figure 3.14: Human intestinal biopsies from the ileum (circles, N = 6 and 4) and the colon 
(squares, N = 6 and 7) were either mock infected with PBS (open symbols) or infected with 
C. jejuni 11168H wild-type strain (black symbols) or the 11168H neuEl mutant (grey 
symbols) for 8 h ex vivo. The supernatants were probed for the presence of hBD-2. 
No statistically significant difference between the amount of hBD-2 secreted in 
response to either C. jejuni 11168H wild-type strain or the 11168H neuBl mutant 
was detected (Figure 3.14). However, a trend was observed in the colonic samples, 
where approximately 1.25 times more hBD-2 was detected in the samples infected 
with the 11168H neuEl mutant. This was not observed for the f/aA mutant (see 
Figure 3.12). 
3.10.6 Absence of the sialic acid residue on C.jejuni 11168H LOS does not 
abrogate the hBD-3 response of ex vivo infected human intestinal 
biopsies 
Human intestinal biopsies from the ileum and the colon were either mock infected 
with PBS or infected with C. jejuni 11168H wild-type strain or with the 11168H 
neuB1 mutant for 8 h ex vivo. The supernatants were probed by ELISA for the 
presence of hBD-3 (Figure 3.15). 
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Figure 3.15: Human intestinal biopsies from the ileum (circles, N = 7 and 4) and the colon 
(squares, N = 6 and 7) were either mock infected with PBS (open symbols) or infected with 
C. jejuni 11168H wild-type strain (black symbols) or the 11168H neuEl mutant (grey 
symbols) for 8 h ex vivo. The supernatants were probed for the presence of hBD-3. 
No statistically significant difference between the amount of hBD-3 secreted In 
response to either C. jejuni 11168H wild-type strain or the 11168H neuBl mutant 
was detected (Figure 3.15). In contrast to the data obtained for hBD-2, no increase 
was observed in the supernatants of colonic tissue infected ex vivo with the 11168H 
neuEl mutant. This suggests that the presence of the sialic acid residue on the C. 
jejuni 11168H LOS is not essential for eliciting an hBD-2 and hBD-3 response in ex 
vivo infected human intestinal tissue. Whether the trend observed with hBD-2 but 
not with hBD-3 in the colonic supernatants reflects a biologically significant result is 
unclear due to the relatively low numbers of replicates. 
3.11 Summary and discussion 
The aim of this study was to assess the feasibility of an EVOC model to investigate 
C. jejuni host-pathogen interactions using primary human intestinal biopsies from 
the colon and terminal ileum. Two studies have demonstrated physical interaction of 
C. jejuni with human intestinal tissue ex vivo (Grant et at., 2006, Haddock et ai., 
2010) and one study has demonstrated secretion of the pro-inflammatory chemokine 
IL-8 by intestinal tissue in response to ex vivo infection with C. jejuni (MacCallum et 
at., 2006). One of the advantages of the EVOC model using whole primary tissue is 
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the fact that all cell types found in vivo in the intestine are present in the tissue and 
barring major damage during removal of the tissue are in the same arrangement. 
Disadvantages include the difficulty of obtaining intestinal tissue, as the research 
institute must be linked with a gastroenterology ward at a hospital. Even then, the 
consent of the patients/parents in the case of paediatric tissue must be obtained. 
Furthermore, the lifespan of such tissue ex vivo is limited. 
These experiments also presented multiple challenges in terms of the number of 
replicates possible and the technical difficulties with splitting samples for 
comparative studies. The appropriate statistically analyses for such data was 
carefully considered. Consultation of a medical statistician (Timothy Collier, 
LSHTM) resulted in the suggestion that an alternative to analysis of the data by 
Student's t-test should be explored. It was suggested that matched pairs of uninfected 
and infected biopsies from the same donor are tested in a paired fashion may be a 
more appropriate method of analysis, as this would represent a "like with like" 
analysis. However, the sizes of the biopsies varied considerably, so that comparison 
of two pieces of tissue from the same patient would not necessarily represent a "like 
with like" comparison due to the different numbers of cytokine and defensin 
secreting cells. Unfortunately, no size or weight measurements of the tissues were 
recorded when the infections were performed, rendering a retrospective 
normalisation of tissue pairs inappropriate. In these circumstances, the independent 
grouping of un infected and infected tissue is the most appropriate approach to the 
statistical analysis of this data. As such, the suggestion that a non-parametric test 
such as the Wilcoxon U-test may be advantageous over the student's t-test due to the 
distribution of some of the data was made. Indeed the Wilcoxon U-test has been used 
by collaborators at ICH following discussions with their in-house medical 
statisticians (Edwards et al., 2010). Therefore, all the datasets were retested using 
the Wilcoxon U-test (data not shown). This statistical reanalysis of the datasets did 
not alter any of the statistical outcomes indicated in the results presented in this 
chapter, suggesting that the student's t-test was an appropriate statistical analysis to 
use under these circumstances. 
In order to achieve more of a "like with like" comparison for future studies, one of 
two modifications to the experimental setup could be applied. Firstly any given piece 
of tissue could be cut into two equal halves, leaving one uninfected and infecting the 
other, thereby creating matched pairs. Secondly, if the tissue pieces are too small to 
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be cut (as was often the case with paediatric biopsies), the weight of each tissue 
piece should be determined prior to commencing the EVOC experiments. This 
would allow the protein levels detected by ELISA in the supernatants to be 
normalised against the weight of the tissue and provide a much better data set for 
analysis by the recommended matched pair approach. 
Initial experiments were performed in order to reproduce the published data 
demonstrating the secretion of IL-8 from human intestinal biopsies after ex vivo 
infection with C. jejuni strains NCTCl1168 and L115 (MacCallum et al., 2006). 
However, in contrast to the published data, no difference was detected between the 
IL-8 present in the supernatants of uninfected and infected tissue (Figure 3.2 and 
3.3). This could be attributed to several factors. Firstly the origin and preparation of 
the tissue for ex vivo culturing differed in several aspects. In the previous study, two 
large tissue samples from two patients were obtained and cut into several small 
pieces for ex vivo infection. This lowers the sample number extensively and may 
skew any results obtained due to the lack of person to person variation. In this study, 
each data point represents one individual patient and as such a much larger sample 
number is covered. Assuming that some of the patients undergoing endoscopy had 
increased IL-8 levels present in their intestine, the chances of including more of 
these in a larger sample number is increased. This would in tum lead to the basal 
levels of uninfected tissue already being high and therefore masking any effect of 
exposure of the tissue to C. jejuni, leading to potential false negative results. 
Secondly, in the previous study the tissue was transported from the endoscopy suite 
to the laboratory in medium containing antibiotics in order to remove the intrinsic 
microflora. As no overgrowth was observed during the initial experiments performed 
in this study and as the original report of an EVOC model did not include antibiotics 
in the transport medium (Hicks et al., 1996), the tissue was transported to the 
laboratory in medium without antibiotics. Removing the natural microflora present 
on the tissue is also counterproductive to one of the advantages of the EVOC model, 
namely to stay as close as possible to the in vivo situation. There is evidence that the 
presence of commensal intestinal bacteria is involved in attenuating inflammation 
(Kelly et al., 2004). The presence or absence of the microflora during the ex vivo co-
culturing of the tissue with C. jejuni might also influence the production of IL-8, 
providing one explanation for the difference between the data presented here and the 
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previously published work. Thirdly, another difference between the previous study 
and the work presented here is the source of the human intestinal tissue. Whilst 
tissue from adult patients was used in the previous work, the work presented here 
utilised paediatric tissue. This is another source of variation between the two studies, 
and may have led to the observed differences between this study and previously 
published work in terms of basal levels of IL-8 secretion as well as inducibility of 
IL-8 per se from ex vivo infected human tissue. 
Previous work demonstrated the production of hBD-2 and hBD-3 in response to C. 
jejuni infection of IEC monolayers in vitro (Zilbauer et al., 2005). As opposed to the 
data obtained for IL-8, analysis of the EVOC supernatants for the presence of the 
two defensin peptides revealed increased amounts of both peptides in the 
supernatants of tissue infected with two different C. jejuni wild-types strains, 
11168H and 81-176. Significant differences between the overall levels of hBD-2 and 
hBD-3 detected in the infected supernatants (around 25 pg/ml for hBD-2 versus 
around 400 pg/ml for hBD-3) may be due to the affinity of hBD-2 for the 
polypropylene plastic of the tubes used for storage of the supernatants and therefore 
reflect an artefact of the experiment rather than the biological situation (Mark Lucas, 
PhD thesis, University of London, 2010). Concentration of the supernatants using 
Amicon centrifugal filter units may allow for the detection of hBD-2 if the 
concentration in the neat sample is below the detection limit of the ELISA. This ex 
vivo data highlights the role for the defensins in the host innate immune response to 
C. jejuni infection. Furthermore, it is the first time that secretion of hBD-2 and hBD-
3 has been demonstrated in response to ex vivo infection of human intestinal biopsies 
with C. jejuni. Further investigation into this finding, for example by analysis of the 
supernatants for other defensin peptides, would be merited. 
Similar to the data obtained for hBD-2 and hBD-3, higher levels of IL-I p and IL-6 
were detected in the supernatants of infected biopsies compared to the uninfected 
controls. This was the first time that these cytokines have been detected from human 
intestinal tissue infected ex vivo with C. jejuni and supports data from other studies 
suggesting that these cytokines are involved in the host innate immune response to 
C. jejuni (Friis et al., 2009, Siegesmund et al., 2004). 
Data from collaborators suggested that C. jejuni 11168H wild-type strain infection of 
DCs leads to the secretion of cytokines that, when co-incubated with naIve T-cells, 
lead to the development of a mixed Th1 / Th17 adaptive immune response (Edwards 
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et al., 2010). To assess whether the activation of a Th17 response could be detected 
in ex vivo infected tissue, the supernatants were screened for the presence of IL-12 
and IL-23. Statistically significant higher levels of both 11-12 and IL-23, as well as 
IL-17 and IFN -,,(, were detected in infected biopsies compared to the uninfected 
controls, suggesting that C. jejuni infection does not only lead to the upregulation of 
defensins in ex vivo infected human intestinal tissue, but also triggers a Th1 / Th17 
adaptive immune response. 
It is still not fully understood which part of the C. jejuni cell is recognised by the 
immune system. Some evidence suggests that the bacterial flagellum, an important 
structure involved in the recognition of other pathogenic bacteria such as Salmonella 
species is not involved in the recognition of C. jejuni. This was confirmed using a C. 
jejuni 11168H flaA mutant lacking the major flagellar filament protein FlaA, which 
elicited a similar level of defensin response as the C. jejuni 11168H wild-type strain. 
As the 11168H flaA mutant still possesses stunted flagella comprised of the FlaB 
flagellin protein and is still able to secrete proteins, it would be interesting to analyse 
a "more complete" aflagellate mutant in the EVOC model system. One suitable 
mutant would be the 11168H rpoN (crS4) mutant, which has been demonstrated to be 
completely aflagellate and secretion-negative (Fernando et al., 2007). Intriguingly, a 
recent report demonstrated that a C. jejuni 81-176 flaA mutant was less able to 
adhere to and form microcolonies and biofilms on primary human intestinal tissue 
(Haddock et al., 2010). Unfortunately, that study did not analyse the innate immune 
response elicited by the wild-type and mutant bacteria, whilst this study did not 
analyse the effect of the 11168H flaA mutation on the "direct" bacteria-tissue 
interactions. It would therefore be interesting to analyse the interaction of the 
11168H flaA mutant with the intestinal tissue by microscopy to determine whether 
the induced hBD-2 and hBD-3 response remained the same as that induced by the 
wild-type strain despite reduced interactions. As the study presented here only 
analyses the levels of hBD-2 and hBD-3 at one time point after infection, an analysis 
of any potential time-dependence of the response, in particular to the 11168H flaA 
mutant, may shed further light on this question. Furthermore, construction and use of 
a 81-176 flaA mutant may highlight potential differences between the two wild-type 
strains. 
Another bacterial surface structure that is recognised by the host is LOS. A 11168H 
neuB1 mutant lacking the sialic acid residue of the wild-type LOS was shown to 
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elicit a similar level of defensin response from the tissue as the wild-type strain, 
suggesting that sialic acid residue of the illS was not involved in modulating the 
response. As some recent evidence has suggested that the LOS may however, still be 
involved in pathogen recognition (Heikema et al., 2010), it would be interesting to 
analyse the effect of more truncated LOS structures, or even of purified LOS from 
the wild type and LOS mutants on defensin expression. C. jejuni 11168H waaC and 
waaF mutants were constructed and preliminarily analysed, but unfortunately not 
studied in the EVOC model. WaaC and WaaF are two glycosyl transferases involved 
in biosynthesis of the C. jejuni illS (Kanipes et al., 2008). 
Taken together, the data presented here demonstrates that in vitro infected human 
intestinal biopsies respond to C. jejuni challenge and could be used to further study 
the interactions of this important human pathogen with the host. 
The model does however have certain limitations that cannot be overlooked. Firstly, 
human intestinal tissue is difficult to obtain, as close collaboration with a 
gastroenterologist and consent of the endoscopy patients are required, so 
experiments must be planned meticulously in order not to waste the available tissue. 
This also limits the number of replicates that can be performed. This limits the wider 
use of the model, as only few laboratories will have access to such tissue. Together 
with the possibility for person to person variation, this may somewhat limit the 
feasibility of the model. One of the advantages of the model, namely that the tissue is 
very close to the in vivo status and contains all cell types present in the gut, does also 
lead to another drawback, as any signal detected in the supernatant cannot be 
attributed to a specific subset of cells. Fractionation of the tissue followed by 
subsequent infection of the individual sub-fractions may partly correct for this, 
however, this will counteract one of the advantages of the model. Further studies 
using defined C. jejuni mutants may shed more light on the interaction between C. 
jejuni and the host tissue and help elucidate what bacterial structures are involved. 
The data presented here demonstrates that the EVOC model is a useful model for 
studying the host innate immune response to C. jejuni. There are, however, several 
limitations to the model that need to be acknowledged and kept in mind when using 
the model 
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Chapter 4 
Development of the Vertical Diffusion 
Chamber model for co-culturing C. jejuni 
with intestinal epithelial cells with 
microaerobic conditions at the apical surface 
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4.1 Introduction 
One major drawback of using in vitro cultured IECs for co-culturing experiments 
with C. j ejuni is the aerobic environment commonly used during co-culturing. As 
well as not being a good model of the micro- to anaerobic environment present in the 
intestinal lumen, the aerobic co-culturing conditions might have detrimental effects 
on the microaerophilic C. jejuni. As such, the interactions of C. jejuni with in vitro 
cultured IECs observed during the co-culturing experiments may be a poor 
representation of what occurs in vivo. To counteract this, a Vertical Diffusion 
Chamber (VDC) was adapted to serve as a co-culturing model. A VDC is composed 
of two plastic half-chambers. The two chambers are clamped together, leaving space 
for a permeable plastic support (Snapwell™ filter) at the interface (Figure 4.1). 
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Figure 4.1: Image of a Vertical Diffusion Chamber (VOC) with the two half-chambers 
separated. The 6-well plate and the hanging support structure used for growing the LEes on 
SnapweWM filters as well as for fluorescently labelled dextran diffusion assays are visible. 
Obtained from www.warneronline.com 
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Once a Snapwell™ filter is inserted, the two compartments are physically separated. 
The principle behind using the VDC to co-culture C. jejuni with IECs is the 
assumption that the IECs grown on Snapwell™ filters will act as a barrier and create 
separate apical and basolateral compartments. The conditions in the two 
compartments can then be individually adjusted in terms of both the medium and the 
gas composition. (Figure 4.2) 
VAIN incubator: 85% N21 10% C021 5% O2 
Apical compartment: 
C.jejuniin desired medium Basolateral compartment: tissue culture medium 
Polarised Caco-2 monolayer on Snapwelr"" filter 
Figure 4.2: Schematic of a Vertical Diffusion Chamber (V DC). Intestinal epithelial cells 
(LECs) are grown on permeable filter supports (SnapweIl™) and inserted into a VDC, thus 
creating an apical and a basolateral compartment. These compartments can then be 
individually adjusted with respect to medium and gas composition to allow the co-culturing 
of the fECs with C.jejuni with microaerobic conditions at the apical surface of the LECs and 
aerobic conditions at the basolateral surface of the IECs. 
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For co-culturing of C. jejuni with IECs, the basolateral compartment was filled with 
tissue culture medium and perfused with a gas mixture containing 95% O2 and 5% 
C02 to allow oxygen supply to the IECs. As the IECs obtain nutrients from the 
basolateral side, the hypothesis was that the apical compartment could be filled with 
media that alone would not support the growth of IECs, such as bacterial growth 
media. More importantly, by placing the VDC into a microaerobic incubator and 
leaving the apical compartment open, the gas composition on the apical side can be 
adjusted to allow for optimal micro aerobic conditions for C. jejuni. The aim of these 
modifications was to create an environment closer to the in vivo situation for the co-
culturing of the bacteria with the IECs and ultimately to analyse the effect of these 
conditions on the pathogen-host interactions of C. jejuni. 
4.2 lEes grow to form a polarised monolayer on Snapwell™ filters 
Not all IEC lines used to study host-pathogen interactions are able to form polarised 
mono layers on permeable filter supports (see section 1.4.2.2). As polarisation is 
essential for the use of an IEC line in the VDC model in order to keep both 
compartments separate and to mimic the intestinal epithelium in vivo, two IEC lines 
that have been previously demonstrated to form polarised monolayers were chosen 
for this study; Caco-2 and T84 IECs (Madara et al., 1987, Chantret et al., 1988). 
Initial studies to assess the growth and polarisation characteristics of the two IEC 
lines grown on Snapwell™ filters were performed prior to performing experiments 
in the VDCs. Caco-2 and T84 cells from the lines available in the laboratory were 
seeded at a density of 5 x 105 cells per Snapwell™ filter and the polarisation 
monitored for up to 21 days. 
4.2.1 Analysis of the permeability of lEe monolayers after 21 days of 
growth by fluorescent dextran diffusion indicates the formation of 
an impermeable monolayer. 
The permeability of an IEC monolayer can be assessed by monitoring the diffusion 
of a fluorescently labelled dextran tracer across the monolayer. This diffusion was 
assessed for both Caco-2 and T84 cells that had been grown for 21 days on 
permeable Snapwell™ filters. For the dextran diffusion assay, the Snapwell™ filters 
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were kept on the hanging support structures that had been used for the growing of 
the lEes as shown in Figure 4.3. The principle behind the assay is that a fully 
polarised and impermeable lEe monolayer would retain all the tracer on the side the 
tracer was added to (A), whilst in the case of an incompletely polarised and therefore 
semi-permeable lEe monolayer, some of the fluorescently labelled tracer would pass 
across the monolayer (B) 
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Figure 4.3: Diagram representing the fluorescent dextran diffusion assay. Fluorescently 
labelled dextran (asterisks) was added to the apical side of an lEe monolayer and incubated 
for 3 h. After the incubation, the amount of fluorescently labelled dextran that had crossed 
the monolayer to the basolateral side of the lEes was determined. ff the IEe monolayer was 
fully confluent and polarised with tight cell-cell junctions, no fluorescently labelled dextran 
was expected to diffuse into the basolateral compartment (A). fn the case of a sub-confluent, 
non-polarised monolayer, some fluorescently labelled dextran was expected to be detected in 
the basolateral compartment (8). 
LECs were grown on Snapwell™ filters for 21 days, washed three times with sterile 
PBS and 500 III of 100 IlM FITC-Iabelled dextran with an average molecular weight 
of 4 kilodaltons (kDa) in Ringer' s solution was added to the apical side of the 
monolayer and incubated for 3 hours at room temperature, with the basolateral side 
of the monolayer immersed in Ringer's solution. The amount of fluorescently 
labelled dextran on the basolateral side of the monolayer was determined post-
incubation by removal of the supernatant and measurement of the fluorescence 
intensity at 488 nm as described in section 2.1 0.7. The percentage of fluorescently 
labelled dextran that had crossed the LEC monolayer was calculated by dividing the 
fluorescence intensity recorded in the basolateral compartment by the fluorescence 
101 
intensity of the input solution. Two different controls were included; empty 
Snapwell™ filters as well as IEC mono layers on Snapwell™ filters that had been 
grown for 21 days but been permeabilised with 0.5% (v/v) Triton X-1OO in PBS for 
20 min at 37°C prior to incubation with the fluorescent marker (Figure 4.4). 
Empty Filter Caco 
Figure 4.4: Analysis of the diffusion of a fluorescent marker across cellular monolayers on 
Snapwell™ filters. The intestinal epithelial cells (lEes) were grown on Snapwell™ filters 
for 21 days and a solution of fluorescently labelled dextran added to the apical side of the 
lEes. After 3 h, the % of diffusion of the fluorescently labelled dextran across the 
monolayer was determined by measuring the relative fluorescence of the basolateral solution 
at 488 nm and dividing the value by the relative fluorescence of the input solution. An empty 
Snapwell™ filter and lEes grown for 21 days on Snapwell™ filters, then permeabilised 
with 0.5% (v/v) Triton X-lOO for 20 min at 37°C were used as controls. 
The diffusion analysis indicated that a polarised monolayer of both Caco-2 and T84 
IECs formed a barrier that was non-permeable to the fluorescent tracer, indicating 
that the IECs had formed an impermeable monolayer. In the two control samples, 
diffusion of the fluorescent tracer across the filter was observed, with the highest 
diffusion occurring across the empty Snapwell™ filters. In addition, the assay 
confirmed that exposure of the IEC monolayer to a 0.5% (v/v) solution of Triton X-
100 solution in PBS for 20 min at 37°C is sufficient to permeabilise the IECs. 
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4.2.2 Analysis of the Polarisation Status of lEes grown on Snapwell™ 
filters for up to 21 days by Laser Scanning Confocal Microscopy 
indicates the formation of a confluent, polarised monolayer. 
Impermeability of the Caco-2 and T84 IEC monolayers to fluorescently labelled 
dextran suggested the formation of a tight, polarised monolayer on Snapwell™ 
filters over a period of 21 days. Analysis of the distribution of brush border actin and 
of the tight junctional protein occludin was performed by Laser Scanning Confocal 
Microscopy (LSCM). IECs were seeded on three Snapwell™ filters and one filter 
was removed and fixed with paraformaldehyde (PFA) after 7, 14 and 21 days 
respectively. The filters were stained for actin and occludin as described in section 
2.10.6 and examined by LSCM. All figures represent in silico derived projections of 
Z-stacks, which was required as the tight junctions containing the occludin protein 
are located at different heights throughout the sample. 
4.2.2.1 Caco-2 cells 
After 7 days of growth, the Caco-2 cells on the filters had completely covered the 
filter. However, the cells only stained weakly for actin and occludin (Figure 4.5). 
Most of the actin was confined to cell-cell junctions, with no apical actin present. 
Occludin was observed at some of the cell-cell junctions. This suggested that 7 days 
of incubation was sufficient for the cells to spread over the filter, but not to form a 
tight, polarised monolayer. At 14 days post-seeding, a stronger actin stain was 
observed, with approximately 40% of the cells staining for actin on the apical 
surface, indicating the development of a brush border (Figure 4.6). Occludin staining 
was observed along the cell-cell junctions in approximately 30% of the cells. At 21 
days post-seeding, strong apical actin staining was observed in approximately 80% 
of the cells, while about 90% of the cell-cell junctions stained positive for occludin 
(Figure 4.7). 
Taken together, impermeability to fluorescent dextran and the LSCM analysis 
demonstrated that Caco-2 cells grew to form a impermeable, polarised monolayer on 
Snapwell™ inserts within 21 days of seeding. 
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Figure 4.5: 5 x 105 Caco-2 intestinal epithelial cells (TECs) were seeded onto Snapwell™ 
filters. After 7 days of growth, a filter was removed and fixed in PFA. The cells were 
processed for immullostaining and stained for occludin (green), actin (red) and the nuclei 
counterstained with DAP} (blue). The images represent projections of a stack of Z-axis 
slices viewed from above. 
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Figure 4.6: 5 x 105 Caco-2 intestinal epithelial cells (TECs) were seeded onto Snapwell™ 
filters . After 14 days of growth, a filter was removed and fixed in PFA. The cells were 
processed for immunostaining and stained for occludin (green), actin (red) and the nuclei 
counterstained with DAPJ (blue). The images represent projections of a stack of Z-axis 
slices viewed from above. 
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Figure 4.7: 5 x 105 Caco-2 intestinal epithelial cells (lECs) were seeded onto SnapweWM 
filters. After 21 days of growth, a filter was removed and fixed in PF A. The cells were 
processed for immunostaining and stained for occludin (green), actin (red) and the nuclei 
counterstained with DAP] (blue). The images represent projections of a stack of Z-axis 
slices viewed from above. 
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4.2.2.2 T84 Cells 
T84 cells were seeded at 5 x 105 cells per Snapwell™ and one Snapwell™ removed 
after 7, 14 and 21 days of growth respectively as described in section 4.1.2.1. 
Staining for actin and occ1udin indicated the presence of a weak occ1udin meshwork 
along the cell-cell junctions as early as 7 days post-seeding (Figure 4.8). The 
development of a complete occludin meshwork was demonstrated at 14 days post-
seeding (Figure 4.9). Furthermore, a strong apical actin stain was observed at 14 
days post-seeding, suggesting the development of a brush border. Incubation of the 
IECs for another 7 days did not dramatically change the appearance of the T84 IEC 
monolayer and was therefore deemed unnecessary (Figure 4.10). As a result, all 
further experiments with T84 cells were performed after 14 days of growth. 
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Figure 4.8: 5 x 105 T84 intestinal epithelial cells (lEes) were seeded onto SnapweJITM filters. 
After 7 days of growth, a filter was removed and fixed in PFA. The cells were processed for 
immunostaining and stained for occludin (green), actin (red) and the nuclei counterstained 
with DAPI (blue). The images represent projections of a stack of Z-axis slices viewed from 
above. 
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Figure 4.9: 5 x 105 T84 intestinal epithelial cells (lEes) were seeded onto SnapweWM filters. 
After 14 days of growth, a filter was removed and fixed in PFA. The cells were processed 
for immunostaining and stained for occludin (green), actin (red) and the nuclei 
counterstained with DAPI (blue). The images represent projections of a stack of Z-axis 
slices viewed from above. 
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Figure 4.10: 5 x 105 T84 intestinal epithelial cells (lEes) were seeded onto Snapwell™ 
filters. After 21 days of growth, a filter was removed and fixed in PFA. The cells were 
processed for immunostaining and stained for occludin (green), actin (red) and the nuclei 
counterstained with DAPT (blue). The images represent projections of a stack of Z-axis 
slices viewed from above. 
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4.2.3 Analysis of the polarisation status of Caco-2 and T84 IECs growing 
on Snapwell™ filters over 21 days by resistance measurement 
indicates the formation of a polarised IEC monolayer for Caco-2 
IECs 
Following analysis of the permeability of Caco-2 and T84 IEC monolayers by 
fluorescent labelled dextran diffusion and qualitative LSCM analysis of the 
polarisation status, a further analysis of the IEC monolayers during the polarisation 
period of 21 and 14 days respectively was performed. Measuring the trans-epithelial 
electrical resistance (TEER) of an IEC monolayer on a permeable support is a direct, 
quantitative method for analysis of the polarisation status of the IEC monolayer. The 
TEER is a direct measurement of the ability of electrons to flow across the 
monolayer. 
4.2.3.1 Caco-2 cells 
5 X 105 Caco-2 cells were seeded directly onto the Snapwell™ filters as described in 
section 2.8.7. After seeding, the TEER was measured at 3 day intervals for up to 21 
days using a Millicell Volt-Ohmmeter as described in section 2.8.8. When Caco-2 
cells were seeded on Snapwell™ filters, the TEER increased over the test period of 
21 days from 0 n cm2 at day 1 to 750 n cm2 after 21 days, confirming the formation 
of an impermeable, polarised monolayer (Figure 4.11). 
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Figure 4.11: 5 x 105 Caco-2 intestinal epithelial cells were seeded onto Snapwell™ filters 
and the trans-epithelial electrical resistance (TEER) recorded over a 21 day period of 
differentiation in a humidified tissue culture incubator at 37°C. Continuous increase of the 
TEER suggests the development of a polarised IEC monolayer. 
4.2.3.2 T84 cells 
5 X 105 T84 cells were seeded directly onto the Snapwell™ filters as described in 
section 2.8.7 and the development of the TEER monitored over 21 days of growth. 
No TEER development was detectable, even after 21 days of growth. This was 
surprising, as both the fluorescent dextran perfusion assay and the LSCM images 
indicated the presence of a tight, polarised monolayer. One explanation may be the 
increased sensitivity of the TEER measuring method, which may be able to detect 
small gaps in the IEC monolayer that are neither accessible to the fluorescent dextran 
tracer nor identifiable by microscopy. As the T84 cells were to be used as the second 
cell line for confirmation of benchmark data obtained with the Caco-2 cell line, the 
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polarisation and impermeability of the T84 IEC monolayers after 14 days of 
polarisation was judged to be acceptable for the experiment. However, the issue of 
the lack of TEER development was considered in the interpretation of subsequent 
experimental data obtained with T84 IECs. 
4.2.4 Ultrastructural analysis of Caco-2 cells grown on Snapwell™ 
filters 
Whilst LSCM is sufficient to visualise the general morphology of an IEC monolayer 
and to highlight the distribution of certain organelles and proteins, this method does 
not allow visualisation of the ultrastructure of the cells. In order to investigate the 
ultrastructural properties of lEes grown on Snapwell™ filters, the cells were 
analysed by transmission electron microscopy (TEM). Analysis of 21 day old Caco-
2 cells by TEM clearly demonstrated the presence of tight junctions and an apical 
brush border containing microvilli (Figure 4.12). This was consistent with the actin 
localisation as visualised by LSCM, indicating that the cells had formed a polarised 
monolayer. 
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Figure 4.12: Analysis of the ultrastructural properties of Caco-2 cells that were differentiated 
on Snapwell™ filters for 21 days. The presence of microvilli and cell-cell junctions are 
indicated (arrows). 
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4.3 Bacteria-free preliminary experiments using the VDC suggest 
that the IEC monolayer integrity is maintained over 24 h of 
maintenance in the VDC with Brucella broth and microaerobic 
conditions at the apical surface 
Mter establishing that the Caco-2 and T84 IECs grew to form polarised monolayers 
on Snapwell™ filters, a series of bacteria-free preliminary experiments were 
performed to assess the effect of maintaining the IECs in the VDC with microaerobic 
conditions at the apical surface over 24 h. 
To set up the VDC, a Snapwell™ filter was removed from the 6-well culturing plate 
(see Figure 3.1), washed three times with sterile PBS and placed onto the O-ring on 
the basolateral half-chamber of the VDC. The apical half-chamber was gently 
snapped onto the basolateral half-chamber and fastened with metal clips. The two 
compartments were filled with the required media (Brucella broth or DMEM for the 
apical compartment, DMEM for the basolateral compartment), starting with the 
apical compartment, to avoid the possibility of liquid pressure from the basolateral 
compartment dislodging some of the IECs. The VDCs that were to be used for 
aerobic incubation experiments were placed into a humidified tissue culture 
incubator containing air enriched with 5% C02 at 3rC. The VDCs to be used for 
microaerobic incubation experiments were placed into the VAIN incubator and the 
basolateral compartment capped off, attached to the gas leads and perfused with a 
mixture of 95% 02 and 5% C02 at a flow rate of approximately one bubble of gas 
every 2 to 3 seconds. 
Initially both compartments of the VDC were filled with tissue culture medium, as 
this is the substrate in which most classical bacteria-IEC co-culturing experiments 
are performed. However it has been demonstrated that tissue culture medium is not 
optimal for C. jejuni culturing and that C. jejuni exhibits a much slower growth rate 
in tissue culture media than in a more suitable medium such as Brucella broth (Dr 
Emily Kay, personal communication). An advantage of the two-compartment setup 
of the VDC is the independent manipulation of the apical and the basolateral 
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compartments. The effects of changing media in the apical compartment from tissue 
culture medium to Brucella broth, whilst keeping the basolateral compartment 
medium as tissue culture medium was therefore also investigated. 
4.3.1 Qualitative assessments of the IEC monolayer integrity after 24 h 
of maintenance in the VDC with microaerobic conditions at the 
apical surface 
IECs are located at the interface between the intestinal lumen and the underlying 
host tissue. IECs absorb their nutrients from the basolateral membrane, whilst the 
apical membrane is immersed in the intestinal contents and is involved in both 
maintaining a barrier as well as transporting nutrients from the intestinal content into 
the bloodstream. The setup of the VDC, with the IECs set between the two 
compartments, will represent the in vivo situation more closely than classical in vitro 
assays. However, experimental confirmation of the integrity of the IECs in the VDC 
system needed to be obtained prior to performing any C. jejuni-IEC co-culture 
experiments. 
During the first trial VDC experiments performed with Brucella broth in the apical 
compartment and tissue culture medium (DMEM) in the basolateral compartment, it 
was observed that even after 24 h of maintenance of a VDC with microaerobic 
conditions at the apical surface of the IECs, the yellow apical Brucella broth and the 
red basolateral DMEM remained separated. In contrast, in a VDC that had been 
maintained with an empty Snapwell™ filter, the two media readily diffused and 
mixed between the compartments (Figure 4.13). This suggests that (i): the IEC 
monolayer efficiently separates the two compartments even after 24 h of 
maintenance with micro aerobic conditions at the apical surface and that (ii): Brucella 
broth on the apical side of the monolayer does not appear to affect the barrier 
function of the IECs. However, this required further quantitative assessment. 
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Figure 4.13: Two vertical diffusion chambers (VDCs) were set up using either an empty 
SnapweJITM filter (A) or using a SnapweJITM that had been used to culture Caco-2 intestinal 
epithelial cells (IECs) for 21 days (B). Both VDCs were maintained with microaerobic 
conditions at the apical surface for 24 h. Even after 24 h of such microaerobic maintenance, 
the IECs retained the ability to keep the two compartments separated as judged by the 
maintained separation of the yellow Brucella broth and the red DMEM. 
4.3.2 Assessment by fluorescently labelled dextran diffusion indicates 
that the IEC monolayer integrity is not affected by maintenance in 
the VDC for 24 h with microaerobic conditions at the apical 
surface 
Separation of the yellow Brucella broth in the apical compartment and the red 
DMEM in the basolateral compartment after 24 h of maintenance of the IECs with 
microaerobic conditions at the apical surface visually indicated an intact IEC 
monolayer. To quantitatively investigate the barrier function ofthe IECs after 24 h of 
maintenance in the VDC, the diffusion of fluorescently labelled dextran across a 
monolayer of both Caco-2 and T84 lECs that had been grown on Snapwell™ filters 
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for 21 or 14 days respectively and maintained for 24 h in VDCs with either aerobic 
or micro aerobic conditions at the apical surface was analysed. 
Monolayers of Caco-2 and T84 IECs were maintained in VDCs with either 
microaerobic or aerobic conditions at the apical surface for 24 h. The chambers were 
dismantled, the IEC monolayers washed three times with PBS and placed back into 
the hanging supports (see Figure 3.1). Three different controls were used: 
i: Empty Snapwell™ filters; 
ii: Snapwell™ filters that had been used to culture Caco-2 IECs for 21 days 
or T84 IECs for 14 days and that had been permeabilised with 0.5% (v/v) 
Triton X-IOO in PBS at 37°C for 20 min; 
iii: Snapwell™ filters that had been used to culture Caco-2 IECs for 21 days 
or T84 IECs for 14 days but had not been incubated in VDCs. 
500 !AI of 100 !AM FITC-labelled dextran with an average molecular weight of 4 kDa 
in Ringer's solution was added to the apical side of the monolayer and incubated for 
3 hours at room temperature, with the basolateral side of the monolayer immersed in 
Ringer's solution. The amount of fluorescently labelled dextran on the basolateral 
side of the monolayer was determined post-incubation by removal of the supernatant 
and measurement of the fluorescence intensity at 488 nm as described in section 
2.10.7. The percentage of diffused tracer was calculated from the fluorescence 
intensity obtained from the basolateral compartment and the fluorescence intensity of 
the input solution. 
A Caco-2 IEC monolayer that had been grown for 21 days and not incubated in a 
VDC retained the fluorescently labelled dextran in the apical compartment, with only 
0.5% of the fluorescently labelled dextran detected in the basolateral compartment 
after 3 h of incubation (Figure 4.14). In contrast, 25.2% of the fluorescently labelled 
dextran was detected in the basolateral compartment after 3 h of incubation using an 
empty Snapwell™ filter. In the case of the Triton X-IOO permeabilised Caco-2 IECs, 
14.3% of the fluorescently labelled dextran was detected in the basolateral 
compartment. For the Caco-2 IECs that had been maintained in the VDC with either 
aerobic or microaerobic conditions at the apical surface, low levels of fluorescently 
labelled dextran were detected in the basolateral compartment; 0.3% and 0.6%, 
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respectively. This demonstrated that maintaining the Caco-2 IECs in the VDC for 24 
h with Brucella broth and either aerobic or microaerobic conditions at the apical 
surface did not impair the permeability of the IEC monolayer 
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Figure 4.14: Caco-2 intestinal epithelial cells (IECs) were grown for 21 days on Snapwell™ 
filters and incubated in vertical diffusion chambers (VDCs) with Brucella broth and either 
aerobic (A) or microaerobic (M) conditions at the apical surface for 24 h. Following 
disassembly of the VDCs, 500 III of 100 IlM FITC-labelled dextran with an average 
molecular weight of 4 kilodaltons (kOa) in Ringer's solution was added to the apical side of 
the monolayer and incubated for 3 hours at room temperature. After 3 hours, the percentage 
of fluorescently labelled dextran that had passed across the monolayer was determined from 
the relative fluorescence of the basolateral solution at 488 nm and the relative fluorescence 
of the input solution. An empty Snapwell™ filter (No cells), IECs grown for 21 days on 
Snapwell™ filters and permeabilised with 0.5% (v/v) Triton X-100 for 20 min at room 
temperature (Triton) and IECs grown for 21 days on Snapwell™ filters (Un) were used as 
controls. 
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A T84 IEC monolayer that had been grown for 14 days and not incubated in a VDC 
successfully retained the fluorescently labelled dextran in the apical compartment, 
with only 0.4% of the fluorescently labelled dextran detected in the basolateral 
compartment after 3 h of incubation (Figure 4.15). In contrast, 25.2% of the 
fluorescently labelled dextran was detected in the basolateral compartment after 3 h 
of incubation using an empty Snapwell™ filter. In the case of the Triton X-lOO 
permeabilised cells, 7.6% of the fluorescently labelled dextran was detected in the 
basolateral compartment. This was slightly lower than the number obtained for 
Triton X-lOO permeabilised Caco-2 IECs, and might reflect a higher level detergent 
resistance by the T84 IECs. For the IECs that had been maintained in the VDC with 
either aerobic or micro aerobic conditions at the apical surface, low levels of 
fluorescently labelled dextran was detected in the basolateral compartment; 1.4% 
and 1.3%, respectively. The levels were slightly higher for the T84 IECs compared 
to the Caco-2 IECs. This may indicate that the T84 monolayer is not as impermeable 
as the Caco-2 monolayer, and is in accordance with the lack of TEER found for the 
T84 IECs. This may also be due to the shorter growth time of the T84 IECs 
compared to the Caco-2 IECs (14 vs. 21 days). 
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Figure 4.15: T84 intestinal epithelial cells (IECs) were grown for 14 days on Snapwell™ 
filters and incubated in vertical diffusion chambers (VDCs) with Brucella broth and either 
aerobic (A) or microaerobic (M) conditions at the apical surface for 24 h. Following the 
dismantling of the VDCs, 500 JA.I of 100 JA.M FITC-Iabelled dextran with an average 
molecular weight of 4 kilodaltons (kDa) in Ringer's solution was added to the apical side of 
the monolayer and incubated for 3 hours at room temperature. After 3 hours, the percentage 
of fluorescently labelled dextran that had passed across the monolayer was determined from 
the relative fluorescence of the basolateral solution at 488 nm and the relative fluorescence 
of the input solution. An empty Snapwell™ filter (No cells), and IECs grown for 14 days on 
Snapwell™ filters and permeabilised with 0.5% (v/v) Triton X-lOO in PBS for 20 min at 
room temperature (Triton) and IECs grown for 14 days on Snapwell™ filters (Un) were used 
as controls. 
This data suggested that maintaining the Caco-2 and T84 IECs in the VDC for 24 h 
with Brucella broth and either aerobic or microaerobic conditions at the apical 
surface did not impair the barrier function of the IEC monolayer 
4.3.3 Assessment of the TEER indicates that the IEC monolayer 
integrity is not atTected by maintenance in the VDC for 24 h with 
microaerobic conditions at the apical surface 
Previously TEER measurements were used to assess the polarisation status of a 
Caco-2 monolayer on Snapwell™ filters over a 21 day period. The same approach 
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was also used to quantitatively assess the effects of maintenance of the IECs in the 
VDC with microaerobic conditions at the apical surface on the integrity of the IEC 
monolayer. Initially, two VDCs were set up containing DMEM in both the apical 
and the basolateral compartments. The TEER was measured after the initial setup 
and these values set as 100%. Subsequently the VDCs were incubated with either 
aerobic or microaerobic conditions at the apical surface of the monolayer. The TEER 
was measured at 3, 6 and 24 h post setup and calculated as the percentage of the 
value at time point O. Three replicate experiments were performed, and the mean and 
standard deviation calculated (Figure 4.16). A small and statistically non-significant 
decrease in the TEER was noted at 3 h post-assembly of the VDC for both 
conditions. However, no further decrease in TEER was noted over the rest of the 24 
h maintenance period. 
123 
Figure 4.16: Caco-2 intestinal epithelial cells (IECs) were grown for 21 days on Snapwell™ 
filters and incubated in vertical diffusion chambers (VDCs) with DMEM in both 
compartments and either aerobic (white bars) or microaerobic (black bars) conditions at the 
apical surface. The trans-epithelial electrical resistance (TEER) was measured after 
assembly of the VDCs and set as 100% (time point 0 h). After 3 h, 6 hand 24 h post-
assembly, the TEER was measured and calculated as a percentage of the value obtained at 
time point O. 
These experiments were then repeated with a set of VDCs where the apical 
compartment contained Brucella broth instead of DMEM (Figure 4.17). For the 
VDC maintained with aerobic conditions at the apical surface, the TEER dropped to 
approximately 75% of the initial value at 3 h post-assembly and remained at that 
level throughout the incubation. For the VDC maintained with microaerobic 
conditions at the apical surface, a drop to 80% of the initial value was observed 3 h 
post assembly. However, the TEER increased in a reproducible manner at 6 hand 24 
h post-assembly, increasing to approximately 120% of the initial value after 24 hours 
of incubation. The difference between the TEER recorded for the two conditions 
reached statistical significance after 24 h of culturing in the VOc. This increase of 
TEER was contrary to expectations. However as the TEER was still present, this 
suggested that the IEC monolayer remained intact during 24 h of maintenance in the 
VDC with Brucella broth and either aerobic or microaerobic conditions at the apical 
124 
surface of the IECs. The increase in TEER after 24 h of culturing in the VDC with 
microaerobic conditions and Brucella broth at the apical surface may reflect a 
response of the IECs to the in vivo like low oxygen conditions. 
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Figure 4.17: Caco-2 intestinal epithelial cells (IECs) were grown for 21 days on Snapwell™ 
filters and incubated in vertical diffusion chambers (VDCs) with Brucella broth in the apical 
compartment and DMEM in the basolateral compartment and either aerobic (white bars) or 
microaerobic (black bars) conditions at the apical surface. The trans-epithelial electrical 
resistance (TEER) was measured after assembly of the VDCs and set as 100% (time point 
0). After 3h, 6h and 24 h post-assembly, the TEER was measured and calculated as a 
percentage of the value obtained at time point o. * = p < 0.05 
4.3.4 Analysis of the distribution of cellular actin and occludin by 
LSCM indicates that the IEC monolayer integrity is not atTected by 
maintenance in the VDC for 24 h with microaerobic conditions at 
the apical surface 
To assess the effect of maintaining a monolayer of IECs in the VDC with 
micro aerobic conditions at the apical surface on the morphology and distribution of 
the tight junctions, the IECs were analysed by LSCM. Caco-2 monolayers were 
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grown for 21 days on Snapwell™ filters and then maintained in VDCs with Brucella 
broth and either aerobic (Figure 4.18) or microaerobic (Figure 4.19) conditions at the 
apical surface for 24 h. Mter incubation, the cells were prepared for LSCM as 
described in section 2.10.6 and stained for actin and the tight junctional protein 
occludin. No difference was observed regarding the distribution of actin between the 
IECs that had been maintained with either aerobic or micro aerobic conditions on the 
apical surface. Furthermore, X-Z- slices of the cells demonstrated that the actin 
localised mainly to two areas, the cell-cell borders and the apical surface of the cells. 
The apical localisation of actin demonstrated that the microvilli-containing brush 
border remained intact, despite incubation with bacterial broth at the apical surface 
and had also been exposed to micro aerobic conditions. No differences were observed 
between the distribution of occludin for IECs that had been maintained in the VDC 
with either aerobic or microaerobic conditions at the apical surface, indicating that 
the IEC monolayer remained intact and the cell-cell junctions were not affected by 
maintenance in the VDC for 24 h with Brucella broth and either aerobic or 
microaerobic conditions at the apical surface. 
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Figure 4.18: Caco-2 intestinal epithelial cells (lECs) were grown for 21 days on Snapwell™ 
filters and maintained in a vertical diffusion chamber (VDC) with Brucella broth in the 
apical compartment and aerobic conditions at the apical surface for 24 h. After the 
incubation, the IECs were processed for immunostaining and stained for occludin (green), 
actin (red) and the nuclei counterstained with OAPI (blue). The images represent projections 
of a stack of Z-axis slices viewed from above. 
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Figure 4.19: Caco-2 intestinal epithelial cells (IECs) were grown for 21 days on Snapwel\TM 
filters and maintained in a vertical diffusion chamber (VDC) with Brucella broth in the 
apical compartment and microaerobic conditions at the apical surface for 24 h. After the 
incubation, the IECs were processed for immunostaining and stained for occludin (green), 
actin (red) and the nuclei counterstained with DAPI (blue). The images represent projections 
of a stack of Z-axis slices viewed from above. 
4.4 Summary and discussion 
This part of the study investigated the growth and polarisation of two human IEC 
lines (Caco-2 and T84) on permeable Snapwell™ filters, and assessed the effect of 
maintaining polarised IEC mono layers in the VDC for up to 24 h with aerobic 
compared to microaerobic conditions in the apical compartment. Both Caco-2 and 
T84 IEC lines were demonstrated to form polarised mono layers on permeable 
Snapwell™ filters after 21 and 14 days of growth respectively. The IECs formed 
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tight junctions containing occludin and display an actin-rich apical brush border. 
This was demonstrated by analysis of permeability of the monolayer to a 
fluorescently labelled tracer, by LSCM, by transmission electron microscopy and by 
measuring the TEER. T84 cells generally polarised faster than Caco-2 cells, with the 
occludin mesh appearing 7 to 14 days after seeding. Another difference observed 
was the absence of any measurable TEER in the T84 IECs, indicating potential gaps 
in the monolayers that were accessible to electrons but not to the 4 kDa fluorescent 
tracer. However, in light of the fact that the T84 IECs were to be used as the second 
confirmatory IEC line as well as for innate immune response studies, combined with 
the LSCM and fluorescent tracer data indicating the presence of an intact monolayer, 
the TEER analysis of growing T84 IECs was not further pursued. Any data obtained 
with the T84 IECs in further studies was analysed with consideration of the lack of 
TEER in the interpretation of the results. 
When Caco-2 IEC monolayers were grown for 21 days on Snapwell™ filters, 
inserted into VDCs and maintained with Brucella broth and microaerobic conditions 
at the apical surface for 24 h, no apparent detrimental effects on the cells were 
observed compared to controls maintained with aerobic conditions at the apical 
surface. No increased diffusion of a fluorescent tracer was detected post-incubation. 
The TEER decreased to around 80% of the value at time point 0 over the first 3 h but 
did not decline any further. Intriguingly, the TEER increased to 120% of the value at 
time point 0 over 24 h when the IECs were maintained in the VDC with 
microaerobic conditions and Brucella broth in the apical compartment, suggesting 
that these conditions lead to an increase in impermeability of the IEC monolayer 
over time. This may reflect a direct effect of these more in vivo like conditions on the 
IECs. Analysis by LSCM indicated that the general morphology of the IECs had not 
changed after 24 h of maintenance with microaerobic conditions at the apical 
surface. The actin distribution was not affected, nor was any difference observed in 
the distribution of occludin. 
This data suggests that the VDC model system is suitable for maintaining IECs 
under conditions that mimic those found in the human intestine, with the apical 
surface of the IECs protruding into the anaerobic environment of the gut and the 
basolateral surface positioned in the more favourable environment of the underlying 
tissue. The VDC model will thus have two benefits for the co-culturing of C. jejuni 
with IECs. Firstly, the model will more closely mimic the situation the bacteria are 
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likely to encounter in the human intestine. Furthermore, the co-culturing of the 
bacteria and the IECs will be possible under micro aerobic conditions at the apical 
surface of the IECs, which may alter the interaction with and invasion of IECs by C. 
jejuni. This is particularly important for the microaerophilic C. jejuni, but may also 
have an effect on the pathogen-host interaction of other enteric pathogens such as the 
anaerobic Clostridium difficile. A previous study using a similar VDC setup to co-
culture the microaerophilic H pylori with Caco-2 IECs demonstrated increased 
bacterial adhesion to the cells, increased synthesis of bacterial virulence factors as 
well as an increased host innate immune response if the bacteria were co-cultured 
with the IECs in the VDC microaerobic compared to aerobic conditions in the apical 
compartment (Cottet et al., 2002). Using the VDC model for C. jejuni instead of H. 
pylori has two advantages. Firstly, C. jejuni is able to invade IECs compared to the 
predominantely extracellular H. pylori. Secondly, the IEC lines used in this study are 
more closely related to the C. jejuni target tissue in the human host, the intestinal 
epithelium, compared to the gastric tissue targeted by H. pylori. 
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Chapter 5 
-_._--_._--_ .. _--
Microaerobic conditions at the apical surface 
increase C. jejuni interactions with and 
invasion of intestinal epithelial cells and lead 
to an increased, polarised innate immune 
response 
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5.1 Introduction 
The data presented in the previous chapter demonstrated that Caco-2 and T84 human 
IECs grow to polarised, impermeable mono layers on Snapwell™ filters over 21 and 
14 days respectively. mcs could be maintained in the VDC for 24 h with Brucella 
broth and microaerobic conditions at the apical surface without any apparent 
detrimental effects on the IECs. No increase in diffusion of a fluorescent tracer 
molecule across Caco-2 and T84 monolayers was detected after 24 h of maintenance 
in the VDC with Brucella broth and microaerobic conditions at the apical surface 
compared to control monolayers with aerobic conditions at the apical surface. 
Furthermore, no significant decrease of the TEER and no difference in the 
distribution of cellular actin or occludin were observed after 24 h of maintenance of 
Caco-2 IECs in the VDC with Brucella broth and microaerobic conditions at the 
apical surface. The microaerobic conditions at the apical surface in the VDC more 
closely resemble the environment found in the intestine than the classical in vitro 
IEC-pathogen co-culturing models performed under aerobic conditions. This will 
allow investigation of the host-pathogen interactions under conditions more closely 
resembling the in vivo situation in the human intestine. 
This chapter reports analysis of the effect of co-culturing C. jejuni wild-type strains 
with IECs maintained in the VDC with microaerobic conditions at the apical surface. 
C. jejuni wild-type strains co-cultured with IECs maintained in the VDC with 
aerobic conditions at the apical surface were used as controls. 
5.2 Co-culturing C.jejuni 11168H wild-type strain bacteria with 
Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment results in higher numbers of bacteria 
interacting with the IECs 
The C. jejuni 11168H wild-type strain was co-cultured with Caco-2 IECs at an MOl 
of approximately 100:1 in VDCs with either aerobic or microaerobic conditions in 
the apical compartment for 3 h, 6 hand 24 h. The number of bacteria interacting with 
the IECs was determined by lysis of the IECs post co-culturing with 0.5% (v/v) 
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Triton-X100 in PBS for 20 min at 37°C and serial dilution and plating of the lysates 
as described in section 2.10.3. 
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Figure 5.1: Caco-2 intestinal epithelial cell (1EC) mono layers were grown on Snapwell™ 
filters for 21 days. C. jejuni 11168H wild-type strain bacteria were co-cultured with Caco-2 
IECs in a vertical diffusion chamber at an MOl of 100:1 for 3, 6 and 24 h with either aerobic 
(white bars) or microaerobic (black bars) conditions in the apical compartment. The numbers 
of interacting bacteria were determined at each time point by lysis of the IECs, serial 
dilution and plating of lysates. * = p < 0.05. 
Mter 3 h of co-incubation, no significant difference was observed between the 
numbers of interacting bacteria after co-culturing with IECs in the VDC with either 
aerobic or microaerobic conditions in the apical compartment (Figure 5.1). Extension 
of the co-culturing time to 6 h resulted in increased numbers of interacting bacteria 
after co-culturing with the IECs in the VDC with microaerobic conditions in the 
apical compartment. However the difference did not reach statistical significance. 
Extension of the co-culturing time to 24 h resulted in a statistically significant, 8-fold 
increase in numbers of interacting bacteria after co-culturing with the IECs in the 
VDC with microaerobic conditions compared to aerobic conditions in the apical 
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compartment. This demonstrated that micro aerobic conditions in the apical 
compartment of the VDC increased the numbers of C. jejuni interacting with the 
IECs. 
5.3 Co-culturing C.jejuni 111688 wild-type strain bacteria with 
Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment results in higher numbers of intracellular 
bacteria 
To investigate whether the C. jejuni 11168H wild-type strain was also more invasive 
as well as more adherent when co-cultured with Caco-2 IECs in the VDC with 
microaerobic conditions in the apical compartment, the numbers of intracellular 
bacteria were determined by gentamicin protection assay as described in section 
2.10.4. The 3 h timepoint was omitted, as the results from the interaction assay 
suggested that this co-culturing time was too short to result in any significant 
difference between the experiments performed with either aerobic or microaerobic 
conditions in the apical compartment of the VDC (Figure 5.1). C. jejuni 11168H 
wild-type strain was co-cultured with Caco-2 IECs at an MOl of approximately 
100:1 in VDCs with either aerobic or microaerobic conditions in the apical 
compartment for 6 hand 24 h. Mter the co-culturing, extracellular bacteria were 
killed by incubation with 150 ~glml of gentamicin in DMEM for 2 h at 37°C. The 
IECs were subsequently lysed, the lysates serially diluted and plated as described in 
section 2.10.4. 
Mer 6 h of co-culturing, 5 times more intracellular bacteria were detected after co-
culturing with IECs in the VDC with micro aerobic conditions compared to aerobic 
conditions in the apical compartment (Figure 5.2). Mter 24 h of co-culturing, 
approximately 75 times more intracellular bacteria were detected after co-culturing 
with IECs in the VDC with microaerobic compared aerobic conditions in the apical 
compartment (Figure 5.2). 
Intriguingly, the number of intracellular bacteria detected after co-culturing with the 
IECs in the VDC with aerobic conditions in the apical compartment dropped 
between 6 and 24 h, while the numbers increased after co-culturing with the IECs in 
the VDC with micro aerobic conditions in the apical compartment. This might be an 
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effect of the oxygen stress encountered by the C. jejuni during co-culturing with the 
Caco-2 IECs under aerobic conditions. This data suggests co-culturing of C. jejuni 
11168H wild-type strain with Caco-2 IECs in the VDC with micro aerobic conditions 
in the apical compartment does not only increase the rate of bacterial interaction with 
the IECs, but also leads to a highly significantly increased invasion phenotype 
compared to co-culturing experiments with aerobic conditions in the apical 
compartment. 
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Figure 5.2: Caco-2 intestinal epithelial cell (lEC) monolayers were grown on Snapwell™ 
filters for 21 days. C. jejuni 11168H wild-type strain bacteria were co-cultured with Caco-2 
IECs in a vertical diffusion chamber at an MOl of 100:1 for 6 and 24 h with either aerobic 
(white bars) or microaerobic (black bars) conditions in the apical compartment. The numbers 
of intracellular bacteria were determined at both time points by killing any extracellular 
bacteria with gentamicin followed by lysis of the IECs, serial dilution and plating of lysates. 
* = p < 0.05, ** = p < 0.01. 
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5.4 Laser Scanning Confocal Microscopy supports the finding that 
co-culturing of C.jejuni 11168H wild-type strain with Caco-2 
IECs in the VDC with microaerobic conditions in the apical 
compartment results in an increased number of interacting and 
intracellular bacteria 
To support the quantitative data generated by the interaction and invasion assays 
suggesting that co-culturing of C. jejuni 11168H wild-type strain with Caco-2 IECs 
in the VDC with microaerobic conditions in the apical compartment results in an 
increased number of interacting and intracellular bacteria compared to control 
experiments with aerobic conditions in the apical compartment, a qualitative 
assessment of the numbers of C. jejuni bacteria localised within the Caco-2 IECs 
after 24 h of co-culturing was performed by LSCM. A C. jejuni 11168H wild-type 
strain modified to express the enhanced green-fluorescent protein (eGPP) from a 
chromosomal locus was utilised for this analysis (Kadyshev et al., 2005b). One 
difficulty with expressing recombinant proteins in C. jejuni is the necessity to 
express the proteins from a chromosomal locus, as the bacteria do not stably harbour 
recombinant expression plasm ids episomally. This reduces the number of copies of 
the recombinant gene to one per cell, which in tum limits the quantity of 
recombinant proteins produced per cell. This can be counteracted by placing the 
gene under the control of a strong promoter. The promoter of the outer membrane 
protein OmpA was used for the eGFP expressing construct used in this study. 
However, the fluorescence of the bacteria was still low compared to other GFP 
expressing bacteria such as Yersinia enterocolitica (Dr Philippa Strong, LSHTM, 
personal communication). This required the use of increased green laser power on 
the microscope, resulting in higher levels of green background fluorescence and 
rapid bleaching of the sample. 
Caco-2 IEC monolayers on Snapwell™ filters were either left uninfected or co-
cultured with C. jejuni 11168H strain expressing eGFP for 24 h in the VDC with 
either aerobic or micro aerobic conditions in the apical compartment. The samples 
were prepared for LSCM as described in section 2.10.6. The IECs were 
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counterstained with Alexa Fluor 555 phalloidin and DAPI to visualise cellular actin 
and DNA as described in section 2.10.6. 
No green fluorescent bacteria were detected in either of the uninfected samples 
(Figure 5.3). The slight hazy green background in the aerobic sample was most 
likely due to the increased laser power as stated previously. When the C. jejuni 
11168H eGFP expressing strain was co-cultured with Caco-2 IECs in the VDC with 
aerobic conditions in the apical compartment, some green fluorescent bacterial cells 
were observed associated with the IECs (Figure 5.4A). However, there were only a 
few bacteria present in the one field of view. Furthermore, detection of bacteria was 
hampered by the scattering of the bacteria over several optical slices. In contrast, 
when C. jejuni 11168H eGFP expressing strain was co-cultured with Caco-2 IECs in 
the VDC with micro aerobic conditions in the apical compartment, numerous green 
fluorescent bacteria were observed (Figure 5.4B), supporting the data from the 
interaction and invasion assays which showed that micro aerobic conditions in the 
apical compartment of the VDC leads to higher numbers of interacting and 
intracellular bacteria compared to aerobic conditions in the apical compartment. 
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Figure 5.3: Caco-2 intestinal epithelial cell (lEC) monolayers were grown on Snapwell™ 
filters for 21 days. The mono layers were then maintained in a vertical diffusion chamber 
(VDC) for 24 h with Brucella broth and either aerobic (A) or microaerobic (B) conditions at 
the apical surface. The IECs were prepared for Laser Scanning Confocal Microscopy and 
stained for DNA (blue) and cellular actin (red). 
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Figure 5.4: Caco-2 intestinal epithelial cell (lEC) monolayers were grown on SnapweJITM 
filters for 21 days. C. jejuni 11168H bacteria expressing eGFP were co-cultured with Caco-2 
lECs in a vertical diffusion chamber (VDC) at an MOl of 100:1 for 24 h with either aerobic 
(A) or microaerobic (B) conditions in the apical compartment. The lECs were prepared for 
Laser Scanning Confocal Microscopy and stained for DNA (blue) and cellular actin (red). 
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5.5 Co-culturing C.jejuni 11168H wild-type strain bacteria with 
T84 IECs in the VDC with microaerobic conditions in the 
apical compartment for 24 h results in higher numbers of 
intracellular bacteria within the IECs 
To eliminate the possibility of Caco-2-specific attributes leading to the increased 
numbers of intracellular C. jejuni 11168H wild-type strain bacteria after co-culturing 
with Caco-2 IECs in the VDC with micro aerobic conditions compared to aerobic 
conditions in the apical compartment, these experiments were repeated with the 
second IEC line, T84. 
The VDC model has a relatively low throughput due to i: long culturing of the IECs 
on Snapwell™ filters prior to the co-culturing experiments, ii: the low numbers of 
parallel experiments that can be performed due to the availability of only 5 VDCs 
and one gas manifold and iii: the long co-culturing times of up to 24 h. 
Consequently, only the assessment of the numbers of intracellular bacteria after 24 h 
of co-culturing with the IECs in the VDC with either aerobic or microaerobic 
conditions in the apical compartment was performed with the second cell line, as the 
difference between the aerobic and the microaerobic conditions was most 
pronounced at this time point. T84 cells were demonstrated to grow to a tight 
monolayer on Snapwell™ filters and no negative effects on the cells was observed 
during 24 h maintenance experiments in the VDC with Brucella broth and 
microaerobic conditions in the apical compartment (see Chapter 4). C. jejuni 11168H 
wild-type strain was co-cultured with T84IECs at an MOl of approximately 100:1 in 
the VDC with either aerobic or microaerobic conditions in the apical compartment 
for 24 h. After the co-culturing, extracellular bacteria were killed by incubation with 
150 I-tg!ml of gentamicin in DMEM for 2 h at 37°C. The IECs were subsequently 
lysed, the lysates serially diluted and plated as described in section 2.10.4 (Figure 
5.5). 
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Figure 5.5: Caco-2 and T84 intestinal epithelial cell (1EC) monolayers were grown on 
Snapwell™ filters for 21 and 14 days respectively. C. jejuni 11168H wild-type strain 
bacteria were co-cultured with Caco-2 or T84 IECs in a vertical diffusion chamber at an 
MOl of 100:1 for 24 h with either aerobic (white bars) or microaerobic (black bars) 
conditions in the apical compartment. The numbers of intracellular bacteria were determined 
by killing any extracellular bacteria with gentamicin followed by lysis of the IECs, serial 
dilution and plating of the lysates .. 
As with the Caco-2 cells, co-culturing of C. jejuni 11168H wild-type strain with T84 
IECs in the VDC with micro aerobic conditions in the apical compartment resulted in 
more intracellular bacteria compared to co-culturing experiments performed with 
aerobic conditions in the apical compartment. The differences between the two 
conditions were not as statistically significant when using T84 IECs compared to 
Caco-2 cells. This might be a result of low levels of oxygen leakage across the T84 
IEC monolayer due lack of complete impermeability as stated in Chapter 4. 
However, this data confirms the data from the Caco-2 IEC co-culturing experiments 
as genuine and not as an IEC line specific phenomenon. 
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5.6 Co-culturing C.jejuni 81-176 wild-type strain bacteria with 
Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment for 24 h results in higher numbers of 
intracellular bacteria within the IECs 
To eliminate the possibility of C. jejuni 11168H wild-type strain-specific 
characteristics leading to the observed increase in intracellular C. jejuni after 24 h of 
co-culturing with Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment compared to control experiments with aerobic conditions in the 
apical compartment, the 24 h intracellular experiments were repeated with another 
widely used laboratory strain, C. jejuni 81-176. C. jejuni 81-176 wild-type strain was 
co-incubated with Caco-2 IECs at an MOl of approximately lDO:l in VDCs with 
either aerobic or microaerobic conditions in the apical compartment for 24 h. Mter 
the co-culturing, extracellular bacteria were killed by incubation with 150 J-tglml of 
gentamicin in DMEM for 2 h at 37°C. The IECs were subsequently lysed, the lysates 
serially diluted and plated as described in section 2.lD.4. The numbers of 
intracellular bacteria obtained for C. jejuni 81-176 wild-type strain were comparable 
to the numbers obtained with C. jejuni 11168H wild-type strain (Figure 5.6). This 
suggests that the finding that co-culturing of C. jejuni with Caco-2 IECs in the VDC 
with microaerobic conditions in the apical compartment results in an increased 
number of intracellular bacteria compared to control experiments with aerobic 
conditions in the apical compartment is not strain-specific. Intriguingly, the numbers 
were very similar for both bacterial strains. This finding is interesting as C. jejuni 
81-176 wild-type strain is generally considered to be more invasive than the 11168H 
wild-type strain. A possible explanation is that the system may be saturated after 24 
h of co-culturing, and that no more bacteria are able to invade the IECs. However 
this is somewhat speculative. Analysis of the differences between C. jejuni 11168H 
and 81-176 wild type strains after shorter co-culturing times would shed more light 
on this question. 
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Figure 5.6: Caco-2 intestinal epithelial cell (1EC) mono layers were grown on Snapwell™ 
filters for 21 days. C. jejuni 11168H and 81-176 wild-type strain bacteria were co-cultured 
with Caco-2 IECs in a vertical diffusion chamber at an MOl of 100:1 for 24 h with either 
aerobic (white bars) or micro aerobic (black bars) conditions in the apical compartment. The 
numbers of intracellular bacteria were determined after co-incubation by killing of any 
extracellular bacteria with gentamicin followed by lysis of the IECs and serial dilution and 
plating of the lysates. * = p < 0.05 
5.7 The increased interaction and invasion of C.jejuni 11168H 
wild-type strain with Caco-2 IECs in the VDC with 
microaerobic conditions in the apical compartment results in a 
possible rearrangement/destruction of the occludin meshwork 
After establishing that the co-culturing of C. jejuni 11168H wild-type strain with 
Caco-2 IECs in the VDC with microaerobic conditions in the apical compartment led 
to increased numbers of interacting and intracellular bacteria and that this was not a 
strain-specific result, the effect of the increased bacterial interaction and invasion on 
the IECs was analysed. 
Previous experimental data has demonstrated that the co-culturing of IECs with C. 
jejuni leads to a disruption of the tight junctional protein occludin (MacCallum et aI., 
2005b, Chen et al., 2006). In order to investigate this in the VDC model and to 
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analyse whether the increased numbers of interacting and intracellular bacteria under 
microaerobic conditions in the apical compartment led to a change in the occludin 
distribution, Caco-2 IECs were co-cultured with C. jejuni 11168H wild-type strain in 
the VDC with either aerobic or microaerobic conditions in the apical compartment 
for 24 h (Figure 5.7B and Figure 5.8B). IECs that had been maintained in the VDC 
without bacteria but with either aerobic or microaerobic conditions in the apical 
compartment for 24 h were included as controls (Figure 5.7A and Figure 5.8A). 
After co-incubation, the IECs were prepared for LSCM and stained for actin and 
occludin as described in section 2.10.6. 
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Figure 5.7: Caco-2 intestinal epithelial cell (LEC) monolayers were grown on Snapwell™ 
filters for 21 days. Control IEC monolayers were maintained in a vertical diffusion chamber 
(VOC) with aerobic conditions, but no bacteria in the apical compartment for 24 h (A). C. 
j ejuni 11168H wild-type strain bacteria were co-cultured with Caco-2 IECs in a VDC at an 
MOl of 100: I for 24 h with aerobic conditions in the apical compartment. (B). After 24 h, 
the lECs were processed for immunostaining and stained for occludin (green), actin (red) 
and the nuclei counterstained with OAPJ (blue). The images represent projections of a stack 
of Z-axis slices viewed from above. 
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Figure 5.8: Caco-2 intestinal epithelial cell (lEC) monolayers were grown on SnapweHTM 
filters for 21 days. Control IEC mono layers were maintained in a vertical diffusion chamber 
(VDC) with microaerobic conditions but no bacteria in the apical compartment for 24 h (A). 
C. jejuni 11168H wild-type strain bacteria were co-cultured with Caco-2 lECs in a VDC at 
an MOl of 100: 1 for 24 h with microaerobic conditions in the apical compartment. (8). After 
24 h, the fECs were processed for immunostaining and stained for occludin (green), actin 
(red) and the nuclei counterstained with DAPI (blue). The images represent projections of a 
stack of Z-axis slices viewed from above. 
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Compared to the uninfected control samples, the occludin staining in the samples 
that had been co-cultured with C. jejuni 11168H wild-type strain appeared to be less 
uniform, with more areas lacking the mesh-like structure around the cells (Figure 5.7 
and Figure 5.8, B compared to A). Furthermore, "blebs" of occludin that appear to 
have detached from the cell membranes were more frequently observed in the 
infected samples. However as microscopical data is not quantitative, it is difficult to 
conclude whether there was a significant between the aerobic and the microaerobic 
samples (Figure 5.7B compared to Figure 5.8B). Analysing the quantities of 
occludin by immunoblot using a protein unaffected by the bacterial interaction as a 
reference would present a more quantitative method to assess the change of occludin 
after 24 h of co-culturing. 
5.8 Increased interaction and invasion of C.jejuni 11168H and 81-
176 wild-type strains co-incubated with IECs in the VDC with 
microaerobic conditions in the apical compartment does not 
result in increased permeability of the monolayer to a 
fluorescent tracer 
As shown in section 4.1.7, the IECs grow to polarised monolayers that are 
impermeable to the fluorescent tracer, fluorescently labelleddextran. Evidence 
obtained by LSCM suggested that the distribution of occludin altered during C. 
jejuni co-culturing with the IECs, suggesting a possible change in IEC monolayer 
permeability. Analogous to the experiments presented in section 4.1.7, the 
permeability of IEC monolayers to fluorescently labelled dextran was assessed after 
24 h of co-culturing with C. jejuni 11168H or 81-176 wild-type strains in the VDC 
with either aerobic or micro aerobic conditions in the apical compartment. Both 
Caco-2 and T84 IECs were used for these experiments (Figure 5.9). 
No increased permeability of the IEC monolayers to the fluorescent tracer was 
detected after 24 h of co-culturing of either wild-type strain with either IEC line. 
Furthermore, no difference was observed between either IEC line that had been co-
cultured with C. jejuni with either aerobic or microaerobic conditions in the apical 
compartment, suggesting that the increased bacterial interaction did not increase 
148 
monolayer permeability after 24 h. This suggests that despite the observed change in 
occludin distribution (Figure 5.7 and Figure 5.8), the overall permeability of the lEe 
monolayer is not altered over 24 h, most likely due to other cell-cell proteins 
maintaining the monolayer integrity. 
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Figure 5.9: Caco-2 (A) and T84 (B) intestinal epithelial cell (IEC) monolayers were grown 
on Snapwell™ filters for 21 and 14 days respectively. C. jejuni 11168H and 81-176 wild-
type strain bacteria were co-cultured with the IECs in a vertical diffusion chamber (VDC) at 
an MOl of 100:1 for 24 h with either aerobic (A) or microaerobic (M) conditions in the 
apical compartment. Untreated IECs (Un), empty Snapwell™ filters (No cells), IECs 
permeabilised with Triton X-100 for 20 min at 37°C (Triton) as well as IECs placed in the 
VDC but left uninfected with either aerobic (A unin) or microaerobic (M unin) conditions at 
the apical surface were used as controls. 500 III of 100 IlM FITC-Iabelled dextran with an 
average molecular weight of 4 kilodaltons (kOa) in Ringer's solution was added to the apical 
side of the monolayer and incubated for 3 hours at room temperature. After 3 hours, the 
percentage of fluorescently labelled dextran that had passed across the monolayer was 
determined from the fluorescence of the basolateral solution at 488 nm and the relative 
fluorescence of the input solution. 
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5.9 The increased bacterial interactions with lEes lead to an 
increased, polarised innate immune response. 
TO assess the effect of the increased bacterial interaction with and invasion of IECs 
in the VDC with microaerobic conditions in the apical compartment on the innate 
immune response of the IECs, the VDC supernatants were analysed for the presence 
of markers of the innate immune system. As the IEC monolayer sits in between the 
two compartments of the VDC, cytokines secreted by the IECs either apically or 
basolaterally can be detected, allowing the detection of polarised responses. 
5.9.1 The increased bacterial interactions with the lEes lead to an 
increased, polarised secretion of IL-8 
IL-8 has been demonstrated to be secreted by IECs in response to C. jejuni infection 
in vitro (Hickey et al., 1999, Watson et al., 2005). To analyse whether the increased 
numbers of interacting and intracellular bacteria observed after co-culturing with 
IECs in the VDC with micro aerobic conditions in the apical compartment were 
recognised by the IECs and translated into an enhanced innate immune response, the 
VDC co-culture supernatants were analysed by ELISA for the presence of IL-8. As 
the VDC is divided into an apical and a basolateral compartment, both compartments 
could be analysed separately, allowing for detection of a polarised, directional innate 
immune response. Previous published data suggested that the IL-8 response of the 
Caco-2 IEC line in response to C. jejuni infection was relatively weak under normal 
tissue culture conditions. Supernatants from 6 h as well as 24 h VDC co-culturing 
experiments with both C. jejuni 11168H and 81-176 wild-type strains were analysed 
for the presence of IL-8. Supernatants from bacteria-free VDC experiments were 
included as negative controls. No IL-8 was detected in any supernatants of Caco-2 
IECs co-cultured with either C. jejuni wild-type strain for 6 h, suggesting that 6 h 
was not enough time to allow for the secretion of detectable amounts of the 
chemokine by the IECs. After 24 h of co-culturing, no IL-8 was detected in the 
supernatants of the uninfected controls apart from one sample (Figure 5.10). For the 
co-culturing experiments with C. jejuni 11168H wild-type strain (Figure 5.lOa), IL-8 
was only detected in the basolateral compartments of co-culturing experiments 
performed with microaerobic conditions in the apical compartment. A stronger IL-8 
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response was detected in the supernatants from the co-culturing experiments with C. 
jejuni 81-176 wild-type strain (Figure 5.lOb). The highest levels were detected in the 
basolateral compartments of co-culturing experiments performed with microaerobic 
conditions in the apical compartment, suggesting that this condition and the resulting 
increased bacterial interaction and invasion leads to an increased, polarised innate 
immune response from the Caco-2 IECs. The finding that C. jejuni 81-176 wild-type 
strain induced a stronger IL-8 response compared to C. jejuni 11168H wild-type 
strain is particularly interesting, as the numbers of intracellular bacteria recovered 
after 24 h of co-culturing did not differ markedly between the two strains (Figure 
5.6). This suggests that reasons other than the numbers of interacting and 
intracellular bacteria such as the presence or absence of certain bacterial virulence 
factors may lead to a differential host innate immune response. 
152 
a un in fected 11168H 
Aerobic Micro Aerobic Micro 
1* .. 
_15 
- • E 
110 .... 
ep ~ 
...J 
- 5 
-
0 
A B A B A B A B 
b uninfected 81-176 
Aerobic Micro Aerobic Micro 
i 
*-. 
..... 7G 
-i, • Q.5O 
...L 
-C9 .. 
... lIT • 2G A ... 
• .6 .. If; 
0 
A B A B A B A B 
Figure 5.10: Caco-2 intestinal epithelial cell (1EC) mono layers were grown on Snapwell™ 
filters for 21 days. C. jejuni 11168H (a) and 81-176 (b) wild-type strain bacteria were co-
cultured with Caco-2 IECs in a vertical diffusion chamber at an MOl of 100: 1 for 24 h with 
either aerobic (Aerobic) or microaerobic (Micro) conditions in the apical compartment. The 
supernatants from the apical (A) and the basolateral (B) compartments of the VDC were 
probed for the presence of Interleukin 8 (IL-8) by ELISA. * = p < 0.05 
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As opposed to the relatively weak IL-8 response reported for Caco-2 IECs, T84 IECs 
have been demonstrated to show a more robust secretion of IL-8 in response to C. 
jejuni infection (MacCallum et al., 2006). To analyse whether this higher response 
would be reproduced in the VDC model, supernatants of T84 cells co-cultured in the 
VDC with C. jejuni 11168H and 81-176 wild-type strains with either aerobic or 
microaerobic conditions in the apical compartment and the supernatants analysed by 
ELISA for the presence of IL-8. Supernatants from bacteria-free experiments were 
included as negative controls. 
As opposed to the Caco-2 IECs and consistent with the literature, some IL-8 was 
detected in the supernatants of uninfected T84 cells (Figure 5.11). Using C. jejuni 
11168H wild-type strain, no increase in the levels of IL-8 was detected in the 
supernatants from co-culturing experiments performed in the VDC with aerobic 
conditions in the apical compartment compared to the uninfected controls (Figure 
5. 11A). Furthermore, no increase in the levels of IL-8 was detected in the apical 
supernatants of co-culturing experiments performed in the VDC with microaerobic 
conditions in the apical compartment. As with Caco-2 cells, significantly more IL-8 
was detected in the basolateral compartments of co-culturing experiments performed 
in the VDC with microaerobic conditions in the apical compartment. The levels of 
IL-8 detected in the basolateral compartments using T84 cells were approximately 
six-fold higher (average of 60 pglml compared to 10 pglml) compared to the Caco-2 
cells. This confirms that, at least in response to C. jejuni 11168H wild-type strain, 
T84 IECs secrete higher levels of IL-8 than Caco-2 IECs. 
Co-culturing of C. jejuni 81-176 wild-type strain with Caco-2 cells led to a 
significant increase in secretion of IL-8 by the IECs compared to IECs that had been 
co-cultured with C. jejuni 11168H wild-type strain (Figure 5.10). Intriguingly, no 
such difference was observed using T84 IECs and the C. jejuni 81-176 wild-type 
strain (Figure 5.11b). The highest levels of IL-8 were still detected in the basolateral 
compartments of co-culturing experiments performed with micro aerobic conditions 
in the apical compartment; however, these were only slightly higher than the levels 
detected when C. jejuni 11168H wild-type strain was used (Figure 5.11). This 
indicates that the IL-8 response by IECs to co-culturing with C. jejuni is dependent 
on the IEC line used as well as the bacterial strain. 
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Figure 5.11: T84 intestinal epithelial cell (1EC) monolayers were grown on SnapwellTM 
filters for 14 days. C. jejuni 11168H (a) and 81-176 (b) wild-type strain bacteria were co-
cultured with T84 IECs in a vertical diffusion chamber (VDC) at an MOl of 100:1 for 24 h 
with either aerobic (Aerobic) or microaerobic (Micro) conditions in the apical compartment. 
The supernatants from the apical (A) and the basolateral (B) supernatants of the VDC were 
analysed for the presence of Interleukin 8 (IL-8) by ELISA * = p < 0.05, ** = p < 0.01 
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5.9.2 The increased bacterial interactions with the lEes lead to an 
increased, polarised secretion of hBD-3 
Human beta defensins (hBDs) are small, antimicrobial peptides secreted in response 
to bacterial infection (see sections 1.3.1 and 3.4 for more details). To analyse the 
effect of the increased interaction with and invasion of IECs co-cultured with C. 
jejuni in the VDC with microaerobic conditions in the apical compartment on the 
secretion of hBDs from the IECs, the supernatants of 24 h co-culture experiments in 
the VDC with either aerobic or microaerobic conditions in the apical compartment 
were analysed by ELISA for the presence of hBD-2 and hBD-3. Supernatants from 
uninfected VDC experiments were included as controls. As with IL-8, both 
compartments of the VDC were analysed to investigate whether any response was 
polarised. 
No hBD-2 was detected in the supernatants of any of the co-culturing experiments. 
As hBD-2 has previously been demonstrated to be secreted by Caco-2 IECs in vitro 
in response to co-culturing with C. jejuni 11168H wild-type strain, it is possible that 
low levels of peptide were present, but undetectable due to adherence of the peptides 
to the plastic tubes the supernatants had been stored in (see section 3.10) 
Low levels of hBD-3 were detected in the supernatants of the uninfected co-culturing 
experiments (Figure 5.12). Using C. jejuni 11168H wild-type strain, no increased 
levels of hBD-3 were detected in the supernatants from co-culturing experiments 
performed in the VDC with aerobic conditions in the apical compartment. Low 
levels of hBD-3 were detected in the apical compartments of co-culturing 
experiments performed with microaerobic conditions in the apical compartment, but 
the increase was not significant compared to the uninfected controls. No increased 
levels of hBD-3 were detected in the basolateral supernatants from the same 
experiments, suggesting that the IECs secreted the hBD-3 peptides in a polarised 
fashion from their apical surface. Intriguingly, higher levels of hBD-3 were detected 
in the supernatants from the experiments using C. jejuni 81-176 wild-type strain 
(Figure 5.12b). The highest levels were detected in the apical compartments of co-
culturing experiments performed with micro aerobic conditions in the apical 
compartment, suggesting that this condition and the resulting increased bacterial 
interaction and invasion leads to an increased, polarised hBD-3 response from the 
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Caco-2 IECs. However, the low numbers of replicates limits the significance of the 
data, and detection of hBD-3 in the same and additional supernatants at a later time 
point was no longer possible, likely due to degradation of the peptides under the 
storage conditions used. Further investigation of the hBD-3 response of IECs co-
cultured with C. jejuni in the VDC would be necessary, but was not carried out due 
to time constraints. 
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Figure 5.12: Caco-2 intestinal epithelial cell (1EC) monolayers were grown on Snapwell™ 
filters for 21 days. C. jejuni 11168H (a) and 81-176 (b) wild-type strain bacteria were co-
cultured with Caco-2 IECs in a vertical diffusion chamber at an MOl of 100:1 for 24 h with 
either aerobic (Aerobic) or microaerobic (Micro) conditions in the apical compartment. The 
supernatants from the apical (A) and the basolateral (B) compartments of the VDC were 
probed for the presence human beta defensins 3 (hBD-3) by ELISA. 
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5.10 Microarray analysis of C.jejuni 11168B gene expression after 6 
and 24 h of co-culturing with Caco-2 IECs in the VDC with 
either aerobic or microaerobic conditions in the apical 
compartment 
In order to investigate the bacterial factors that contribute to the increased interaction 
with and invasion of IECs by C. jejuni after co-culturing in the VDC with 
microaerobic compared to aerobic conditions in the apical compartment, the gene 
expression profiles of C. jejuni 11168H wild-type strain bacteria co-cultured with 
Caco-2 IECs for 6 and 24 h in the VDC with either aerobic or microaerobic 
conditions in the apical compartment were analysed using microarrays. Total RNA 
was isolated from C. jejuni 11168H that had been co-cultured with Caco-2 IECs in 
the VDC for 6 hand 24 h with either aerobic or microaerobic conditions in the apical 
compartment as described in section 2.12. The gene expression profiles were 
analysed using standard microarray techniques as described in section 2.12. The 
exact experimental setup is shown in Figure 5.13. Replicates from three independent 
VDCs per condition (6 h aerobic, 6 h microaerobic, 24 h aerobic, 24 h micro aerobic) 
were obtained. It should be noted that the RNA was isolated from bacteria that were 
suspended in the apical compartment and not necessarily in contact with the IECs. 
Hence, the data obtained will not reflect the transcription profiles of bacteria directly 
in contact with the IECs but the transcription profiles of bacteria under conditions 
leading to the observed increased interaction and invasion of IECs, which may lead 
to the discovery of factors involved in the observed phenotype. 
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Figure 5.13: Schematic of the experimental setup of the microarray analysis 
The gene expression profile for C. jejuni 11168H co-cultured with Caco-2 IECs with 
aerobic conditions in the apical compartment at each time point was set as the 
reference. The gene expression profile acquired for C. jejuni 11168H co-cultured 
with Caco-2 IECs with microaerobic conditions in the apical compartment was 
compared to the reference profile at both time points using GeneSpring software. As 
the classical method of gene expression analysis, where a cut-off (generally 2-fold) 
is chosen and the genes above and below this cut-off statistically examined for 
significance, yielded no statistically significant differences between the aerobic and 
the microaerobic gene expression profiles, an alternative method of analysis was 
used. The method is similar to that described previously (Kamal et ai., 2007). To 
determine which genes were differentially expressed between the aerobic and 
microaerobic profiles, a P - value of 0.05 was selected to test whether the 
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normalised expression level of a gene in the microaerobic profile was statistically 
different from the normalised expression level in the aerobic profile. ANOV A 
(ANalysis Of VAriance) methodology was used as the statistical test,using a 
Benjamini & Hochberg False Discovery Rate as the Multiple Testing Correction 
within the GeneSpring software. 
5.10.1 Analysis of C.jejuni 11168H gene expression after 6 h of co-
culturing with Caco-2 IECs in the VDC indicates possible 
differences in metabolic activity under microaerobic conditions 
Microarray analysis of C. jejuni 11168H gene expression after 6 hand 24 h of co-
culturing with Caco-2 IECs in the VDC with either aerobic or microaerobic 
conditions in the apical compartment indicated that only a small number of genes are 
differentially expressed between bacteria co-cultured with Caco-2 IECs in the VDC 
with aerobic or microaerobic conditions in the apical compartment. As the gene 
expression profiles obtained after 6 hand 24 h of co-culturing C. jejuni 11168H 
under aerobic conditions were set as the reference for the analysis, a specific gene 
that is indicated as up-regulated under micro aerobic conditions can also be 
considered to be down-regulated under aerobic conditions. 
S.10.1.1 C.jejuni 11168H genes up-regulated after 6 h of co-culturing 
with Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment 
Microarray analysis indicated that 43 genes were up-regulated in C. jejuni 11168H 
after 6 h of co-culturing with Caco-2 IECs in the VDC with microaerobic conditions 
in the apical compartment (selected genes Table 5.1, see Appendix I for full gene 
list). The gene showing the stongest up-regulation was Cj1511c (fdhA), annotated as 
coding for a putative formate dehydrogenase large subunit protein. Formate 
dehydrogenase proteins (FDH) are a set of enzymes that catalyse the oxidation of 
formate to bicarbonate, donating the electrons to a second substrate such as 
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Nicotinamide Adenine Dinucleotide (NAD) (Ferry, 1990). This may be indicative of 
the activation of a different respiratory pathway during co-culturing under 
microaerobic conditions. This is supported by the finding that two other genes found 
to be up-regulated after co-culturing under micro aerobic conditions are annotated as 
being involved in electron transport/respiration, Cj1186 and Cj0414. Further 
experiments are needed to identify the role of this possible change in respiration on 
the interaction and invasion of the IECs. Four other up-regulated genes are annotated 
as coding for ribosomal proteins. This might indicate that more protein translation is 
occurring during microaerobic co-culturing. Furthermore, several genes coding for 
proteins involved in cellular metabolism were found to be up-regulated. 
Unfortunately no functional characterisation data for the products of these genes is 
available to date, making any further hypotheses regarding the involvement of these 
gene products in the observed increased C. jejuni interaction with and invasion of 
IECs after co-culturing in the VDC with microaerobic conditions in the apical 
compartment highly speculative. 
One up-regulated gene that has been characterised is deeR. The product of this gene 
has been demonstrated to be the response regulator of the DccRS two-component 
regulatory system (MacKichan et al., 2004). DccRS has been shown to be required 
for the in vivo colonisation of chicks but dispensable for in vitro growth, and several 
genes of unknown function were indicated to be regulated by the DccRS regulon 
(MacKichan et al., 2004). A further study demonstrated activity of the DccRS 
regulon in the late stationary phase, identified a set of nine genes as the DccRS 
regulon and ruled out any influence on the transcription of genes outside the DccRS 
regulon (Wosten et al., 201Oa). Three genes within the DccRS regulon may be of 
particular interest; Cj0606, Cj0607 and Cj0608 have been annotated as encoding a 
putative type I secretion system, due to similarity to an E. eoli alpha-haemolysin 
secretion system (Gundogdu et al., 2007). However, none of these three genes have 
been functionally characterised in C. jejuni, so the role of Cj0606, Cj0607 and 
Cj0608 in host-pathogen interactions is still unclear. 
162 
Table S.l: A selection of genes indicated by micro array analysis to be up-regulated in C. 
jejuni 11168H after 6 h of co-culturing with Caco-2 IECs in the VDC with microaerobic 
conditions in the apical compartment. 
NCTC11168 gene Normalised fold-change Annotation 
number 
Cj151le 2.3 fdhA putative formate 
dehydrogenase large 
subunit 
Cj1l86e 2 petA putative ubiquinol-
cytochrome C reductase 
iron-sulfur subunit 
Cj1705e 2.0 Binds third domain of 23S 
rRNA and protein L29; part 
of exit tunnel 
Cj0414 1.8 putative oxidoreductase 
subunit 
Cj1591 1.6 SOS ribosomal protein L36 
Cj0330e 1.6 SOS ribosomal protein L32 
Cj1223e (deeR) 1.4 two-component response 
regulator 
Cj0961e 1.4 SOS ribosomal protein L34 
5.10.1.2 C.jejuni 11168H genes down-regulated after 6 h of co-culturing 
with Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment 
Microarray analysis indicated that 24 genes were down-regulated in C. jejuni 
11168H after 6 h of co-culturing with Caco-2 IECs in the VDC with microaerobic 
conditions in the apical compartment (selected gene Table 5.2, see Appendix II for 
full gene list).Most of these genes are annotated as putative or hypothetical, with no 
further information available. However one gene product has been studied in more 
detail. HtrB, a lipid A biosynthesis lauroyl acetyltransferase has been shown to be 
essential for responsiveness to harsh environments (Phongsisay et al., 2007). The 
finding that htrB is down-regulated after microaerobic co-culturing (also indicating 
up-regulated after aerobic co-culturing) supports the hypothesis that the bacteria are 
under more stress during the aerobic co-culturing in the VDC. 
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Table 5.2: A selection of genes indicated by microarray analysis to be down-regulated in C. 
jejuni 11168H after 6 h of co-culturing with Caco-2 IECs in the VDC with micro aerobic 
conditions in the apical compartment. 
NCTC11168 gene Normalised fold-change Annotation 
number 
Cj1134 (htrB) 1.5 lipid A biosynthesis lauroyl 
acyltransferase 
5.10.2 Analysis of C.jejuni 11168H gene expression after 24 h of co-
culturing with Caco-2 IECs in the VDC indicates possible down-
regulation of genes involved in CPS biosynthesis and in stress 
response under microaerobic conditions 
Microarray analysis indicated that a greater number of C. jejuni 11168H genes are 
differentially expressed between bacteria co-cultured with Caco-2 IECs under 
aerobic or microaerobic conditions after 24 h compared to after 6 h in the VDC. 
5.10.2.1 C.jejuni 11168H genes up-regulated after 24 h of co-culturing 
with Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment 
Microarray analysis indicated that 73 genes were up-regulated in C. jejuni 11168H 
after 24 h of co-culturing with Caco-2 IECs in the VDC with microaerobic 
conditions in the apical compartment (selected genes Table 5.3, see Appendix III for 
full gene list). The only virulence factor identified was ciaB (see section 1.2.2), 
indicating a possible role for CiaB in mediating the increased interaction and 
invasion of C. jejuni after 24 h of co-culturing with Caco-2 IECs in the VDC with 
microaerobic conditions in the apical compartment. No other "classical" virulence 
factors were identified. Furthermore, most of the genes indicated as up-regulated 
under micro aerobic conditions have not been functionally characterised. Perhaps the 
most interesting gene identified to be up-regulated is Cj1176c (tatA), encoding a 
Sec-independent protein translocase, which is part of the Twin Arginine secretion 
machinery that targets proteins to the periplasm of Gram-negative bacteria (Berks, 
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1996). Proteins exported by this pathway include enzymes involved in electron 
transport. The FdhA protein found to be up-regulated after 6 h of microaerobic co-
culturing (See section 5.10.1.1) has been shown to be a substrate for the TAT 
secretion system (Hitchcock et al., 2010). Even though the fdhA gene was no longer 
up-regulated after 24 h of co-culturing under microaerobic conditions, it can be 
hypothesised that either i) higher levels of the protein are still present in the 
cytoplasm and need to be secreted or ii) the translocase may be involved in secretion 
of other proteins that in tum may have an effect on C. jejuni interactions with and 
invasion of IECs. However, this is highly speculative and further functional 
characterisation of TatA as well as construction of a 11168H tatA mutant and 
subsequent analysis of the interaction and invasion numbers would be required to 
support the role of TatA in C. jejuni interactions with IECs. 
Table 5.3: A selection of genes indicated by microarray analysis to be up-regulated in C. 
jejuni 11168H after 24 h of co-culturing with Caco-2 IECs in the VDC with microaerobic 
conditions in the apical compartment. 
NCTCl1168 gene Normalised fold-change Annotation 
number 
Cj1176c (tatA) 2.2 Sec-independent protein 
translocase 
Cj0914c (ciaB) 1.3 CiaB protein 
5.10.2.2 C.jejuni 11168H genes down-regulated after 24 h of co-culturing 
with Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment 
Microarray analysis indicated that 53 genes were down-regulated in C. jejuni 
11168H after 24 h of co-culturing with Caco-2 IECs in the VDC with microaerobic 
conditions in the apical compartment (selected genes Table 5.4, see Appendix IV for 
full gene list). The products of three of the down-regulated genes (Cj1447c, Cj1440c 
and Cj1425c) have been demonstrated to be involved in CPS synthesis. Recent 
evidence demonstrated that CPS locus genes were down-regulated when the C. jejuni 
11168H wild-type strain was co-cultured and passaged with IECs (Corcionivoschi et 
al., 2009). It is possible that the observed down-regulation of the three genes after 24 
h of co-culturing of C. jejuni 11168H with Caco-2 IECs in the VDC with 
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microaerobic conditions in the apical compartment may be a result of the co-
culturing gas concentration and therefore be one of the factors involved in the 
increased interaction and invasion of C. jejuni under these conditions. Further studies 
using C. jejuni 11168H capsular mutants are needed to assess the involvement of the 
C. jejuni CPS in the increased interaction with and invasion of IECs when co-
cultured with Caco-2 IECs in the VDC with microaerobic conditions in the apical 
compartment. 
Microarray analysis indicated that four genes with annotated functions involved in 
DNA repair were found to be down-regulated in C. jejuni 11168H co-cultured with 
Caco-2 IECs in the VDC with microaerobic conditions in the apical compartment: 
Cj0642 (recN), Cjl085c (m/D), Cj0198c (rarA) and Cj0799c (ruvA). This would 
support the hypothesis that the bacteria are experiencing more oxygen stress when 
co-cultured with IECs under aerobic compared to microaerobic conditions. Three 
flagellar genes were also down-regulated in the microaerobic dataset, Cj0319 (JliG, 
encoding the flagellar motor switch protein G), Cj0720c (fliC) and Cj0549 (fliS,), 
indicating that altered motility under microaerobic conditions might be involved in 
the increased interaction with and invasion of IECs. Another gene found to be down-
regulated under microaerobic conditions was Cj0843c, a putative lytic 
transglycosylase. A 11168H Cj0843c mutant has been shown to exhibit higher 
numbers of intracellular bacteria than the wild-type strain in a standard tissue culture 
assay (Abdi Elmi, LSHTM, personal communication). As such, it could be 
hypothesised that downregulation of Cj0843c under microaerobic conditions would 
lead to increased levels of interaction and invasion with the IECs. Further studies are 
needed to investigate the role of the Cj0843c protein in the C. jejuni IEC 
interactions. 
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Table 5.4: A selection of genes indicated by microarray analysis to be down-regulated in C. 
jejuni 11168H after 24 h of co-culturing with Caco-2 IECs in the VDC with microaerobic 
conditions in the apical compartment. 
NCTCl1168 gene Normalised fold-change Annotation 
number 
Cj1447c (kpsT) 1.1 Capsule polysaccharide 
export ATP-binding protein 
Cj0642 (recN) 1.1 Putative DNA repair 
protein 
Cj0843c 1.1 Putative secreted 
transglycosy lase 
Cj0319 (fliG) 1.2 Flagellar motor switch 
protein G 
Cj0720c (flaC) 1.2 Flagellin 
Cj0549 (JUS) 1.3 Flagellar protein FliS 
Cj1686c (topA) 1.4 DNA topoisomerase I 
Cjl085c (mid) 1.6 Transcription-repair 
coupling factor 
Cj0198c (rarA) 1.8 Recombination factor 
protein 
Cj0799c (ruvA) 2.9 Holliday junction DNA 
helicase 
In summary, microarray analysis of the gene expression of C. jejuni 11168H after 6 
hand 24 h of co-culturing with Caco-2 lECs in the VDC with either aerobic or 
microaerobic conditions in the apical compartment demonstrated only minor 
differences in gene expression between bacteria co-cultured with IECs with aerobic 
or micro aerobic conditions in the apical compartment. Apart from ciaB (up-regulated 
after 24 h of co-culturing with microaerobic conditions in the apical compartment of 
the VDC), no "classical" C. jejuni virulence factors were identified. Additionally, 
genes involved in stress response and DNA damage repair were indicated to be up-
regulated after co-culturing with aerobic conditions in the apical compartment. 
Taken together, this preliminary microarray gene expression analysis suggests that 
C. jejuni gene products that have to date not been functionally characterised might be 
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involved in mediating the increased interaction with and invasion of IECs observed 
when co-cultured in the VDC with micro aerobic conditions in the apical 
compartment. Alternatively, the bacteria might be under more stress when co-
cultured with IECs with aerobic conditions in the apical compartment of the VDC 
and therefore exhibit less interaction with and invasion of the IECs. However the 
relatively low numbers of replicates (three replicates per time point and co-culturing 
condition) and the fact that the mRNA isolated during these experiments most likely 
represents bacteria under the different co-culturing conditions rather than bacteria 
actually interacting with IECs render the dataset somewhat preliminary. Further 
replicate experiments and different RNA isolation methodology as well as follow up 
studies analysing the interaction and invasion ability of C. jejuni 11168H strains 
mutated in the genes identified by the microarray analysis are needed to strengthen 
and confirm the data obtained by this first round of experiments. 
5.11 Summary and discussion 
Mter establishing in the previous chapter that Caco-2 and T84 IECs could be 
maintained in the VDC with microaerobic conditions at the apical surface for at least 
24 h without any apparent detrimental effects, the effect of co-culturing C. jejuni 
11168H wild-type strain bacteria with IECs under microaerobic conditions was 
assessed. A time-dependent increase in the numbers of both interacting and 
intracellular C. jejuni 11168H wild-type strain bacteria was demonstrated after co-
culturing with Caco-2 IECs in the VDC with microaerobic conditions in the apical 
compartment. This was demonstrated using quantitative interaction and invasion 
assays as well as by semi-quantative LSCM. The findings were further confirmed 
using a second C. jejuni wild-type strain (c. jejuni 81-176) as well as a second IEC 
line (T84) to rule out possible strain- or cell line-specific effects. Qualitative analysis 
of the distribution of occludin suggested a possible minor disruption of the occludin 
meshwork due to the increased numbers of interacting and intracellular C. jejuni 
11168H wild-type strain bacteria after co-culturing with Caco-2 IECs in the VDC 
with microaerobic conditions in the apical compartment. However, analysis of the 
diffusion of a fluorescent tracer across IEC monolayers that had been co-cultured 
with C. jejuni 11168H and 81-176 wild-type strains in the VDC did not demonstrate 
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increased diffusion, suggesting that the overall barrier function of the monolayer was 
unaffected by the increased bacterial interaction and invasion. However, the 
increased levels of bacterial interaction and invasion were demonstrated to lead to an 
increased, polarised innate immune response from the IECs. More IL-8 was detected 
after micro aerobic co-culturing, suggesting that the IECs were able to sense and 
respond to the increased bacterial challenge. More IL-8 was detected in the 
basolateral supernatants compared to the apical supernatants. This suggests that the 
IL-8 secretion by the IECs occurs in a polarised fashion, with the chemokine being 
secreted from the basolateral side of the IECs. This concurs with the biological 
function of IL-8 as a neutrophil attractant, which would be of limited use in the 
intestinal lumen. In accordance with the literature, a marked difference in the amount 
of secreted IL-8 was detected between the two IEC lines used, with the T84 IECs 
demonstrating higher levels of secretion compared to the Caco-2 IECs. Both C. 
jejuni wild-type strains used induced similar levels of IL-8 secretion from T84 IECs, 
but differed in the ability to induce an IL-8 response from the Caco-2 IECs, despite 
demonstrating similar numbers of interacting and intracellular bacteria. This suggests 
that C. jejuni strain specific factors as well as IEC line specific factors contribute to 
the level of innate immune response observed in these experiments. In addition to 
IL-8, higher levels of hBD-3 were detected after micro aerobic co-culturing of C. 
jejuni with IECs in the VDC. Unfortunately, the number of samples was too low for 
detailed statistical analysis. A trend for apical secretion was observed, however. This 
stands in contrast to the mainly basolateral secretion of IL-8, but concurs with the 
biological function of hBD-3 as an antimicrobial peptide. Further studies are 
required to clarify these observations. This data demonstrates that the two-
compartmental setup of the VDC allows for efficient identification of a polarised 
host response. 
Microarray analysis of the gene expression of C. jejuni 11168H wild-type strain after 
6 hand 24 h co-culturing with Caco-2 IECs in the VDC with either aerobic or 
microaerobic conditions at the apical surface revealed relatively small differences in 
gene expression under the two conditions. No virulence factors were identified by 
this analysis, suggesting that potentially other gene products that to date have not 
been linked with virulence may be involved in mediating C. jejuni-IEC interactions. 
Several genes linked to stress responses were found to be up-regulated after co-
culturing under aerobic conditions, suggesting that the bacteria are exposed to stress 
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when co-cultured with the IECs under aerobic conditions. While this finding cannot 
be directly linked to higher levels of interaction and invasion, it can be hypothesised 
that bacteria under stress will interact with IECs less readily than those under non-
stressed conditions. This concurs with the finding that fewer intracellular C. jejuni 
11168H wild-type strain bacteria were recovered after 24 h of co-culturing with 
Caco-2 IECs in the VDC with aerobic conditions in the apical compartment 
compared to the numbers obtained after 6 h of co-culturing. However genes with 
products putatively involved in respiration/electron transport were found to be up-
regulated after co-culturing with microaerobic conditions in the apical compartment, 
particularly after 6 h of co-culturing. This may indicate that alternative respiratory 
pathways are activated during co-culturing with microaerobic conditions in the 
apical compartment. However the relatively low numbers of replicates (three 
replicates per time point and co-culturing condition) and the fact that the mRNA 
isolated during these experiments most likely represents bacteria under the different 
co-culturing conditions rather than bacteria actually interacting with IECs render the 
dataset somewhat preliminary. Further replicate experiments and different RNA 
isolation methodology as well as follow up studies analysing the interaction and 
invasion ability of C. jejuni 11168H strains mutated in the genes identified by the 
micro array analysis are needed to strengthen and confirm the data obtained by this 
first round of experiments. Further studies are required to confirm this finding. 
Additionally, three genes that are part of the CPS locus were found to be down-
regulated after 24 h of micro aerobic co-culturing. A recent study demonstrated 
down-regulation of CPS genes when in contact with IECs in vitro (Corcionivoschi et 
al., 2009). It can be speculated that down-regulation of the CPS may lead to 
exposure of C. jejuni surface structures that may be involved in mediating bacterial 
interactions with the lECs. A similar mechanism has been demonstrated to occur in 
Neisseria meningitidis, where the CPS is down-regulated prior to attachment to and 
invasion of cells, allowing for the unmasking of surface structures involved in 
intimate adhesion (Deghmane et al., 2002). 
Gene expression was only analysed after 6 hand 24 h of co-culturing of C. jejuni 
11168H with IECs in the VDC. These two time points offer only two snapshots of 
what is most likely a dynamic interaction between C. jejuni and the IECs over time. 
As changes in C. jejuni gene expression may occur immediately after exposure to 
conditions and IECs in the VDC, gene expression analysis at additional timepoints, 
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possibly starting as early as 30 min after co-culturing, will shed more light on the 
dynamics of these interactions. 
As the gene expression profiles described above represent only a preliminary dataset 
due to the low number of replicates (three per time point and co-culturing condition, 
see Figure 5.13) and the fact that the mRNA isolated during these experiments most 
likely represents bacteria under the different co-culturing conditions rather than 
bacteria actually interacting with IECs, further in-depth analysis of the dataset, such 
as a hypergeometric analysis, to assess for over- or under-representation of a 
functional category of genes in any dataset was not performed. However, for future 
studies that will include more replicates, more time points and different RNA 
samples, a more in-depth analysis of the data will be appropriate to extract more 
information from the data 
Another limitation of the microarray analysis of C. jejuni gene expression after co-
culturing with IECs in the VDC is the relatively low yield of RNA extractable for 
such analysis. This is a result of the low volume of bacterial suspension as well as 
the low bacterial concentration used in the VDC co-culturing (-4 x 108 bacteria per 
VDC) compared to a standard protocol for RNA analysis, where RNA would be 
harvested from 2 ml of a late logarithmic phase C. jejuni culture containing 
approximately 4 x 109 bacteria (Jagannathan et al., 2001, Kamal et al., 2007). 
Pooling of samples from several rounds of co-culturing might increase the yield of 
mRNA. Alternatively, next generation mRNA sequencing could be used to analyse 
the gene expression of C. jejuni after co-culturing with Caco-2 IECs in the VDC. As 
this novel technique is becoming less expensive and has the potential for very high 
throughput and more quantitative analysis, this would allow for in-depth analysis of 
C. jejuni 11168H gene expression during co-culturing with Caco-2 IECs in the VDC, 
enabling the analysis of a greater number of time points. 
The data reported in this part of the study supports the finding reported for a similar 
VDC model used for H. pylori, demonstrating increased numbers of adherent 
bacteria when co-cultured with Caco-2 IECs under microaerobic conditions (Cottet 
et al., 2002). As both H. pylori and C. jejuni require micro aerobic conditions for 
growth, the finding that microaerobic conditions promote interactions of the 
organisms with host cells is unsurprising. However, a recent study using a VDC to 
analyse the interaction of the facultative anaerobe EHEC with IECs under anaerobic 
conditions demonstrated increased interactions of the bacteria when co-cultured with 
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anaerobic/microaerobic conditions in the apical compartment of the VDC (Schuller 
et al., 2010). This suggests that the behaviour of not only microaerobic bacteria but 
also of bacteria that are capable of proliferating under atmospheric oxygen 
concentration is changed when co-cultured with IECs under microaerobic or 
anaerobic conditions. This demonstrates that the VDC model is an improved and 
very useful model for analysis of host-pathogen interactions of a wide range of 
pathogenic bacteria under conditions more closely resembling the in vivo situation in 
the human intestinal lumen. 
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Chapter 6 
Investigation of bacterial factors involved in 
the increased interaction with and invasion of 
lEes observed under micro aerobic conditions 
at the apical surface 
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6.1 Introduction 
The data presented in the previous chapter demonstrated that co-culturing the C. 
jejuni 11168H wild-type strain with IECs in the VDC with microaerobic conditions 
in the apical compartment leads to an increased number of bacteria interacting with 
and invading the IECs. Analysis of the changes in gene expression between bacteria 
co-cultured with IECs with either aerobic or microaerobic conditions in the apical 
compartment of the VDC did not reveal any obvious virulence factors involved in 
the increased lEe interaction and invasion of C. jejuni. 
As a second approach to further analyse the molecular basis of the increased 
bacterial interaction with and invasion of the IECs in the VDC with microaerobic 
conditions in the apical compartment, the numbers of interacting and intracellular 
bacteria were determined for three C. jejuni 11168H mutants. It was hypothesised 
that if a gene product is involved in modulating the increased interaction and 
invasion under microaerobic conditions, then a strain mutated in that gene would no 
longer exhibit the increased interaction and invasion phenotype with microaerobic 
conditions in the apical compartment of the VDC. This approach was successfully 
used to demonstrate a role for the type III secretion effector EspA in increasing the 
numbers of interacting EHEC with IECs. An espA mutant demonstrated reduced 
increase in interaction with the IECs when co-cultured with IECs in the VDC with 
anaerobic conditions in the apical compartment (Schuller et al., 2010). 
The three C. jejuni 11168H mutants chosen for this study were: 
• 11168H ciaB mutant. The CiaB protein has been proposed to have a role in 
IEC invasion by C. jejuni. However, the exact role of the protein is 
controversial within the Campylobacter research community. 
• 11168H flaA mutant. The major flagellin subunit protein FlaA has been 
demonstrated to have a role in IEC invasion by C. jejuni. 
• 11168H rpoN mutant: The alternative sigma factor 0"54 (RpoN) has been 
demonstrated to have a role in regulation of C. jejuni flagellar biosynthesis. 
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As the most striking differences between the numbers of interacting and intracellular 
bacteria were observed after 24 h when the C. jejuni 11168H wild-type strain was 
co-cultured with IECs in the VDC with micro aerobic conditions in the apical 
compartment, the three C. jejuni 11168H mutants were initially assessed at this time 
point. 
6.2 A 11168H ciaB mutant does not exhibit reduced numbers of 
interacting and intracellular bacteria when co-cultured with 
Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment 
The Campylobaeter Invasion Antigen (Cia) proteins have been reported to be 
required for bacterial entry into epithelial cells (Konkel et al., 1999a). It was 
originally proposed that the proteins were secreted by a type III secretion system 
(TTSS) due to sequence homology with other TTSS effector proteins (Konkel et al., 
1999a). However, sequencing of the first C. jejuni genome demonstrated the absence 
of a TTSS in the C. jejuni NCTC11168 genome (Parkhill et al., 2000) and it has 
since been proposed that the Cia proteins are secreted via the flagellum (Konkel et 
al., 2004). Some reports state that a C. jejuni F38011 ciaB mutant exhibits a 
reduction in host cell invasion and that mutation of ciaB abolishes secretion of all 
Cia proteins (Konkel et al., 1999b, Konkel et al., 1999a). Recently, a C. jejuni 
F38011 ciaC, mutant was also demonstrated to exhibit reduced host cell invasion 
(Christensen et al., 2009). However, there has always been controversy about the 
role of the Cia proteins in IEC invasion by C. jejuni and a recent report states that the 
invasion of a C. jejuni 81-176 ciaB mutant strain did not differ from that of the 
parental wild-type strain (Novik et al., 2010). Data obtained at the LSHTM using a 
11168H ciaB mutant demonstrated lower numbers of interacting and intracellular 
11168H ciaB mutant bacteria compared to the C. jejuni 11168H wild-type strain 
using standard tissue culture assays (Neveda Naz, LSHTM, personal 
communication). However, this data has not yet been confirmed using a 
complemented 11168H ciaB mutant. 
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The decision was made to assess the interaction and invasion numbers of the 11168H 
ciaB mutant in the VDC model. 
A 11168H ciaB mutant was obtained from Neveda Naz (LSHTM) and insertion of 
the KanR cassette into the ciaB gene verified by PCR (Figure 6.1). 
3kb ~ 
2.5kb~ 
2kb ~ 
1.5kb ~ 
lkb ~ 
M wt ciaB mut -ve 
Figure 6.1: Genomic DNA was isolated from the C. jejuni 11168H wild-type strain and 
11168H daB mutant. Primers annealing to the 5'- and the 3'-end of the daB gene were used 
to amplify peR products of 1.8 kb and 3.2 kb from the wild-type strain and mutant genomic 
DNA templates respectively, demonstrating successful disruption of the daB gene in the 
11168H daB mutant. 
After verifying mutation of the ciaB gene, the 11168H ciaB mutant was co-cultured 
with Caco-2 IECs in the VDC for 24 h with either aerobic or micro aerobic 
conditions in the apical compartment and the numbers of interacting bacteria 
determined by lysis of the IECs post incubation and serial dilution and plating of the 
lysates (Figure 6.2A). The numbers of intracellular bacteria were determined by 
killing the extracellular bacteria with gentamicin prior to IEC lysis as described in 
section 2.10.4 (Figure 6.2B). The numbers obtained were compared to those 
previously obtained with the C. jejuni 11168H wild-type strain (See sections 5.2 and 
5.3). 
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Figure 6.2: C. jejuni 11168H wild-type strain and the 11168H ciaB mutant were co-cultured 
with Caco-2 intestinal epithelial cells (lECs) in a vertical diffusion chamber (VDC) at an 
MOl of 100:1 for 24 h with either aerobic (white bars) or microaerobic (black bars) 
conditions in the apical compartment. The numbers of interacting bacteria were determined 
by lysis of the IECs after co-culturing, serial dilution and plating of the lysates (A). The 
numbers of intracellular bacteria were determined by killing of any extracellular bacteria 
with gentamicin followed by lysis of the IECs and serial dilution and plating of the lysates 
(B). 
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The numbers of interacting and intracellular 11168H ciaB mutant bacteria did not 
differ from those observed for the C. jejuni 11168H wild-type strain after 24 h of co-
culturing in the VDC with either aerobic or microaerobic conditions in the apical 
compartment. This suggests that either CiaB is not involved in mediating the 
increased interaction and invasion observed in the VDC model or that other 
virulence factors compensate for the ciaB mutation over the relatively long co-
incubation period of 24 h, especially as the original report demonstrating the 
involvement of CiaB in IEC invasion by C. jejuni utilised shorter co-culturing times 
(30 mins for interaction and 3 h for invasion (Konkel et ai., 1999a). As the original 
report also states that a C. jejuni F38011 ciaB mutant is defective in secretion of all 
Cia proteins (Konkel et ai., 1999b), the results shown here would suggest that the 
Cia proteins as such are not involved in the increased interaction and invasion of 
IECs by C. jejuni co-cultured with microaerobic conditions in the apical 
compartment of the VDC. This data is in contrast to the original reports on CiaB and 
also to recent data obtained with this C. jejuni 11168H ciaB mutant at the LSHTM 
(Neveda Naz, personal communication), but in accordance with the recent analysis 
of an 81-176 ciaB mutant (Novik et ai., 2010). This merits further investigation into 
the numbers of interacting and intracellular bacteria for the 11168H ciaB mutant and 
a 81-176 ciaB mutant in the VDC model, especially at shorter co-culturing time 
points. However, due to time and throughput constraints, this was not pursued 
further in this study. 
There are two possible explanations for the data presented above. One is that CiaB 
has no role in C. jejuni interactions with and invasion of IECs and therefore the 
finding that a 11168H ciaB mutant does not exhibit lower numbers of interacting and 
intracellular bacteria in the VDC model compared to the C. jejuni 11168H wild-type 
strain is an accurate observation. Alternatively it is possible that the VDC model 
does not allow the detection of differences between numbers of interacting and 
intracellular bacteria between a C. jejuni strain and a mutant after 24 h of co-
culturing. To confirm that the VDC model was able to detect differences in the 
invasive phenotype of a C. jejuni mutant, 11168H flaA and rpoN mutants were 
analysed in the VDC model. 
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6.3 Two non-motile C.jejuni 11168H mutants exhibit reduced 
numbers of interacting and intracellular bacteria when co-
cultured with Caco-2 IECs in the VDC with microaerobic 
conditions in the apical compartment 
As stated above, the role of CiaB is not without controversy within the 
Campylobaeter research community. On the other hand, motility has been widely 
reported to be essential for C. jejuni to interact with and especially to invade IECs. 
To identify whether motility under micro aerobic conditions was important, the 
interaction and invasion numbers of two non-motile mutants were analysed. The two 
mutants chosen were the C. jejuni 11168HflaA and rpoN mutants. 
6.3.1 A 11168HflaA mutant exhibits reduced numbers of interacting 
and intracellular bacteria when co-cultured with Caco-2 IECs in 
the VDC with microaerobic conditions in the apical compartment 
The C. jejuni flaA gene encodes the major flagellin subunit protein FlaA. Together 
with FlaB, the FlaA protein makes up the flagellar filament (Guerry et al., 1991). 
Regulation of C. jejuni flagellar biogenesis is highly complex and is controlled in 
part by the alternative sigma factors (154 (RpoN) and (128 (FliA). Additionally, the 
anti-sigma factor-like protein FlgM has been demonstrated to be a temperature-
dependent regulator of both (154_ and (128_ dependent flagellin expression (Wosten et 
al., 20 lOb ). A C. jejuni F38011 flaA mutant has been demonstrated to be non-motile 
and unable to secrete the Cia proteins (Konkel et aI., 2004). A C. jejuni 81116 flaA 
mutant has previously been demonstrated to exhibit a reduction in host cell invasion 
(Wassenaar et al., 1991), and the role of the major flagellin subunit protein FlaA in 
C. jejuni IEC invasion is widely accepted. As such, a 11168HflaA mutant can serve 
as a robust control. 
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A 11168HfiaA mutant was obtained from the LSHTM Campylabaeter jejuni mutant 
library (http://crf.lshtm.ac.ukD and insertion of the KanR cassette into the fiaA gene 
confirmed by PCR (Figure 6.3). 
3kb ~ 
2.5kb~ 
2kb ~ 
1.5kb~ 
M wt flaA mut -ve 
Figure 6.3: Genomic DNA was isolated from the C. jejuni 11168H wild-type strain and the 
11168H flaA mutant. Primers annealing to the 5' - and the 3' -end of the flaA gene were used 
to amplify peR products of 1.5 kb and 2.9 kb from wild-type strain and mutant genomic 
DNA templates, respectively, demonstrating successful disruption of the flaA gene in the 
11168H flaA mutant. 
Mter veryfing mutation of the fiaA gene, the 11168H fiaA mutant was co-cultured 
with Caco-2 IECs in the VDC for 24 h with either aerobic or microaerobic 
conditions in the apical compartment and the numbers of interacting bacteria 
determined by lysis of the IECs post incubation and serial dilution and plating of the 
lysates (Figure 604A). The number of intracellular bacteria was determined by killing 
the extracellular bacteria with gentamicin prior to IEC lysis as described in section 
2.1004 (Figure 604B). The numbers obtained were compared to those previously 
obtained with the C. jejuni 11168H wild-type strain (See sections 5.2 and 5.3). 
180 
A 
B 
-
'ii 
~ 
t 
c 
tn 
...... 
~ 
I&. 
U 
!. 1.0-10" 
-CD 
tal 
-. i a 1.0-
u ...... 
I!~ C I&. 1.0 
_u 
DatfOIIic 
II mlcroaerobie 
11l68Hwt J 1 J48Bwt jItIA.... jItIA .'Ida_ 
Daenlilic 
II mlcroaerobie .-----*,--....... 
1.01C10'..I.ooj .............. -
1116811wt 11168Hwt jIGot.... jItIA.1daJd 
Figure 6.4: C. jejuni 11168H wild-type strain and 11168H flaA mutant bacteria were co-
cultured with Caco-2 intestinal epithelial cells (IECs) in a vertical diffusion chamber (VDC) 
at an MOl of 100:1 for 24 h with either aerobic (white bars) or microaerobic (black bars) 
conditions in the apical compartment. The numbers of interacting bacteria were determined 
by lysis of the IECs after co-culturing, serial dilution and plating of the lysates (A). The 
numbers of intracellular bacteria were determined by killing of any extracellular bacteria 
with gentamicin followed by lysis of the IECs and serial dilution and plating of the lysates 
(B). * = P < 0.05 
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The numbers of interacting 11168H flaA mutant bacteria were slightly higher than 
those observed for C. jejuni 11168H wild-type strain when co-cultured with the 
Caco-2 IECs in the VDC with aerobic conditions in the apical compartment (Figure 
6.4A). However, when co-cultured with microaerobic conditions in the apical 
compartment, the numbers of interacting flaA mutant bacteria were significantly 
lower than those observed for the C. jejuni 11168H wild-type strain. Furthermore, 
under microaerobic conditions, the 11168H flaA mutant demonstrated a reduced 
increase in interacting bacteria compared to the wild-type strain (Figure 6.4A, 
compare differences between columns 1-2 and 3-4), suggesting the 11168H flaA 
mutant was no longer able to respond to the microaerobic conditions in the same way 
as the wild-type strain. The numbers of intracellular 11168H flaA mutant bacteria 
were lower than those observed for the C. jejuni 11168H wild-type when co-cultured 
with Caco-2 IECs in the VDC independent of the conditions in the apical 
compartment, with the difference reaching statistical significance after co-culturing 
with microaerobic conditions in the apical compartment (Figure 6.4B). Furthermore, 
the 11168H flaA mutant demonstrated a reduced increase in the numbers of 
intracellular bacteria when co-cultured with microaerobic conditions in the apical 
compartment compared to the wild-type strain (Figure 6.4B, compare differences 
between columns 1-2 and 2-3), suggesting the 11168H flaA mutant was no longer 
able to respond to the microaerobic conditions in the same way as the C. jejuni 
11168H wild-type strain in terms of IEC invasion. 
These differences suggest that bacterial motility during co-culturing with IECs in the 
VDC with micro aerobic conditions in the apical compartment is an important 
determinant of the increased interaction and invasion of the C. jejuni 11168H wild-
type strain compared to aerobic conditions. 
6.3.2 A 11168H rpoN mutant exhibits reduced numbers of interacting 
and intracellular bacteria when co-cultured with Caco-2 IECs in 
the VDC with microaerobic conditions in the apical compartment 
Flagellar gene transcription in C. jejuni has been demonstrated to be regulated in part 
by the two alternate sigma factors, cr28 and cr54• While expression of the major 
flagellar subunit FlaA is regulated by cr28 (FliA), the expression of the minor flagellar 
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subunit FlaB as well as the flagellar hook protein FlgE are regulated by cr54 (RpoN) 
(Jagannathan et al., 2001, Kamal et al., 2007). A 11168H rpoN mutant has been 
demonstrated to be aflagellate and non-motile (Fernando et aI., 2007, Jagannathan et 
al." 2001). Further studies of a C. jejuni 11168H rpoN exhibited a reduction in HeLa 
cell interaction and invasion under standard tissue culture conditions, as well as 
reduced CFUs in chick colonisation experiments (Fernando et al., 2007). Microarray 
analysis of the gene expression profile of the C. jejuni 11168H rpoN mutant 
identified multiple differentially expressed genes (both flagellar and non-flagellar 
related) compared to the wild-type strain (Kamal et al., 2007). 
A 11168H rpoN mutant was obtained from Dr Nick Dorrell (LSHTM) and screened 
for insertion of the KanR cassette into the rpoN gene by PCR (Figure 6.5). 
Approximately 900 bp of the rpoN gene had been deleted in the construction of the 
mutant, so the difference in PCR product size between the wild-type and the mutant 
was expected to be approximately 500 bp (Nick Dorrell, personnel communication). 
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Figure 6.5: Genomic DNA was isolated from the C. jejuni 11168H wild-type strain and a 
11168H rpaN mutant strain. As 900 bp of the rpaN gene had been deleted during 
construction of the mutant, a difference in PCR product size of 500 bp was expected for the 
insertional mutant. Primers annealing to the 5' - and the 3' -end of the rpaN gene were used to 
amplify PCR products of 1.2 kb and 1.7 kb from the wild-type strain and the mutant 
genomic DNA templates, respectively, demonstrating successful disruption of the rpaN gene 
in the 11168H rpaN mutant. 
After verifying mutation of the rpaN gene, the 11168H rpaN mutant was co-cultured 
with Caco-2 IECs in the VDC for 24 h with either aerobic or microaerobic 
conditions in the apical compartment, and the numbers of interacting bacteria 
determined by lysis of the IECs post incubation and serial dilution and plating of the 
lysates (Figure 6.6A). The number of intracellular bacteria was determined by killing 
the extracellular bacteria with gentamicin prior to IEC lysis as described in section 
2.10.4 (Figure 6.6B). The numbers obtained were compared to those previously 
obtained with the C. jejuni 11168H wild-type strain (See sections 5.2 and 5.3). 
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Figure 6.6: C. jejuni 11168H wild-type strain and 11168H rpoN mutant bacteria were co-
cultured with Caco-2 intestinal epithelial cells (lECs) in a vertical diffusion chamber (VDC) 
at an MOl of 100:1 for 24 h with either aerobic (white bars) or microaerobic (black bars) 
conditions in the apical compartment. The numbers of interacting bacteria were determined 
by lysis of the IECs after co-culturing, serial dilution and plating of the lysates (A). The 
numbers of intracellular bacteria were determined at both time points by killing of any 
extracellular bacteria with gentamicin followed by lysis of the IECs and serial dilution and 
plating of the lysates (B). 
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The numbers of interacting 11168H rpoN mutant bacteria did not differ from the 
numbers observed for the C. jejuni 11168H wild-type strain when co-cultured with 
Caco-2 IECs in the VDC for 24 h with aerobic conditions in the apical compartment 
(Figure 6.6A, compare columns 1 with 3). However, when co-cultured with Caco-2 
IECs in the VDC with microaerobic conditions in the apical compartment, the 
numbers of interacting 11168H rpoNmutant bacteria were lower than those obtained 
for the C. jejuni 11168H wild-type bacteria (Figure 6.6A, compare columns 2 with 
4). Furthermore and similar to the flaA mutant, under micro aerobic conditions the 
11168H rpoN mutant demonstrated a reduced increase in interacting bacteria 
compared to the wild-type strain (Figure 6.6A, compare differences between 
columns 1-2 and 3-4), suggesting the 11168H rpoN mutant was no longer able to 
respond to the microaerobic conditions in the same way as the C. jejuni 11168H 
wild-type strain 
The numbers of intracellular 11168H rpoN mutant bacteria when co-cultured with 
Caco-2 IECs with aerobic conditions in the apical compartment of the VDC were 
slightly higher than those obtained with the C. jejuni 11168H wild-type strain, 
however the difference was not statistically significant (Figure 6.6B, compare 
columns 1 with 3). When co-cultured with microaerobic conditions in the apical 
compartment, however, the numbers of intracellular 11168H rpoN mutant bacteria 
were approximately ten times lower than those obtained for the C. jejuni 11168H 
wild-type strain (Figure 6.6B, compare columns 2 with 4). Furthermore under 
microaerobic conditions, the 11168H rpoN mutant demonstrated a reduced increase 
in the numbers of intracellular bacteria compared to the wild-type strain (Figure 
6.6B, compare differences between columns 1-2 and 3-4) suggesting the 11168H 
rpoN mutant was no longer able to respond to the microaerobic conditions in terms 
of invasion in the same way as the C. jejuni 11168H wild-type strain. 
Taken together, the findings presented above demonstrate that under these 
experimental conditions and at 24 h post-infection, the 11168H flaA and rpoN 
mutants exhibited lower numbers of interacting and intracellular bacteria after 24 h 
of co-culturing in the VDC compared to the C. jejuni 11168H wild-type strain, in 
particular with micro aerobic conditions in the apical compartment. Intriguingly, both 
the flaA and rpoN mutants demonstrated a reduced increase in the numbers of 
intracellular bacteria under micro aerobic conditions compared to the wild-type 
strain, indicating that motility is one of the factors leading to increased interaction 
186 
with and invasion of the IECs observed for the C. jejuni 11168H wild-type strain 
when co-cultured with microaerobic conditions at the apical surface. 
6.4 The phenotypes of the two non-motile C.jejuni 11168H mutants 
with respect to interaction and invasion of IECs after co-
culturing with Caco-2 IECs in the VDC are more pronounced 
after a shorter period of co-culturing 
All experiments described above utilised the relatively long co-incubation time of 24 
h. This time point was initially chosen as the differences between the numbers of 
interacting and intracellular C. jejuni 11168H wild-type strain bacteria recovered 
after co-culturing with IECs with microaerobic conditions at the apical surface were 
the most significant (See Chapter 5). However, most common in vitro co-culturing 
models utilise far shorter co-incubation times. Therefore, the numbers of interacting 
and intracellular bacteria were assessed at 6 h co-incubation for the 11168HflaA and 
the rpoN mutants. 
6.4.1 The phenotype of the 11168HfloA mutant with respect to 
interaction and invasion of IECs after co-culturing with Caco-2 
IECs in the VDC is more pronounced after a shorter period of co-
culturing 
The 11168HflaA mutant was co-cultured with Caco-2 IECs in the VDC with either 
aerobic or micro aerobic conditions in the apical compartment for 6 h and the 
numbers of interacting and intracellular bacteria determined. 
After 6 h of co-culturing, the numbers of interacting 11168H flaA mutant bacteria 
when co-cultured with Caco-2 IECs in the VDC were the same independent of 
whether the bacteria had been had been co-cultured with aerobic or microaerobic 
conditions in the apical compartment of the VDC (Figure 6.7 A, compare columns 3 
and 7). Furthermore, the numbers were lower than those observed for the C. jejuni 
11168H wild-type strain (Figure 6.7A, compare columns 1 with 3 for aerobic and 5 
with 7 for microaerobic). Intriguingly, when compared with the data obtained after 
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24 h of co-culturing, the 11168HflaA demonstrated a greater increase in the number 
of interacting bacteria between time points 6 hand 24 h compared to the C. jejuni 
11168H wild-type strain, independent of the co-culturing condition (Figure 6.7A, 
compare all column pairs). Furthermore, the increase in bacterial numbers between 
the 6 h and the 24 h time points was more pronounced after co-culturing with 
microaerobic conditions at the apical surface. This suggests that i: aerobic co-
culturing may "mask" a phenotype and ii: in the case of the 11168H flaA mutant, 
longer co-culturing allows for compensation of the "lower interacting" phenotype. 
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Figure 6.7: C. jejuni 11168H wild-type strain and 11168H flaA mutant bacteria were co-
cultured with Caco-2 intestinal epithelial cells (IECs) in a vertical diffusion chamber (VDC) 
at an MOl of 100:1 for 24 h or 6 h with either aerobic (white bars) or microaerobic (black 
bars) conditions in the apical compartment. The numbers of interacting bacteria were 
determined by lysis of the IECs after co-culturing, serial dilution and plating of the lysates 
(A). The numbers of intracellular bacteria were determined at both time points by killing of 
any extracellular bacteria with gentamicin followed by lysis of the IECs and serial dilution 
and plating of the lysates (B). * = P < 0.05, *** = P < 0.001 
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Previous published data demonstrated that a C. jejuni 81116 flaA mutant exhibited 
markedly reduced potential for IEC invasion (JIassenaar et ai., 1991). After 24 h of 
co-culturing with Caco-2 IECs in the VDC, the number of intracellular 11168HflaA 
mutant bacteria was lower than the number obtained for C. jejuni 11168H wild-type 
strain, independent of the co-culturing conditions (Figure 6.7B, compare columns 2 
with 4 and 6 with 8). After 6 h of co-culturing, the difference between the 11168H 
flaA mutant and the wild-type strain was more pronounced (Figure 6.7B, compare 
columns 1 with 3 and columns 5 with 7). Intriguingly, after 6 h of co-culturing, the 
numbers of intracellular 11168H flaA mutant bacteria were higher for experiments 
performed with aerobic conditions in the apical compartment of the VDC compared 
to the experiments performed with micro aerobic conditions in the apical 
compartment (Figure 6.7B, compare columns 3 with 7 for the mutant and columns 1 
with 5 for the wild-type strain), an inversion of all previously obtained data. 
Additionally, when compared with the data obtained after 24 h of co-culturing, the 
11168H flaA mutant appeared to have partially recovered under microaerobic 
conditions but not under aerobic conditions (Figure 6.7B, compare differences 
between columns 3-4 for aerobic and 7-8 for microaerobic). 
This data suggests that bacterial motility is not only important for IEC invasion by C. 
jejuni per se, but that the observed increased invasion after co-culturing C. jejuni 
11168H wild-type strain with Caco-2 IECs in the VDC with microaerobic conditions 
in the apical compartment compared to aerobic conditions may also be linked to the 
motility of the bacteria. Hence, a non-motile bacterial mutant loses the ability to 
respond to the microaerobic, in vivo-like conditions and is less invasive when co-
cultured with IECs under microaerobic conditions. Interestingly, with regards to both 
interacting and intracellular bacteria, the phenotype of the 11168H flaA mutant is 
more pronounced at shorter co-culturing time points, suggesting that motility is 
particularly important at early phases of interaction and invasion, and that longer co-
incubations allow for partial compensation of the phenotype, possibly through the 
action of other bacterial factors. 
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6.4.2 The phenotype of the 11168H rpoN mutant with respect to 
interaction and invasion of IECs after co-culturing with Caco-2 
IECs in the VDC is more pronounced after a shorter period of co-
culturing 
After 24 h of co-incubation, lower numbers of interacting and intracellular bacteria 
were observed for the 11168H rpaN mutant compared to the C. jejuni 11168H wild-
type strain (Figure 6.4). Furthermore, the 11168H rpaN mutant demonstrated a 
reduced increase in the number of interacting and intracellular bacteria after co-
culturing with Caco-2 IECs in the VDC under micro aerobic conditions compared to 
the wild-type strain. To analyse the phenotype of the 11168H rpaN mutant after a 
shorter co-culturing time, the 11168H rpaN mutant was co-cultured with Caco-2 
IECs in the VDC for 6 h with either aerobic or micro aerobic conditions in the apical 
compartment and the numbers of interacting and intracellular bacteria determined 
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Figure 6.8: C. jejuni 11168H wild-type strain and 11168H rpoN mutant bacteria were co-
cultured with Caco-2 intestinal epithelial cells (IECs) in a vertical diffusion chamber (VDC) 
at an MOl of toO:1 for 6 h with either aerobic (white bars) or microaerobic (black bars) 
conditions in the apical compartment. The numbers of interacting bacteria were determined 
by lysis of the IECs after co-culturing, serial dilution and plating of the lysates (A). The 
numbers of intracellular bacteria were determined at both time points by killing of any 
extracellular bacteria with gentamicin followed by lysis of the IECs and serial dilution and 
plating of the lysates (B). * = P < 0.05, *** = p < 0.001 
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Mter 6 h of co-culture, the numbers of interacting 11168H rpoN mutant bacteria 
were lower than those obtained for C. jejuni 11168H wild-type strain, independent of 
the co-culturing conditions (Figure 6.8A, compare columns 1 with 3 and columns 4 
with 7). Intriguingly, the numbers of interacting 11168H rpoN mutant bacteria were 
lower after co-culturing with micro aerobic compared to aerobic conditions in the 
apical compartment of the VDC (Figure 6.8A, compare columns 3 with 7). This 
differed from the results obtained for the non-motile 11168HflaA mutant, where the 
numbers of interacting bacteria were approximately the same after 6 h of co-
culturing in both conditions (Figure 6.7 A, compare columns 3 with 7). 
The numbers of intracellular 11168H rpoN mutant bacteria were also assessed after 6 
h of co-culturing. The number of intracellular 11168H rpoN mutant bacteria was 
lower than the number obtained for the C. jejuni 11168H wild-type strain, 
independent of the co-culturing conditions (Figure 6.8B, compare columns 1 with 3 
and columns 4 with 7). Furthermore, in contrast to the C. jejuni 11168H wild-type 
strain, the number of intracellular 11168H rpoN mutant bacteria was lower after co-
culturing with micro aerobic conditions in the apical compartment of the VDC 
compared to co-culturing with aerobic condition in the apical compartment (Figure 
6.8B, compare columns 1 with 5 and columns 3 with 7), which again represents an 
inversion of the data obtained with the C. jejuni 11168H wild-type strain. 
In summary, lower numbers of interacting and intracellular 11168H flaA and rpoN 
mutant bacteria were observed after 6 h of co-culturing with Caco-2 IECs in the 
VDC compared to the numbers obtained with the C. jejuni 11168H wild-type strain, 
independent of the co-culturing condition. However, regarding the differences 
between the aerobic and the microaerobic co-culturing conditions, roughly equal 
numbers of interacting 11168H flaA mutant bacteria were observed under both 
conditions, in contrast to the wild-type strain, where higher numbers of interacting 
bacteria were recovered under after co-culturing with microaerobic conditions in the 
apical compartment. Furthermore, lower numbers of intracellular 11168H flaA 
mutant bacteria were observed after co-culturing under micro aerobic compared to 
aerobic conditions. This is the opposite of the wild-type strain, where higher 
numbers of intracellular bacteria were found after co-culturing under microaerobic 
compared to aerobic conditions. This phenotype was more pronounced for the 
11168H rpoN mutant, where lower numbers of interacting as well as lower numbers 
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of intracellular bacteria were found after co-culturing under micro aerobic compared 
to aerobic conditions. 
These findings suggest that motility is essential, but not the only factor involved in 
the increased bacterial invasion under micro aerobic conditions in the VDC. Even 
though both mutants are non-motile, there are a number of phenotypic differences 
due to the two mutations. Whilst the flaA mutant lacks the major flagellin subunit 
protein FlaA, a F38001 flaA mutant has been shown to still possess a truncated 
flagellar filament and to be secretion positive (Konkel et al., 2004). On the other 
hand, the rpoN mutant has been shown to be completely aflagellate, microarray 
analysis revealed multiple transcriptional changes, including genes not involved in 
flagellar biosynthesis and the mutant has been shown to be secretion negative 
(Kamal et al., 2007, Fernando et al., 2007). 
As rpoN codes for one of the two alternative sigma factors of C. jejuni, it is possible 
that the rpoN mutant is unable to modulate the transcription of a plethora of other 
genes under the control of RpoN. If the regulation of any of these genes is changed 
during co-culturing with IECs in the VDC with microaerobic conditions in the apical 
compartment in the C. jejuni 11168H wild-type strain resulting in increased 
interaction and invasion of the lECs by bacteria, it can be hypothesised that the 
11168H rpoN mutant, which is unable to modulate the expression of these genes due 
to the absence of 0'54, would no longer be able to exhibit an increased interaction and 
invasion. 
6.5 Complementation of the rpoN mutation gene partially restores 
the phenotype of the 11168H rpoN mutant 
As C. jejuni does not readily support episomal elements such as plasmid vectors, 
complementation requires the insertion of a functional copy of the gene back into the 
chromosome. A vector described recently, pCAM148, (Hitchen et al., 2010) was 
used to complement the rpoN mutation in the 11168H rpoN mutant. The vector was 
engineered to carry a 2179 bp fragment corresponding to nucleotides 205297-
207475 of the C. jejuni NCTCl1168 genome. This stretch of nucleotides was 
originally annotated as a probable pseudogene (Cj0223), and this was confirmed by 
the re-annotation of the C. jejuni NCTC11168 genome (Gundogdu et al., 2007). 
Within the 2179 bp fragment, the vector was engineered to carry a chloramphenicol 
194 
resistance cassette lacking a transcriptional terminator, followed by a small multiple 
cloning site (MCS) comprised of recognition sites for the restriction endonucleases 
Ncol and Nhel. The gene to be complemented can be directionally cloned into the 
MCS and will be expressed from the constitutively active CamR promoter. 
6.5.1 Cloning of the rpoN gene into the complementation vector 
pCAM148 
The rpoN gene was amplified by PCR from C. jejuni 11168H wild-type strain 
genomic DNA using a forward primer that had been designed to anneal 15 bases 
upstream of the ATG start codon in order to include the ribosomal binding site and a 
reverse primer that annealed to the 3' end of the rpoN gene. 
The PCR product was purified, digested with Ncol and Nhel and ligated between the 
NcollNhel sites of the complementation vector. Successful cloning was confirmed by 
purifying plasmid pCAMI48::rpoN from E. coli and digesting the purified plasmid 
with Ncol and Nhel. Release of a DNA fragment of the correct size from both 
plasmids, but not from the original empty vector used for cloning, demonstrated the 
successful cloning of a fragment of the correct size into the complementation vector 
(Figure 6.9). Sequencing of the insert confirmed successful cloning of the C. jejuni 
11168H rpoN gene into pCAM148 (data not shown). 
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Figure 6.9: Two clones of plasmid DNA of 11168H rpaN cloned into pCAM148 as well as 
the empty pCAM148 vector were digested with Neal and Nhel and the fragments separated 
by agarose gel electrophoresis (CUT). Uncut versions of each plasmid were included as 
controls (UNCUT). Release of a fragment of 1.3 kb from both pCAM148 constructs 
containing the rpaN insert confirmed the cloning of a DNA fragment of the correct size into 
pCAM148. 
6.5.2 Transformation of the 11168H rpoN mutant with the 
complementation construct 
Clone 1 of the complementation plasmids was introduced into the 11168H rpaN 
mutant by electroporation as described in section 2.9.10. Chloramphenicol resistant 
clones were anal ysed by PCR using the primers used to origin all y amplify the rpaN 
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gene from C. jejuni 11168H genomic DNA. The presence of both a wild-type and a 
mutant PCR product in both clones analysed confirmed the presence of the 
complementation construct (Figure 6.10). 
2 kb -----J> 
lj kb -----J> 
J kb -----J> 
Figure 6.10: Chromosomal DNA was prepared from the C. jejuni 11168H wild-type strain, 
the 11168H rpoN mutant and four clones of 11168H rpoN mutant transformed with the 
complementation construct. PCR reactions were performed using primers annealing to the 5' 
and the 3 ' end of the rpoN gene sequence and the products analysed by agarose gel 
electrophoresis. The presence of both the wild-type and the mutant PCR products in all four 
complemented clones demonstrated the successful reintroduction of the rpoN gene back into 
the 11168H rpoN mutant. 
Prior to use of the complemented 11168H rpaN mutant in VDC assays, two other 
experiments were performed to confirm that the mutation was not only genetically 
but also functionally complemented. 
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6.5.3 The motility phenotype of the 11168H rpoN mutant is partially 
complemented by expression of a functional copy of rpoN 
Motility is a pheno.type than can be assessed using so.ft agar swanning plates. A 
previo.us study has sho.wn that a C. jejuni 11168H rpaN mutant is no.n-mo.tile 
(Fernando. et al., 2007). To. analyse whether mo.tility was co.mplemented by 
reintroductio.n o.f a functio.nal co.py o.f the rpaN gene, the C. jejuni 11168H wild-type 
strain, the 11168H rpaN mutant as well as the co.mplemented 11168H rpaN mutant 
were assessed fo.r mo.tility as described in sectio.n 2.11.1. As expected, the C. jejuni 
11168H wild-type strain displayed no.nnal mo.tility, while the 11168H rpaN mutant 
was no.n-mo.tile. The complemented 11168H rpaN mutant sho.wed so.me mo.tility, 
albeit less than the wild-type, suggesting at o.nly partial complementatio.n was 
o.ccurring (Figure 6.11). This finding was no.t unexpected, as the rpaN mutatio.n will 
mo.st likely effect the expressio.n o.f several o.ther genes, which may no.t be 
completely rescued by the reco.mbinant pro.tein. Furthenno.re, it has been 
demo.nstrated that the FlgRS two.-compo.nent regulato.ry system is the master 
regulato.r o.f the Campylabaeter jejuni flagellum hierarchy and invo.lved in 
co.ntro.lling the expressio.n o.f rpaN (Wo.sten et al., 2004). In the co.mplemented rpaN 
mutant, ho.wever, rpaN is under the co.ntrol o.f a constitutively active promo.ter, 
which may have an influence o.n the pheno.type due to. different effects o.n genes 
regulated by Rpo.N. 
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Figure 6.11: The motility of the C. jejuni 11168H wild-type strain (wt), the 11168H rpoN 
mutant (mut), as well as the complemented 11168H rpoN mutant (comp) determined. After 
72 h on soft agar plates, the complemented 11168H rpoN mutant showed partial rescue of 
motility. 
6.5.4 The autoagglutination phenotype of the 11168H rpoN mutant is 
complemented by expression of a functional copy of rpoN 
Previously published data demonstrated that the presence of the flagellum is one of 
the key factors leading to bacterial aggregation(Golden et ai., 2002). As the 11168H 
rpoN mutant is aflagellate, this assay would allow for another rapid assessment of 
the efficiency of the complementation. The C. jejuni 11168H wild-type strain, 
11168H rpoN mutant as well as complemented 11168H rpoN mutant were assessed 
for their autoagglutination properties as described in section 2.11.2. As expected, the 
C. jejuni 11168H wild-type strain displayed a strong autoagglutinating phenotype, 
while hardly any autoagglutination was observed for the 11168H rpoN mutant 
(Figure 6.12). Autoagglutination comparable to the wild-type strain was observed for 
the complemented 11168H rpoN mutant, suggesting that re-introduction of a 
functional copy of the rpoN gene into the 11168H rpoN mutant restored the wild-
type autoagglutination phenotype. 
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Figure 6.12: The autoagglutination of the C. jejuni 11168H wild-type strain (wt), the 
11168H rpaN mutant (mut), as well as the complemented 11168H rpaN mutant (comp) was 
determined. Complementation of the 11168H rpaN mutant fully restored the 
autoagglutination phenotype. 
The results from the motility and autoagglutination experiments suggested that re-
insertion of a functional copy of the rpoN gene into the chromosome of a 11168H 
rpoN mutant partially restored flagellar filament functionality, as the presence of a 
functional flagellum has been demonstrated to be essential for autoagglutination of 
C. jejuni (Golden et ai., 2002). As the motility was only partially restored, however, 
it is probable that the function of the flagellar apparatus is only partially 
complemented. 
Nonetheless, the complemented 11168H rpoN mutant was co-cultured with Caco-2 
IECs in a VDC with either aerobic or microaerobic conditions in the apical 
compartment for 6 and 24 h and the rate of interaction and invasion determined and 
compared to those obtained for the C. jejuni 11168H wild-type strain and the 
11168H rpoN mutant. 
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Figure 6.13: C. jejuni 11168H wild-type strain (11168H wt), 11168H rpoN mutant (rpoN 
mut) and complemented 11168H rpoNmutant (comp) bacteria were co-cultured with Caco-2 
intestinal epithelial cells (IECs) in a vertical diffusion chamber (VDC) at an MOl of 100:1 
for 6 h with either aerobic (white bars) or micro aerobic (black bars) conditions in the apical 
compartment. The numbers of interacting bacteria were determined by lysis of the IECs after 
co-culturing, serial dilution and plating of the lysates (A). The numbers of intracellular 
bacteria were determined at both time points by killing of any extracellular bacteria with 
gentamicin followed by lysis of the IECs and serial dilution and plating of the lysates (B). 
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Figure 6.14: C. jejuni 11168H wild-type strain (11168H wt), rpoN mutant (rpoN mut) and 
complemented 11168H rpoN mutant (comp) bacteria were co-cultured with Caco-2 
intestinal epithelial cells (IECs) in a vertical diffusion chamber (VDC) at an MOl of 100:1 
for 24 h with either aerobic (white bars) or microaerobic (black bars) conditions in the apical 
compartment. The numbers of interacting bacteria were determined by lysis of the IECs after 
co-culturing, serial dilution and plating of the lysates (A). The numbers of intracellular 
bacteria were determined at both time points by killing of any extracellular bacteria with 
gentamicin followed by lysis of the IECs and serial dilution and plating of the lysates (B). 
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Mter 6 h of co-culturing, complementation of the 11168H rpoN mutant partially 
restored wild-type levels of interaction (Figure 6.13A) and invasion (Figure 6.13B). 
Most importantly, higher numbers of interacting and intracellular complemented 
11168H rpoN mutant bacteria were found after incubation in the VDC with 
microaerobic conditions compared to aerobic conditions in the apical compartment 
(black compared to white bars). This had been observed for the C. jejuni 11168H 
wild-type strain but not for the 11168H rpoN mutant. This confirmed the important 
role for RpoN in increasing the ability of C. jejuni to interact and invade IECs under 
microaerobic compared to aerobic conditions. Mter 24 h of co-culturing, 
complementation of the 11168H rpoN mutant partially restored wild-type levels of 
interaction (Figure 6.14A) and invasion (Figure 6.14B). 
The reason for the partial complementation of the 11168H rpoN mutant interaction 
and invasion phenotype by reintroducing a functional copy back into the mutant may 
be due to the fact that, as suggested previously, only partial restoration of motility 
was achieved. Evidence presented here as well as other studies have highlighted the 
importance of motility for C. jejuni interaction and invasion of IECs, so partial 
restoration of motility would most likely only lead to partial restoration of the 
interaction and invasion phenotype. In wild-type C. jejuni, rpoN expression has been 
demonstrated to be controlled and enhanced by FlgR (Wosten et al., 2(04). In the 
complemented rpoN mutant, however the complemented rpoN gene is under a 
constitutively active promoter, which may not accurately reflect the transcriptional 
activity of the native rpoN gene, in tum leading to expression profiles of genes 
controlled by RpoN to differ between the wild-type and the complemented 11168H 
rpoN mutant. 
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6.6 Summary and discussion 
The data presented in Chapter 5 demonstrated that co-culturing of C. jejuni 11168H 
wild-type strain with IECs in the VDC with microaerobic conditions in the apical 
compartment led to a time-dependent increase in the number of bacteria interacting 
with and invading the IECs. This part of the study investigated the role of bacterial 
factors involved in mediating this increased interaction and invasion. 
Interestingly, a 11168H ciaB mutant was shown to interact and invade IECs in the 
VDC to the same level as the wild-type strain after 24 h of co-culturing, independent 
of the oxygen conditions in the apical compartment. This is in contrast to previous 
data that suggests that a C. jejuni F38011 ciaB mutant is less able to invade IECs 
than the wild-type (Konkel et al., 1999b) and recent data obtained with this 11168H 
ciaB mutant (Neveda Naz, LSHTM). However, that data has recently been 
challenged by another study demonstrating no difference between the interaction and 
invasion of a C. jejuni 81-176 ciaB mutant and the parental wild-type strain (Novik 
et al., 2010). The results obtained with a C. jejuni 11168H ciaB mutant in the VDC 
support the evidence obtained with a C. jejuni 81-176 ciaB mutant, suggesting that 
the originally reported reduced invasive phenotype of the C. jejuni F38011 ciaB 
mutant may be a result of strain variation, or possibly even due to polar/non-specific 
effect, as no complementation of the phenotype of C. jejuni F38011 was reported. 
Further studies of C. jejuni ciaB mutants, possibly from different strain backgrounds, 
may shed light on the CiaB conundrum. Additionally, as the original data 
demonstrating the requirement of CiaB for IEC invasion used relatively short co-
culturing times (Konkel et al., 1999a), this may suggest that CiaB is particularly 
important for the early stage of C. jejuni IEC invasion. Therefore, analysis of the 
11168H ciaB mutant after shorter co-culturing times in the VDC may shed more 
light on the importance of CiaB. However, due to time and throughput constraints, 
the 11168H ciaB mutant was not further analysed. 
Motility has long been implicated to be important for the ability of C. jejuni to 
interact and in particular to invade IECs in classical in vitro co-culturing assays 
(Szymanski et al., 1995). To investigate whether motility was important for 
interaction and invasion of IECs by C. jejuni in the VDC model, two non-motile C. 
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jejuni mutants were analysed. The 11168HflaA mutant is unable to produce the main 
flagellar filament protein FlaA, whilst the 11168H rpoN mutant lacks the alternative 
sigma factor (554. When co-cultured with Caco-2 IECs in the VDC for 24 h, both 
mutants showed weak attenuation in regards to interaction with the IECs. However 
. ' 
both the C. jejuni 11168H flaA and the rpoN mutants exhibited lower numbers of 
intracellular bacteria compared to the C. jejuni 11168H wild-type strain after 24 h of 
co-culturing, particularly when co-cultured with microaerobic conditions in the 
apical compartment of the VDC. This suggests that the absence of functional flagella 
inhibits the ability of C. jejuni to increase the interaction and invasion of Caco-2 
IECs when co-cultured in the VDC with micro aerobic conditions in the apical 
compartment. Intriguingly, the phenotypes of both the 11168H flaA and rpoN 
mutants were more pronounced after 6 h of co-culturing in the VDC compared to 24 
h of co-culturing. Both mutants showed significantly reduced numbers of interacting 
and intracellular bacteria compared to the C. jejuni 11168H wild-type strain. 
Interestingly, at this time point, more flaA and rpoN mutant bacteria were found to 
be interacting with the IECs after co-culturing in the VDC with aerobic compared to 
microaerobic conditions in the apical compartment. This supports the hypothesis that 
increased motility in microaerobic conditions is an important cause of the increased 
bacterial interaction and invasion. Intriguingly, the phenotype was more apparent 
after shorter co-culturing times and both mutants appeared to be able to "catch-up" 
with the wild-type strain after longer co-incubation with the IECs. This suggests that 
motility is particularly important at the early stages of infection. This observation 
may also be in part due to the wild-type strain losing some of the motility after 
longer co-culturing. Alternatively, as both mutants are non-motile and exhibit 
impaired autoagglutination, it is possible that after longer co-culturing, some of the 
wild-type bacteria have agglutinated and fallen away from the IECs in the VDC, 
while the two mutants are still in suspension. This is more pronounced in the VDC 
model setup, where the IECs are mounted vertically, and the bacteria need to 
actively swim towards the IECs while being pulled towards the bottom of the VDC 
by gravity. This is in contrast to the classical tissue culture method, where the IECs 
are located at the bottom of a tissue culture flask, and even non-motile bacteria down 
are brought into proximity of the IECs by gravity. In order to investigate this 
hypothesis, a flagellated and autoagglutinating but non-motile mutant such as a C. 
jejuni 11168H Cj0248 mutant (Ozan Gundogdu, personal communication) should be 
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co-cultured with IECs in the VDC and analysed for interaction with and invasion of 
the IECs. 
Compared to the 11168H flaA mutant, the 11168H rpoN mutant exhibited a more 
pronounced phenotype, with fewer bacteria interacting with and invading the IECs. 
This may be due to the fact that while the flaA mutant lacks the major flagellar 
filament protein, the bacteria still possess a truncated flagellum as well as a flagellar 
hook and a basal body, and is still able to secrete proteins (Konkel et al., 2004). The 
rpoN mutant on the other hand is completely aflagellate, does not possess a flagellar 
hook and is not able to secrete proteins (Fernando et al., 2007). Furthermore, 
microarray analysis of gene transcription of a C. jejuni 11168H rpoN mutant 
revealed multiple changes, in genes involved in flagellar biosynthesis and structure 
as well as in non-flagellar genes (Kamal et al., 2007). Therefore, the rpoN mutation 
may have a more global effect on the bacteria, and hence a more severe impact on 
the ability of the bacteria to interact with the IECs. 
Re-introduction of a functional copy of the rpoN gene into the chromosome of the 
11168H rpoN mutant fully restored the autoagglutination phenotype, and partially 
restored the motility, interaction and invasion phenotypes of the mutant. As RpoN 
acts as an alternative sigma factor, which has been shown to be controlled by FlgR, it 
is likely that the constitutive expression of RpoN from the complementation 
construct is not at the exact same level as it would be in the C. jejuni 11168H wild-
type strain, resulting in different downstream expression of genes controlled by 
RpoN, which in turn would lead to a different phenotype. Gene expression analysis 
of the complemented 11168H rpoN mutant would allow further clarification of this 
point. 
Taken together, the data presented here demonstrates the importance of bacterial 
motility in the interaction with and invasion of IECs by C. jejuni. This data also 
indicates that changed/increased motility under microaerobic conditions is an 
important factor in the increased interaction and invasion of the IECs reported in the 
previous Chapter 6. This may well be reflective of the environment of the human 
intestine, where the conditions are microaerobic or even anaerobic. The findings 
reported here suggest that C. jejuni potentially exhibits stronger motility when inside 
the human intestine. This would aid the bacteria in swimming through the intestinal 
contents towards the IECs in vivo and therefore facilitate attachment and invasion. 
As all classical C. jejuni IEC co-culturing models used to date have been performed 
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under aerobic conditions, it is likely that the conditions have been suboptimal for the 
bacteria, and have hence hampered the discovery of the molecular basis of C. jejuni 
pathogenesis. 
Further evidence obtained using the 11168H rpoN mutant, which is also non-motile, 
suggested that bacterial motility was not the sole reason for the increased interaction 
and invasion of the IECs observed under microaerobic conditions. It remains to be 
determined which genes are differentially expressed in the 11168H rpoN mutant 
compared to the 11168H flaA mutant and thus may have an influence in C. jejuni 
interactions with and invasion of IECs. 
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Chapter 7 
Summary and future studies 
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7.1 Introduction 
Despite the prevalence of C. jejuni as a causative agent of human foodbome 
gastroenteritis, the molecular basis of the organism's pathogenicity is still poorly 
understood compared with other enteric pathogens. This can mainly be attributed to 
i: the lack of a convenient small animal model of the disease and ii: certain 
drawbacks with the commonly used in vitro models when applied to the study of C. 
jejuni pathogenesis. 
The research reported in this study describes the development of two models to study 
the pathogenesis of C. jejuni. Both models were chosen to more closely mimic the 
situation encountered by the pathogen in vivo in the human intestine. The EVOC 
model utilised ex vivo cultured human intestinal tissue to mimic the complex host 
tissue encountered by C. jejuni in vivo, whilst the VDC model mimics the 
microaerobic/anaerobic nature of the intestinal lumen. 
7.2 EVOC model summary 
The EVOC model employed whole primary human intestinal biopsies in order to 
present the bacteria with a more in vivo-like complex tissue, compared to the 
commonly employed "single cell-type" in vitro co-culturing using epithelial or other 
cell types. This model has previously been used to microscopically study the 
interaction of C. jejuni with human intestinal tissue (Grant et al., 2006, Haddock et 
al., 2010) as well as to analyse the host innate immune response to C. jejuni, 
demonstrating an increased secretion of the pro-inflammatory cytokine IL-8 in 
response to C. jejuni infection ex vivo (MacCallum et al., 2006). In contrast to 
published data, no increased secretion of IL-8 was detected from tissue co-cultured 
with C. jejuni 11168H and 81-176 wild-type strains. However, co-culturing of the 
tissue with C. jejuni 11168H and 81-176 wild-type strains was demonstrated to lead 
to increased secretion of several other innate immune response markers, including 
human beta-defensins hBD-2 and hB-3. This was the first time that these peptides 
have been demonstrated to be secreted from ex vivo infected tissue, and supports 
previous data demonstrating a role for these pep tides in the intestinal epithelial 
defence against C. jejuni. As primary tissue is difficult to obtain, and initial 
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experiments demonstrated no difference between the two different C. jejuni wild-
type strains with regards to the response elicited from ex vivo infected tissue, it was 
decided to perform further EVOC experiments with only the C. jejuni 11168H wild-
type strain. Evidence was obtained that C. jejuni 11168H wild-type strain induced a 
mixed Thl / Th17 response in the tissue ex vivo, supporting data obtained by 
collaborators at the ICH (Edwards et al., 2010). Furthermore, a 11168HflaA mutant 
lacking the major flagellar filament protein FlaA and a 11168H neuEl mutant 
lacking the sialic acid residue of the LOS were analysed for the induction of hBD-2 
and hBD-3. Both mutants elicited similar levels of secretion of hBD-2 and hBD-3 
from ex vivo cultured human intestinal tissue compared to the C. jejuni 11168H wild-
type strain, suggesting that the presence of the flagellar filament and the sialic acid 
residue are not required for the induction of an hBD-2/hBD-3 response from ex vivo 
co-cultured human intestinal tissue. 
7.3 EVOC model future work 
As discussed at the end of Chapter 3, the EVOC model possesses several limitations 
such as possible strong person-to-person variation, as well as the problem that any 
response detected from the whole tissue cannot easily be attributed to a specific cell 
type within the whole tissue. Fractionation of the tissue followed by individual co-
culturing of the fractions with C. jejuni could be performed to assess the contribution 
of specific cell subsets to the ex vivo response to C. jejuni infection. Furthermore, the 
mounting of the tissue on foam supports followed by inoculation of the bacteria 
straight onto the tissue may result in some bacteria being able to gain access to parts 
of the tissue they would not necessarily be able to in vivo, such as the underlying 
immune cells. Modifying the EVOC model as described in Schuller et al., 2009, 
where the tissue was mounted between two small plastic discs with only the apical, 
epithelial side protruding, may be a way to address this issue. Even though the 
EVOC model cannot be used for high throughput screening, the model should be 
further employed to study C. jejuni-host interactions, as this model offers a closer 
reflection of the situation encountered by the pathogen in vivo regarding the 
complexity of the host tissue encountered. In terms of C. jejuni mutants, bacteria 
deficient in or possessing modified surface structures such as a more truncated WS, 
completely aflagellate mutants such as a 0'54 (rpoN) mutant or mutants possessing 
flagella yet lacking the O-linked glycosylation of the flagellar subunits should be 
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studied using the EVOC model to further investigate the role of C. jejuni surface 
structures in host-pathogen interactions. Another interesting aspect of the EVOC 
model that has not been considered in this study is the microscopical analysis of the 
interaction of different C. jejuni strains and mutants with the tissue, analysing the 
interaction and potentially, tissue- and cell-invasion of the different strains. 
Additionally, as opposed to analysing secreted components of the host immune 
response to the C. jejuni challenge, potential changes of intracellular signalling 
molecules such as signal kinase-cascades should be studied. 
7.4 VDC model summary 
One of the major drawbacks when applying standard in vitro models to study C. 
jejuni is the presence of atmospheric levels of oxygen. The VDC model described in 
Chapters 4-6 uses a Vertical Diffusion Chamber to co-culture C. jejuni with human 
intestinal epithelial cells (lECs). The setup of the model allows for the bacteria to be 
maintained under microaerobic conditions at the apical surface of the IECs, while 
supplying oxygen to the IECs from the basolateral side. This mimics the 
microaerobic/anaerobic environment encountered by C. jejuni in vivo in the human 
intestine more closely that the classical aerobic co-culturing method. A time 
dependent increase in both the numbers of C. jejuni interacting with as well as 
invading the IECs was detected when the bacteria were co-cultured in the VDC 
under microaerobic compared to aerobic conditions. Furthermore, an increased, 
polarised IL-8 response was detected from IECs that had been co-cultured with C. 
jejuni under microaerobic conditions, suggesting that the IECs responded to the 
increased bacterial interaction and invasion. Microarray studies of the gene 
expression of the C. jejuni 11168H wild-type strain co-cultured with IECs in the 
VDC with either aerobic or microaerobic conditions in the apical compartment 
demonstrated only minor differences between the gene expression profiles of C. 
jejuni 11168H co-cultured with IECs in the VDC with either aerobic or microaerobic 
conditions in the apical compartment. No "classical" C. jejuni virulence factors were 
detected to be differentially expressed under the two conditions, suggesting that i: 
other C. jejuni proteins may be involved in modulating the increased interaction with 
and invasion of IECs under micro aerobic conditions, ii: microarray analysis was not 
sensitive enough to detect differences in gene expression or iii: the two time points 
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investigated (6 hand 24 h) were too late to detect important changes In gene 
expression under microaerobic conditions in the VDC. 
Analysis of three defined C. jejuni 11168H mutants suggested that bacterial motility 
was an important factor in the increased interaction and invasion observed under 
microaerobic conditions, as two non-motile mutants demonstrated less of a 
"increased interactive and invasive" phenotype when co-cultured under microaerobic 
conditions, particularly after short co-culturing times. Complementation of one of 
these mutations restored wild-type levels of interaction and invasion. 
7.5 VDC model future work 
From the model perspective, the VDC model has proved to possess some clear 
advantages over aerobic in vitro C. jejuni-IEC co-culturing models. The environment 
created by the VDC more closely mimics the environment encountered by C. jejuni 
in the human intestine, and led to a highly significant increase in numbers of bacteria 
interacting with and invading the IECs compared to control co-culturing experiments 
performed with aerobic conditions in the apical compartment. This will be useful for 
further studies of C. jejuni host-pathogen interactions. One factor that needs to be 
considered when using the VDC model is that the long co-culturing times employed 
for some of the experiments appeared to mask the phenotypes of the 11168H flaA 
and the 11168H rpoN mutants. Whether this is due to the altered autoagglutination 
phenotype of the mutants as discussed in Chapter 6, or per se a limitation of the 
model remains to be elucidated. However, after shorter co-culturing times, the model 
was able to confirm the reduced invasive phenotype of the two non-motile C. jejuni 
mutants studied. Possibly longer co-culturing experiments should be used for 
experiments requiring maximal numbers of interacting and intracellular bacteria, 
while experiments aimed at elucidating differences between C. jejuni strains or 
mutants should be restricted to shorter co-culturing times. Further studies will be 
required to confirm this suggestion. 
Several features regarding the technical/setup side of the VDC model must be 
considered prior to applying the model to study any pathogenic organism. Firstly, the 
IECs must be grown to form an impermeable monolayer on Snapwell™ filters. This 
takes between 14 and 21 days depending on the cell line used and makes the 
experiments fairly lengthy compared to classical co-culturing experiments performed 
in tissue culture plates and using IECs grown for between 1 day and 7 day. On the 
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other hand, only after such a long period of polarisation have the IECs been 
demonstrated to form a fully polarised monolayer. Such polarised monolayers mimic 
the situation in vivo in the human intestinal epithelium much more closely than the 
non-polarised, non-confluent IEC lines used in some studies, and as such provide 
another advantage of the VDC model. Secondly, the Snapwell™ filters are 
significantly more expensive, with one filter (Le. one experimental replicate) costing 
about £4 compared to approximately £1 for a 24-well tissue culture plate (up to 24 
experimental replicates or approximately £0.04 per replicate). The main limitation of 
the VDC, however, is the relatively low throughput. This is mainly due to the 
availability of VDC chambers and the setup requiring the gas manifold. As such, 
only relatively low numbers of parallel replicates could be performed in this study, in 
contrast to the classical tissue culture method, where one or more 24-well or even 
96-well plates of IECs can be simultaneously co-cultured with a pathogen. The 
model is therefore less suitable for large-scale screening experiments or experiments 
requiring a high number of replicates. Therefore, while the model is better than the 
classical, aerobic tissue-culture method due to the more closely mimicked in vivo 
situation, especially for bacteria such as C. jejuni that have a stringent atmospheric 
requirement, the model still has certain limitations that need to be taken into account 
when designing experiments. 
The model has proven feasible for studying C. jejuni interactions with IECs, but still 
has certain limitations such as low throughput, and being relatively expensive and 
laborious compared to classical co-culturing methods. Further investigation should 
include a more detailed analysis of gene transcription of C. jejuni co-cultured under 
both atmospheric conditions by high-throughput mRNA sequencing (RNASeq). This 
will give a better understanding of the effects of co-culturing than the data obtained 
using microarrays. However, the limitation will still be the low quantities of RNA 
available from the co-culturing experiments; pooling of several samples from 
different VDCs might address this. Whilst the relatively low throughput of the VDC 
model limits the potential for high throughput screening experiments, it would still 
be interesting to assess further C. jejuni wild-type strains and mutants using the VDC 
model, especially if data obtained by RNASeq highlighted any novel, 
uncharacterised genes as being involved in the increased interaction and invasion. As 
more intracellular C. jejuni were recovered after microaerobic co-culturing with the 
IECs, the numbers of intracellular bacteria may be sufficient to isolate enough 
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mRNA for microarray or RNASeq analysis of the intracellular bacteria. Furthermore, 
the intracellular fate of C. jejuni could be studied by microscopy using markers for 
different endosomal pathways, a method that was previously hampered by the low 
numbers of intracellular C. jejuni in the classical co-culturing model. 
The effect of the increase in interacting and intracellular C. jejuni on the IECs should 
be investigated in more detail. Analysis of the effect of the bacteria on intracellular 
kinase cascades should be assessed. Additionally, a multiplex ELISA should be used 
to analyse the host innate immune response with regards to further cytokines or 
defensin peptides. Alternatively, as the levels of cytokines or defensin peptides 
secreted by the IECs may be below the detection limit of an ELISA method, the 
transcriptional activity of genes related to the innate immune response should be 
analysed either by microarray or even by RNASeq. 
Combining the two models by setting up human intestinal tissue in the VDC with 
micro aerobic conditions in the apical compartment was contemplated, however, 
problems with the tissue integrity of the whole biopsy under these experimental 
conditions were anticipated (Keith Lindley and Stephanie Schiiller, personal 
communications), and in light of i: the difficulty of obtaining human intestinal tissue 
and ii: the relative low throughput of both the models, this setup was not pursued. 
However, further investigation into this setup would certainly be merited. 
Taken together, the work presented in this thesis describes the development of two 
models for studying the host-pathogen interactions of C. jejuni. Both models aimed 
to create an environment more closely mimicking the environment encountered by 
C. jejuni in vivo in the human intestine. The EVOC model demonstrated for the first 
time that infection of human intestinal tissue ex vivo with C. jejuni led to the 
secretion of hBD-2 and hBD-3. Additionally, the model demonstrated for the first 
time that infection of human intestinal tissue ex vivo with C. jejuni led to the 
development of a Th-1/Th-17 response. The VDC model demonstrated that co-
culturing of IECs with C. jejuni in the VDC with microaerobic conditions in the 
apical compartment lead to a highly significant increase of both interacting and 
intracellular bacteria. The VDC model also demonstrated an increased, polarised 
innate immune response by the IECs. Further studies using these two models will 
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shed new light onto the hitherto relatively elusive molecular pathogenesis 
mechanisms of the world's most prevalent foodborne pathogen, C. jejuni. 
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8 Appendices 
8.1. Appendix I: C.jejuni 11168H genes identified by microarray 
analysis to be up-regulated after 6 h of co-culturing with Caco-
2 IECs in the VDC with microaerobic conditions in the apical 
compartment 
ORFnumber Normalised data Re-annotation 
Cj151Jc 2.3 fdhA putative formate dehydrogenase large subunit 
Cj1705c 2.0 
binds third domain of 23S rRNA and protein L29; part of 
exit tunnel 
Cj1J86c 2.0 
petA putative ubiquinol-cytochrome C reductase 
iron-sulfur subunit 
Cj1325 1.9 putative methyltransferase 
Cj0347 1.9 rpF N-(5'-phosphoribosyl) anthranilate isomerase 
Cj0414 1.8 putative oxidoreductase subunit 
Cj0473 1.7 nusG transcription antitermination protein NusG 
Cj0207 1.6 translation initiation factor IF-3 
Cj1591 1.6 50S ribosomal protein L36 
Cj0330c 1.6 50S ribosomal protein L32 
Cj1439c 1.6 glfUDP-galactopyranose mutase part of the capsule locus 
Cj0859c 1.6 hypothetical protein 
Cj1267c 1.6 hydA NilFe-hydro.e:enase small chain 
Cj0581 1.5 dinucleoside polyphosphate hydrolase 
Cj0329c 1.5 putative glycerol-3-phosphate acyltransferase PlsX 
Cjl027c 1.5 gyrA DNA .e:vrase subunit A 
CjOOO7 1.5 gltB glutamate synthase lar.e:e subunit 
Cjl028c 1.5 putative purine/pyrimidine phosphoribosyltransferase 
Cj0397c 1.5 hypothetical protein 
Cj0519 1.5 putative rhodanese-like domain protein 
Cj0995c 1.5 hemB delta-arninolevulinic acid dehydratase 
Cj0802 1.5 cysteinyl-tRNA synthetase 
Cj0315 1.5 putative HAD-superfamily hydrolase 
Cj0398 1.4 gatC asparty1!glutamyl-tRNA amidotransferase subunit C 
Cj0462 1.4 hypothetical protein 
Cj1223c 1.4 deeR two-component response regulator 
CjlJ72c 1.4 hypothetical protein 
Cj0953c 1.4 urH de novo purine biosynthesis 
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Cj0961c 1.4 50S ribosomal protein L34 
CjOO92 1.4 putative periplasmicprotein 
Cj0789 1.4 cca putative multifunctional Cca protein RNA synthesis 
Cj1621 1.3 putative periplasmic protein 
CjD271 1.3 bacterioferritin comigratory protein homolog 
Cj0348 1.3 trpB trYQtophan synthase subunit beta 
Cj0320 1.3 fliH flagellar assembly protein H 
Cj0146c 1.3 trxB thioredoxin reductase 
Cj0498 1.3 trpC indole-3-glycerol-phosphate synthase 
Cj0237 1.3 cynT carbonic anyhydrase 
Cj0976 1.3 putative methyltransferase 
Cj0891c 1.2 serA D-3-phosphoglycerate dehydrogenase 
Cj0934c 1.2 putative sodium:amino-acid symporter family protein 
CjOO55c 1.2 hypothetical protein 
Cj0552 1.2 hydrophobic protein 
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8.2 Appendix ll: C.jejuni 11168H genes identified by micro array 
analysis to be down-regulated after 6 h of co-culturing with 
Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment 
ORFnumber Normalised data Re-annotation 
Cj0304c 1.3 bioC putative biotin synthesis protein 
Ci0522 1.3 putative Na+/Pi cotransporter protein 
Ci1634c 1.3 chorismate synthase 
Cj041 0 1.4 fumarate reductase iron-sulfur protein 
Cj0486 1.4 possible L-fucose symporter 
Cj0303c 1.4 modA putative molybdate-binding lipoprotein 
Ci1666c 1.4 putative periplasmic protein 
Ci0988c 1.5 very hypothetical protein 
Cj1079 1.5 putative periplasmic protein 
Cj1l34 1.5 htrB lipid A biosynthesis lauroyl acyltransferase 
Ci0728 1.6 putative periplasmic protein 
Ci0590 1.6 putative SAM-dependent methyltransferase 
Cj0737 1.6 
putative hemagglutination activity domain-containing 
protein 
Cj0560 1.7 putative MATE family transport protein 
Ci1521c 1.7 putative CRISPR-associated protein 
Ci0290c 1.8 pseudogene (partial J{ipn 
Cj1581c 1.9 putative peptide ABC transporter ATP-binding protein 
Ci0302c 2.0 putative molybdenum-pterin binding protein 
Ci0141c 2.0 putative ABC transporter integral membrane protein 
Ci0422c 2.0 putative H-T-H containing protein 
Ci1378 2.2 seLA selenocysteine svnthase 
Cj1352 2.3 ceuB enterochelin uptake permease 
Ci1629 2.5 exbD2 putative exbD/tolR family transport protein 
Cj1393 2.6 metC' putative cystathionine beta-lyase 
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8.3 Appendix III: C.jejuni 11168H genes identified by microarray 
analysis to be upregulated after 24 h of co-culturing with Caco-
2 IECs in the VDC with microaerobic conditions in the apical 
compartment 
ORFnumber Normalised data Re-annotation 
Cj1325 2.8 putative methyltransferase 
Cj1176c 2.2 tatA Sec-independent protein translocase 
Cj0985c 2.1 hipO hippurate hydrolase 
CjOO73c 2.1 hypothetical protein 
Cj0922c 2.1 
pebC amino-acid ABC transporter ATP-binding 
protein 
Cj1326 2.0 hypothetical protein 
Cj0347 2.0 trpF N-{5'-phosphoribosyl)anthranilate isomerase 
Ci0592c 1.9 putative periplasmic protein 
Ci0920c 1.9 putative ABC-type amino-acid transporter permease 
Cj0628 1.8 putative lipoprotein 
Cj0127c 1.8 aceD acetyl-CoA carboxylase subunit beta 
Cj1558 1.8 hypothetical protein 
Cj1273c 1.8 
rpoZ DNA-directed RNA polymerase subunit 
omega 
Cj0346 1.6 trpD anthranilate synthase component II 
Cjl172c 1.6 hypothetical protein 
Cj1668c 1.6 putative periplasmic protein 
Cj1560 1.6 pseudogene 
Cj0802 1.6 cysS cysteinyl-tRNA synthetase 
Cj0813 1.6 
kdsB 3-deoxy-manno-octulosonate cytidylyl-
transferase 
Cj0459c 1.6 hypothetical protein 
CjOO29 1.6 ansA cytoplasmic L-asparaginase 
Cj1321 1.6 putative transferase LSO 
Cj1193c 1.6 putative periplasmic protein 
Cj0152c 1.6 hypothetical protein 
Cj1345c 1.5 putative periplasmic protein 
Cj0244 1.5 rpm! 50S ribosomal protein 135 
Cj1186c 1.5 
petA putative ubiquinol-cytochrome C reductase 
iron-sulfur subunit 
Cj1639 1.5 NifU protein 
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Cj1503c 1.5 
putA putative / b.-l-pyrroline-5-carboxylate 
dehydrogenase 
Cj1705c 1.5 50S ribosomal protein L23 
Cj0960c 1.5 putative ribonuclease P protein component 
Cj0330c 1.5 50S ribosomal protein L32 
Cj0898 1.5 putative histidine triad (HIT) family protein 
Cj1603 1.5 
hisF imidazole glycerol phosphate synthase 
subunit HisF 
Cj1681c 1.5 cysQ CvsQ protein 
Cj0685c 1.5 cipA invasion protein CipA 
CjOO92 1.4 putative periplasmic protein 
Cj1616 1.4 
chuC putative hemin uptake system ATP-binding 
protein 
Ci0912c 1.4 cysM cysteine synthase 
Cj1207c 1.4 putative lipoprotein thiredoxin 
Cj0771c 1.4 putative NLP A family lipoprotein 
Cj0129c 1.4 outer membrane protein 
CjOO70c 1.4 hypothetical protein 
Ci1719c 1.4 euA 2-isopropylmalate synthase 
Cj0371 1.4 hypothetical protein 
Cj0234c 1.4 frr ribosome recycling factor 
Cj0507 1.4 rnafMaf-like protein 
Cj1541 1.4 LamB/ycsF family protein 
Cj0979c 1.4 putative secreted nuclease 
Cj0362 1.3 putative integral membrane protein 
Cj0914c 1.3 CiaB protein 
CiOO89 1.3 putative lipoprotein 
Cj1537c 1.3 acs acetyl-CoA synthetase 
Cj0407 1.3 I~t prolipoprotein diacybdyceryl transferase 
Cj0290c 1.3 pseudogene 
Cj0489 1.3 aid' putative aldehyde dehydrogenase N-terminus 
Cj0424 1.3 putative acidic periplasmic protein 
Cj1508c 1.3 fdhD formate dehydrogenase accessory protein 
Cj1543 1.3 putative allophanate hydrolase subunit 2 
Cj0854c 1.3 putative periplasmic protein 
Cj0466 1.3 nssR transcriptional regulator 
Cj0473 1.3 nusG transcription antitermination protein NusG 
Cj0682 1.2 hypothetical protein 
Cj1115c 1.2 putative phosphatidylserine decarboxylase-related protein 
CjOO68 1.2 pspA protease 
Cj1254 1.2 hypothetical protein 
CjOO99 1.2 birA biotin--protein ligase 
Cj0808c 1.2 hypothetical protein 
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Cj0408 1.2 frdC fumarate reductase cytochrome b-556 subunit 
Cj0460 1.2 nusA transcription elongation factor NusA 
Cj1504c 1.2 seW putative selenide, water dikinase 
Cj0734c 1.1 his.! histidine-binding protein precursor 
Cj0306c 1.1 bioF 8-amino-7 -oxononanoate synthase 
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8.4 Appendix IV: C.jejuni 11168H genes identified by microarray 
analysis to be down-regulated after 24 h of co-culturing with 
Caco-2 IECs in the VDC with microaerobic conditions in the 
apical compartment 
ORFnumber Normalised data Re-annotation 
Cj1680c 1.1 putative periplasmic protein 
Cj1447c 1.1 kpsT capsule polysaccharide export ATP-binding protein 
Cj0642 1.2 recN putative DNA repair protein 
Cj0843c 1.1 putative secreted transglycosylase 
Cj1234 1.1 1(iyS glycyl-tRNA synthetase subunit bet 
Cj0847 1.1 vsd phosphatidylserine decarboxylase 
Cj1241 1.1 putative MFS transport protein arabinose efflux 
CiJ040c 1.2 putative MFS transport protein cyanate transport 
Ci1484c 1.2 putative membrane protein 
Cj1600 1.2 hisH imidazole glycerol phosphate synthase subunit HisH 
Cj0272 1.2 hypothetical protein 
Cj0343c 1.2 putative integral membrane protein 
Cj0238 1.2 putative mechanosensitive ion channel family protein 
Cj0652 1.2 pbvC penicillin-binding protein 
Cj0574 1.2 ilvI acetolactate synthase 3 catalytic subunit 
Cj0319 1.2 JfiG fla~el1ar motor switch protein G 
Cj1655c 1.2 nhaAl Na( + )/H( +) antiporter 
Cj0720c 1.2 !laC flagellin 
Cj0850c 1.3 putative MFS transport protein Su~ar transporter 
Cj0265c 1.3 
putative cytochrome C-type haem-binding periplasmic 
protein 
Cj0849c 1.3 hvpotheticalprotein 
Cj0549 1.3 (liS fla~el1ar protein FliS 
Cj1294 1.3 vseC C4 aminotransferase 
Cj0453 1.3 thiC thiamine biosynthesis protein ThiC 
Cj0931c 1.3 ar1(H argininosuccinate lyase 
Cj0174c 1.3 cfbvB putative iron-uptake ABC transporter permease 
Cj0241c 1.3 putative iron-binding protein 
Cj1440c 1.3 putative sugar transferase capsule locus 
Cj0846 1.3 putative metallophosphoesterase 
Cj0293 1.3 surE stationary phase survival protein SurE 
Cj1685c 1.4 bioB biotin synthase 
Cj1669c 1.4 DNA ligase 
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Cj1686c 1.4 topA DNA topoisomerase I 
Cj1277c 1.4 putative ABC transporter ATP-bindinJ:!; protein 
Cj1555c 1.4 hypothetical protein 
Ci0263 1.4 zupT zinc transporter ZupT 
CiOO53c 1.4 mnmA tRNA-specific 2-thiouridylase MnrnA 
Cj1425c 1.5 
hddA putative D-glycero-D-manno-heptose 7-phosphate 
kinase capsule locus 
CiOO81 1.5 cydA cytochrome bd oxidase subunit I 
Ci1119c 1.5 p~IG putative integral membrane protein 
Cj0316 1.5 pheA chorismate mutase/prephenate dehydratase 
CilO85c 1.6 mid transcription-repair coupling factor 
Cj1224 1.6 putative iron-binding protein 
Ci0303c 1.6 modA putative molybdate-binding l~oprotein 
Cj0456c 1.6 hypothetical protein 
Ci1l38 1.6 putative glycosyltransferase LOS 
Ci0439 1.6 dhC putative succinate dehydrogenase subunit C 
Ci1098 1.7 pyrB aspartate carbamoyltransferase catalytic subunit 
Ci01l1 1.7 periplasmic protein 
Cj1529c 1.7 purM phosphoribosylaminoimidazole synthetase 
CjOO82 1.7 cydB cytochrome bd oxidase subunit II 
Ci0480c 1.7 H-T-H motif 
Cj0437 1.7 sdhA succinate dehydrogenase flavoprotein subunit 
Cj0198c 1.7 recombination factor protein RarA 
Ci0501 1.8 pseudo 
CjOO32 1.9 
putative type lIS restriction Imodification enzyme, 
C-terminal half 
Cj1l70c 2.1 omp50 50 kda outer membrane protein precursor 
CjOO17c 2.4 dsbI disulphide bond formation protein 
Cj0799c 2.9 ruvA Holliday junction DNA helicase Ruv A 
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